Z94.4-11 Selection, use, and care of respirators Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Legal Notice for Standards Canadian Standards Association (CSA) standards are developed through a consensus standards development process approved by the Standards Council of Canada. This process brings together volunteers representing varied viewpoints and interests to achieve consensus and develop a standard. Although CSA administers the process and establishes rules to promote fairness in achieving consensus, it does not independently test, evaluate, or verify the content of standards. Disclaimer and exclusion of liability This document is provided without any representations, warranties, or conditions of any kind, express or implied, including, without limitation, implied warranties or conditions concerning this document’s fitness for a particular purpose or use, its merchantability, or its non-infringement of any third party’s intellectual property rights. CSA does not warrant the accuracy, completeness, or currency of any of the information published in this document. CSA makes no representations or warranties regarding this document’s compliance with any applicable statute, rule, or regulation. IN NO EVENT SHALL CSA, ITS VOLUNTEERS, MEMBERS, SUBSIDIARIES, OR AFFILIATED COMPANIES, OR THEIR EMPLOYEES, DIRECTORS, OR OFFICERS, BE LIABLE FOR ANY DIRECT, INDIRECT, OR INCIDENTAL DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES, HOWSOEVER CAUSED, INCLUDING BUT NOT LIMITED TO SPECIAL OR CONSEQUENTIAL DAMAGES, LOST REVENUE, BUSINESS INTERRUPTION, LOST OR DAMAGED DATA, OR ANY OTHER COMMERCIAL OR ECONOMIC LOSS, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR ANY OTHER THEORY OF LIABILITY, ARISING OUT OF OR RESULTING FROM ACCESS TO OR POSSESSION OR USE OF THIS DOCUMENT, EVEN IF CSA HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES. In publishing and making this document available, CSA is not undertaking to render professional or other services for or on behalf of any person or entity or to perform any duty owed by any person or entity to another person or entity. The information in this document is directed to those who have the appropriate degree of experience to use and apply its contents, and CSA accepts no responsibility whatsoever arising in any way from any and all use of or reliance on the information contained in this document. CSA is a private not-for-profit company that publishes voluntary standards and related documents. CSA has no power, nor does it undertake, to enforce compliance with the contents of the standards or other documents it publishes. Intellectual property rights and ownership As between CSA and the users of this document (whether it be in printed or electronic form), CSA is the owner, or the authorized licensee, of all works contained herein that are protected by copyright, all trade-marks (except as otherwise noted to the contrary), and all inventions and trade secrets that may be contained in this document, whether or not such inventions and trade secrets are protected by patents and applications for patents. Without limitation, the unauthorized use, modification, copying, or disclosure of this document may violate laws that protect CSA’s and/or others’ intellectual property and may give rise to a right in CSA and/or others to seek legal redress for such use, modification, copying, or disclosure. To the extent permitted by licence or by law, CSA reserves all intellectual property rights in this document. Patent rights Attention is drawn to the possibility that some of the elements of this standard may be the subject of patent rights. CSA shall not be held responsible for identifying any or all such patent rights. Users of this standard are expressly advised that determination of the validity of any such patent rights is entirely their own responsibility. Authorized use of this document This document is being provided by CSA for informational and non-commercial use only. The user of this document is authorized to do only the following: If this document is in electronic form: load this document onto a computer for the sole purpose of reviewing it; search and browse this document; and print this document if it is in PDF format. . . . Limited copies of this document in print or paper form may be distributed only to persons who are authorized by CSA to have such copies, and only if this Legal Notice appears on each such copy. In addition, users may not and may not permit others to alter this document in any way or remove this Legal Notice from the attached standard; sell this document without authorization from CSA; or make an electronic copy of this document. . . . If you do not agree with any of the terms and conditions contained in this Legal Notice, you may not load or use this document or make any copies of the contents hereof, and if you do make such copies, you are required to destroy them immediately. Use of this document constitutes your acceptance of the terms and conditions of this Legal Notice. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Update No. 1 Z94.4-11 May 2012 Note: General Instructions for CSA Standards are now called Updates. Please contact CSA Information Products Sales or visit shop.csa.ca for information about the CSA Standards Update Service. Title: Selection, use, and care of respirators — originally published August 2011 The following revisions have been formally approved: • • Revised Outside front cover and title page New National Standards of Canada text Deleted None Update your copy by inserting these revised pages. Keep the pages you remove for reference. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. CAN/CSA-Z94.4-11 A National Standard of Canada (approved May 2012) Selection, use, and care of respirators Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Legal Notice for Standards Canadian Standards Association (CSA) standards are developed through a consensus standards development process approved by the Standards Council of Canada. This process brings together volunteers representing varied viewpoints and interests to achieve consensus and develop a standard. Although CSA administers the process and establishes rules to promote fairness in achieving consensus, it does not independently test, evaluate, or verify the content of standards. Disclaimer and exclusion of liability This document is provided without any representations, warranties, or conditions of any kind, express or implied, including, without limitation, implied warranties or conditions concerning this document’s fitness for a particular purpose or use, its merchantability, or its non-infringement of any third party’s intellectual property rights. CSA does not warrant the accuracy, completeness, or currency of any of the information published in this document. CSA makes no representations or warranties regarding this document’s compliance with any applicable statute, rule, or regulation. IN NO EVENT SHALL CSA, ITS VOLUNTEERS, MEMBERS, SUBSIDIARIES, OR AFFILIATED COMPANIES, OR THEIR EMPLOYEES, DIRECTORS, OR OFFICERS, BE LIABLE FOR ANY DIRECT, INDIRECT, OR INCIDENTAL DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES, HOWSOEVER CAUSED, INCLUDING BUT NOT LIMITED TO SPECIAL OR CONSEQUENTIAL DAMAGES, LOST REVENUE, BUSINESS INTERRUPTION, LOST OR DAMAGED DATA, OR ANY OTHER COMMERCIAL OR ECONOMIC LOSS, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE), OR ANY OTHER THEORY OF LIABILITY, ARISING OUT OF OR RESULTING FROM ACCESS TO OR POSSESSION OR USE OF THIS DOCUMENT, EVEN IF CSA HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INJURY, LOSS, COSTS, OR EXPENSES. In publishing and making this document available, CSA is not undertaking to render professional or other services for or on behalf of any person or entity or to perform any duty owed by any person or entity to another person or entity. The information in this document is directed to those who have the appropriate degree of experience to use and apply its contents, and CSA accepts no responsibility whatsoever arising in any way from any and all use of or reliance on the information contained in this document. CSA is a private not-for-profit company that publishes voluntary standards and related documents. CSA has no power, nor does it undertake, to enforce compliance with the contents of the standards or other documents it publishes. Intellectual property rights and ownership As between CSA and the users of this document (whether it be in printed or electronic form), CSA is the owner, or the authorized licensee, of all works contained herein that are protected by copyright, all trade-marks (except as otherwise noted to the contrary), and all inventions and trade secrets that may be contained in this document, whether or not such inventions and trade secrets are protected by patents and applications for patents. Without limitation, the unauthorized use, modification, copying, or disclosure of this document may violate laws that protect CSA’s and/or others’ intellectual property and may give rise to a right in CSA and/or others to seek legal redress for such use, modification, copying, or disclosure. To the extent permitted by licence or by law, CSA reserves all intellectual property rights in this document. Patent rights Attention is drawn to the possibility that some of the elements of this standard may be the subject of patent rights. CSA shall not be held responsible for identifying any or all such patent rights. Users of this standard are expressly advised that determination of the validity of any such patent rights is entirely their own responsibility. Authorized use of this document This document is being provided by CSA for informational and non-commercial use only. The user of this document is authorized to do only the following: If this document is in electronic form: load this document onto a computer for the sole purpose of reviewing it; search and browse this document; and print this document if it is in PDF format. . . . Limited copies of this document in print or paper form may be distributed only to persons who are authorized by CSA to have such copies, and only if this Legal Notice appears on each such copy. In addition, users may not and may not permit others to alter this document in any way or remove this Legal Notice from the attached standard; sell this document without authorization from CSA; or make an electronic copy of this document. . . . If you do not agree with any of the terms and conditions contained in this Legal Notice, you may not load or use this document or make any copies of the contents hereof, and if you do make such copies, you are required to destroy them immediately. Use of this document constitutes your acceptance of the terms and conditions of this Legal Notice. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. The Canadian Standards Association (CSA), under whose auspices this National Standard has been produced, was chartered in 1919 and accredited by the Standards Council of Canada to the National Standards system in 1973. It is a not-for-profit, nonstatutory, voluntary membership association engaged in standards development and certification activities. CSA standards reflect a national consensus of producers and users — including manufacturers, consumers, retailers, unions and professional organizations, and governmental agencies. The standards are used widely by industry and commerce and often adopted by municipal, provincial, and federal governments in their regulations, particularly in the fields of health, safety, building and construction, and the environment. Individuals, companies, and associations across Canada indicate their support for CSA’s standards development by volunteering their time and skills to CSA Committee work and supporting the Association’s objectives through sustaining memberships. The more than 7000 committee volunteers and the 2000 sustaining memberships together form CSA’s total membership from which its Directors are chosen. Sustaining memberships represent a major source of income for CSA’s standards development activities. The Association offers certification and testing services in support of and as an extension to its standards development activities. To ensure the integrity of its certification process, the Association regularly and continually audits and inspects products that bear the CSA Mark. In addition to its head office and laboratory complex in Toronto, CSA has regional branch offices in major centres across Canada and inspection and testing agencies in eight countries. Since 1919, the Association has developed the necessary expertise to meet its corporate mission: CSA is an independent service organization whose mission is to provide an open and effective forum for activities facilitating the exchange of goods and services through the use of standards, certification and related services to meet national and international needs. For further information on CSA services, write to Canadian Standards Association 5060 Spectrum Way, Suite 100 Mississauga, Ontario, L4W 5N6 Canada The Standards Council of Canada (SCC) is the coordinating body of the National Standards System, a coalition of independent, autonomous organizations working towards the further development and improvement of voluntary standardization in the national interest. The principal objects of the SCC are to foster and promote voluntary standardization as a means of advancing the national economy, benefiting the health, safety, and welfare of the public, assisting and protecting the consumer, facilitating domestic and international trade, and furthering international cooperation in the field of standards. A National Standard of Canada (NSC) is a standard prepared or reviewed by an accredited Standards Development Organization (SDO) and approved by the SCC according to the requirements of CAN-P-2. Approval does not refer to the technical content of the standard; this remains the continuing responsibility of the SDO. An NSC reflects a consensus of a number of capable individuals whose collective interests provide, to the greatest practicable extent, a balance of representation of general interests, producers, regulators, users (including consumers), and others with relevant interests, as may be appropriate to the subject in hand. It normally is a standard which is capable of making a significant and timely contribution to the national interest. Those who have a need to apply standards are encouraged to use NSCs. These standards are subject to periodic review. Users of NSCs are cautioned to obtain the latest edition from the SDO which publishes the standard. The responsibility for approving standards as National Standards of Canada rests with the Standards Council of Canada 270 Albert Street, Suite 200 Ottawa, Ontario, K1P 6N7 Canada Cette Norme nationale du Canada est offerte en anglais et en français. Although the intended primary application of this Standard is stated in its Scope, it is important to note that it remains the responsibility of the users to judge its suitability for their particular purpose. ®Registered trade-mark of Canadian Standards Association (National Standards of Canada text inserted May 2012) Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. National Standard of Canada (approved May 2012) CAN/CSA-Z94.4-11 Selection, use, and care of respirators Prepared by Approved by Standards Council of Canada Published in August 2011 by Canadian Standards Association A not-for-profit private sector organization 5060 Spectrum Way, Suite 100, Mississauga, Ontario, Canada L4W 5N6 1-800-463-6727 • 416-747-4044 Visit our Online Store at shop.csa.ca Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 100% The Canadian Standards Association (CSA) prints its publications on Rolland Enviro100, which contains 100% recycled post-consumer fibre, is EcoLogo and Processed Chlorine Free certified, and was manufactured using biogas energy. To purchase CSA Standards and related publications, visit CSA’s Online Store at shop.csa.ca or call toll-free 1-800-463-6727 or 416-747-4044. ISBN 978-1-55491-684-9 © Canadian Standards Association — 2011 All rights reserved. No part of this publication may be reproduced in any form whatsoever without the prior permission of the publisher. (Copyright page replaced May 2012) Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. CSA Standards Update Service Z94.4-11 August 2011 Title: Selection, use, and care of respirators Pagination: 111 pages (ix preliminary and 102 text), each dated August 2011 To register for e-mail notification about any updates to this publication • go to www.ShopCSA.ca • click on E-mail Services under MY ACCOUNT • click on CSA Standards Update Service The List ID that you will need to register for updates to this publication is 2421329. If you require assistance, please e-mail [email protected] or call 416-747-2233. Visit CSA’s policy on privacy at www.csagroup.org/legal to find out how we protect your personal information. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. CSA Standard Z94.4-11 Selection, use, and care of respirators Published in August 2011 by Canadian Standards Association A not-for-profit private sector organization 5060 Spectrum Way, Suite 100, Mississauga, Ontario, Canada L4W 5N6 1-800-463-6727 • 416-747-4044 Visit our Online Store at www.ShopCSA.ca Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 100% The Canadian Standards Association (CSA) prints its publications on Rolland Enviro100, which contains 100% recycled post-consumer fibre, is EcoLogo and Processed Chlorine Free certified, and was manufactured using biogas energy. To purchase CSA Standards and related publications, visit CSA’s Online Store at www.ShopCSA.ca or call toll-free 1-800-463-6727 or 416-747-4044. ISBN 978-1-55491-684-9 © Canadian Standards Association — 2011 All rights reserved. No part of this publication may be reproduced in any form whatsoever without the prior permission of the publisher. Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. © Canadian Standards Association Selection, use, and care of respirators Contents Technical Committee on Selection, Use, and Care of Respirators vi Preface viii 1 Scope 1 2 Reference publications 2 3 Definitions 3 4 Respiratory protection program 8 4.1 General 8 4.2 Employer responsibility 8 4.2.3 Program roles 8 4.3 Program components 9 5 Roles and responsibilities 9 5.1 Program administrator 9 5.2 Respirator users 10 5.3 Supervisor 10 Person selecting respirators 10 5.4 5.5 Respirator fit tester 11 5.6 Issuer of respirators 11 5.7 Respirator maintenance personnel 11 5.8 Health care professional 11 6 Hazard assessment 11 6.1 General 11 6.2 Steps in hazard assessment for non-bioaerosol workplace contaminants 12 6.2.1 Determination of hazard 12 6.2.2 Identification of contaminants 12 6.2.3 Identification of physical state 12 6.2.4 Measurement or estimation of concentrations 12 6.2.5 Determination of oxygen level 13 6.2.6 Identification of occupational exposure limits 13 6.2.7 Determination of the existence of an IDLH atmosphere 13 6.2.8 Determination of an applicable substance-specific standard 13 6.2.9 Determination of the presence of oil 13 6.2.10 Determination of skin or eye absorption and irritation characteristics 13 6.3 Monitoring respiratory hazards 13 7 Respirator selection 14 7.1 General 14 Classification of respirators 14 7.2 7.2.3 Supplied-air suits 14 7.2.4 Escape respirators 15 7.3 Selection procedures 15 7.3.1 General 15 7.3.2 Respirator selection for protection against bioaerosols 15 7.3.3 Respirator selection for protection against non-bioaerosol workplace contaminants 18 7.3.4 Using the respirator selection flow chart 18 August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. iii Z94.4-11 © Canadian Standards Association 8 Training 26 8.1 Competencies 26 8.1.1 General 26 8.1.2 Respirator selection process 26 8.1.3 Respirator user screening and medical assessment 26 8.1.4 Fit testing 26 8.1.5 Instruction 26 8.1.6 Care and practical use 27 8.1.7 Limitations 27 8.1.8 Repair and maintenance 27 8.2 Provision of training 27 Training records 28 8.3 9 Respirator fit testing 28 9.1 General 28 9.2 Respirator interference concerns 29 9.2.1 General 29 9.2.2 Facial hair 29 9.2.3 Personal conditions 29 9.2.4 Personal effects or accessories 30 9.2.5 PPE integration 30 9.3 Pass criteria 30 9.4 Qualitative fit testing (QLFT) 30 9.5 Quantitative fit testing (QNFT) 31 9.6 Fit test records 31 10 Use of respirators 31 10.1 General 31 10.1.1 User requirements 31 10.1.2 Breakthrough detection 31 10.1.3 Tight-fitting respirator seal with skin 31 10.1.4 User seal check of face-to-facepiece seal 32 10.2 Change-out procedures, schedules, and service time 32 10.2.1 General 32 10.2.2 Gas/vapour-removing cartridges or canisters 32 10.3 Breathing gas 33 10.4 Communications 34 10.5 Buddy breathing 34 10.6 Special requirements for general industrial use 34 10.6.1 Use in high- and low-temperature environments 34 10.6.2 Use of respirators in IDLH atmospheres 34 11 Cleaning, inspection, maintenance, and storage of respirators 34 11.1 General 34 11.2 Cleaning and sanitizing 35 11.3 Inspection 35 11.3.1 General 35 11.3.2 Inspection coverage 35 11.3.3 Inspection of SCBA cylinders 36 11.4 Repair and test 37 11.5 Storage 37 11.5.4 Storage of cylinders not in current use 37 11.5.5 Rotation of cylinders in current use 38 11.6 Hydrostatic testing and marking of SCBA cylinders 38 iv Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association 11.6.1 11.6.2 11.6.3 11.7 Selection, use, and care of respirators General 38 Hydrostatic test 38 Cylinder markings 38 Filling of cylinders 39 12 Health surveillance 39 13 Program evaluation 40 13.1 General 40 14 Recordkeeping 40 14.1 General 40 14.2 Records of hazard assessments 41 14.3 Records of respirator selection 41 14.4 Records of respirator fit testing 41 14.5 Records of training 41 14.6 Records of inspection, maintenance, and storage 41 14.6.1 General 41 14.6.2 Inspection records for emergency-use SCBA 42 14.7 Records of health surveillance 42 14.8 Records of program evaluations 42 Annexes A (informative) B (mandatory) C (mandatory) D (informative) E (informative) F (informative) G (informative) H (informative) I (informative) J (informative) K (informative) L (informative) M(informative) N (informative) — — — — — — — — — — — — — — User seal checks 46 Qualitative respirator fit tests (QLFT) 48 Quantitative respirator fit tests (QNFT) 58 Use of SCBA in low-temperature environments 65 Health surveillance 70 Procedures for cleaning and sanitizing respirators 73 Respirator classification, characteristics, and limitations 74 Reduced oxygen concentration 82 Buddy breathing 84 Checklist of competency for respirator fit testers 86 Scenarios using selection wheels in Figures 2 and 3 88 Classification of biohazardous agents by risk group 92 Illustrations of acceptable and unacceptable facial hair for tight-fitting respirators 99 Additional guidance for qualified persons on respirator selection in health care environments 101 Tables 1 — Applicable qualitative fit test (QLFT) methods and pass criteria for tight-fitting respirators 43 2 — Applicable quantitative fit test (QNFT) methods and pass criteria for tight-fitting respirators 44 3 — Summary of training matrix 45 Figures 1 — Respirator selection flow chart 21 2 — Control banding approach for bioaerosols in health care facilities 23 3 — Control banding approach for bioaerosols in general workplace environments 24 4 — Hierarchy of respiratory protection 25 August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. v Z94.4-11 © Canadian Standards Association Technical Committee on Selection, Use, and Care of Respirators T. Mehes T.I.M. Enterprises Limited, Sudbury, Ontario K. Armstrong Draeger Safety Canada Limited, Mississauga, Ontario B. Borst 3M Canada Company, London, Ontario N. Brochu Air Liquide Canada Inc., Montréal, Québec Representing Compressed Gas Association D. Brown Ontario Ministry of Labour, Toronto, Ontario B. Cliffe Maxxam Analytics Inc., Mississauga, Ontario A. Cutz Occupational Hygiene Association of Ontario, Toronto, Ontario J. Dastous Ce/Ci Training and Services Inc., Rosemère, Québec K. DeFalco Public Health Agency of Canada, Ottawa, Ontario P. Ficzycz Pallas Athene Consulting Inc., Port Moody, British Columbia M. Gagné Commission de la santé et de la sécurité du travail du Québec, Montréal, Québec R. Gaw Correctional Service of Canada, Ottawa, Ontario P. Gilmour WorkSafe BC, Kamloops, British Columbia M. Gupta Draeger Safety Canada Limited, Mississauga, Ontario A. Hall Toronto Fire Services, Toronto, Ontario E. Karpinski Human Resources and Skills Development Canada, Canada Labour Program, Gatineau, Québec vi Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Chair Associate Associate Associate August 2011 © Canadian Standards Association Selection, use, and care of respirators R. Kwan Atomic Energy of Canada Limited, Chalk River, Ontario B. Kwong Calgary, Alberta S. Lefebvre Honeywell Safety Products, Anjou, Québec R. Lindia Ottawa Fire Services, Ottawa, Ontario D. Lucas Fanshawe College, London, Ontario R. McEachern The Fire Fighters’ Association of Ontario, Orillia, Ontario S. McIntyre St. Michael’s Hospital, Toronto, Ontario A. Monteath The Hospital for Sick Children, Toronto, Ontario Associate W. Newcomb NIOSH/NPPTL, Pittsburgh, Pennsylvania, USA Associate D. Nikkel Winnipeg, Manitoba D. Romanowicz Ontario Power Generation, Pickering, Ontario M. Russo Construction Safety Association of Ontario, Toronto, Ontario J. Schingh Ottawa, Ontario S. Siu Occupational Health Physician, London, Ontario S. Smith 3M Canada Company, Brockville, Ontario K. Sparks MSA Canada, Toronto, Ontario H. Tomsic Metro Vancouver, Burnaby, British Columbia P. Voisine Department of National Defence, Ottawa, Ontario T. Yarwood North York, Ontario R. Meyers Canadian Standards Association, Mississauga, Ontario August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Associate Associate Project Manager vii Z94.4-11 © Canadian Standards Association Preface This is the fourth edition of CSA Z94.4, Selection, use, and care of respirators. It supersedes the previous editions published in 2002, 1993, and 1982. This Standard sets out requirements for the selection, use, and care of respirators and for the administration of an effective respiratory protection program in the workplace. Its purpose is to protect respirator users from any known or potential respiratory hazards. In developing this edition of the Standard, a Z94.4 Technical Rewrite Subcommittee was established to address Technical Committee issues and comments and to develop a draft for review by the Technical Committee. The Subcommittee, including a number of Working Groups that were established to work on various clauses of the Standard, spent considerable time reviewing the latest research and the most current literature, including other relevant standards and regulations. A number of significant changes have been introduced in this edition of the Standard. A notable change is the expansion of the scope of the Standard to include guidance on respirator selection for protection against bioaerosols. To facilitate decision making in the absence of complete information (e.g., no established occupational exposure limits or regulatory guidance), a new control banding approach has been introduced that provides a qualified person with an effective tool for selecting the appropriate level of respiratory protection against bioaerosol agents. Other changes made in this edition include the updating of fit testing protocols and provisions addressing respirator interference concerns. The following new annexes have also been added: • Checklist of competency for respirator fit testers (Annex J) • Scenarios using selection wheels in Figures 2 and 3 (Annex K) • Classification of biohazardous agents by risk group (Annex L) • Illustrations of acceptable and unacceptable facial hair for tight-fitting respirators (Annex M) • Additional guidance for qualified persons on respirator selection in health care environments (Annex N) Also updated are the clauses pertaining to training requirements and to the limitations and capabilities of respirator types. An important improvement to the Standard is the revision of the respirator selection flow chart and the corresponding figure specifying the hierarchy of respiratory protection (Figure 4). This figure provides a list of acceptable respirator options based on assigned protection factors (APFs). This Standard was prepared by the Technical Committee on Selection, Use, and Care of Respirators, under the jurisdiction of the Strategic Steering Committee on Occupational Health and Safety, and has been formally approved by the Technical Committee. August 2011 Notes: (1) Use of the singular does not exclude the plural (and vice versa) when the sense allows. (2) Although the intended primary application of this Standard is stated in its Scope, it is important to note that it remains the responsibility of the users of the Standard to judge its suitability for their particular purpose. (3) This publication was developed by consensus, which is defined by CSA Policy governing standardization — Code of good practice for standardization as “substantial agreement. Consensus implies much more than a simple majority, but not necessarily unanimity”. It is consistent with this definition that a member may be included in the Technical Committee list and yet not be in full agreement with all clauses of this publication. (4) To submit a request for interpretation of CSA Standards, please send the following information to [email protected] and include “Request for interpretation” in the subject line: (a) define the problem, making reference to the specific clause, and, where appropriate, include an illustrative sketch; (b) provide an explanation of circumstances surrounding the actual field condition; and (c) where possible, phrase the request in such a way that a specific “yes” or “no” answer will address the issue. Committee interpretations are processed in accordance with the CSA Directives and guidelines governing standardization and are published in CSA’s periodical Info Update, which is available on the CSA website at http://standardsactivities.csa.ca. (5) CSA Standards are subject to periodic review, and suggestions for their improvement will be referred to the appropriate committee. To submit a proposal for change to CSA Standards, please send the following information to [email protected] and include “Proposal for change” in the subject line: viii Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators (a) Standard designation (number); (b) relevant clause, table, and/or figure number; (c) wording of the proposed change; and (d) rationale for the change. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. ix Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. © Canadian Standards Association Selection, use, and care of respirators Z94.4-11 Selection, use, and care of respirators 1 Scope 1.1 This Standard sets out requirements for the selection, use, and care of respirators and for the administration of an effective respiratory protection program in the workplace. 1.2 This Standard is not intended to address the selection of (a) respirators for aircraft oxygen systems; (b) supplied-air suits; or (c) respirators for protection against radiological contaminants. This Standard applies to all other aspects of a respiratory protection program for these respirators. 1.3 This Standard is applicable to the selection, use, and care of respirators for non-emergency and emergency situations but is not intended to address the requirements for protection for first responders during CBRN (chemical, biological, radiological, and nuclear) events. See CAN/CGSB/CSA-Z1610. 1.4 This Standard is not intended to address (a) underwater breathing devices (see CSA Z275.2); or (b) inhalators and resuscitators. 1.5 The values given in SI units are the units of record for the purposes of this Standard. The values given in parentheses are for information and comparison only. 1.6 In CSA standards, “shall” is used to express a requirement, i.e., a provision that the user is obliged to satisfy in order to comply with the standard; “should” is used to express a recommendation or that which is advised but not required; and “may” is used to express an option or that which is permissible within the limits of the standard. Notes accompanying clauses do not include requirements or alternative requirements; the purpose of a note accompanying a clause is to separate from the text explanatory or informative material. Notes to tables and figures are considered part of the table or figure and may be written as requirements. Annexes are designated normative (mandatory) or informative (nonmandatory) to define their application. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 1 Z94.4-11 © Canadian Standards Association 2 Reference publications This Standard refers to the following publications, and where such reference is made, it shall be to the edition listed below. CSA (Canadian Standards Association) B339-08 Cylinders, spheres, and tubes for the transportation of dangerous goods B340-08 Selection and use of cylinders, spheres, tubes, and other containers for the transportation of dangerous goods, Class 2 Z94.3-07 Eye and face protectors Z180.1 (under development) Compressed breathing air and systems CAN/CSA-Z275.2-04 Occupational safety code for diving operations Z317.2-10 Special requirements for heating, ventilation, and air-conditioning (HVAC) systems in health care facilities Z1006-10 Management of work in confined spaces CAN/CGSB/CSA-Z1610-11 (under development) Protection of first responders from chemical, biological, radiological, and nuclear (CBRN) events ACGIH (American Conference of Governmental Industrial Hygienists) Threshold Limit Values and Biological Exposure Indices (published annually) AIHA (American Industrial Hygiene Association) Guidance for Conducting Control Banding Analyses, 2007 2009 Emergency Response Planning Guidelines (ERPG) and Workplace Environmental Exposure Level (WEEL) Handbook. CDC/NIH (Centers for Disease Control and Prevention/National Institutes of Health) Biosafety in Microbiological and Biomedical Laboratories (BMBL), Fifth Edition, 2009 CGA (Compressed Gas Association) C-1-2009 Methods for Pressure Testing of Compressed Gas Cylinders C-6-2007 Standards for Visual Inspection of Steel Compressed Gas Cylinders C-6.1-2006 Standards for Visual Inspection of High Pressure Aluminum Compressed Gas Cylinders C-6.2-2009 Guidelines for Visual Inspection and Requalification of Fiber Reinforced High Pressure Cylinders 2 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators G-4.3-2007 Commodity Specification for Oxygen Government of Canada Transportation of Dangerous Goods Act, S.C. 1992, c. 34, and the Regulations thereto NFPA (National Fire Protection Association) 1404-2006 Standard for Fire Service Respiratory Protection 1500-2007 Standard on Fire Department Occupational Safety and Health Program 1981-2007 Standard on Open-Circuit Self-Contained Breathing Apparatus (SCBA) for Emergency Services NIH (National Institutes of Health) NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), May 2011 NIOSH (National Institute for Occupational Safety and Health) No. 2005-149 (2005) NIOSH Pocket Guide to Chemical Hazards No. 87-116 (1987) A Guide to Industrial Respiratory Protection NRCC (National Research Council Canada) National Building Code of Canada, 2010 Other publications Brosseau, L.M., N.V. McCullough, and K. Harriman, “Selecting Respiratory Protection for Exposure to Pathogenic Biological Aerosols” in American Industrial Hygiene Conference and Exposition 2009 PDC 606. Greenspan, Lewis, “Functional equations for the enhancement factors for CO2-free moist air” in Journal of Research of the National Bureau of Standards — A. Physics and Chemistry, Vol. 80A, No. 1, January–February, 1976, pp. 41–44. Hyland, R.W. and A. Wexler, “Formulations for the thermodynamic properties of the saturated phases of H2O from 173.15 K to 473.15 K” in ASHRAE Transactions 89(2A), 1983, pp. 500–519. McCullough, N.V. and L.M. Brosseau, “Selecting Respirators for Control of Worker Exposure to Infectious Aerosols” in Infection Control and Hospital Epidemiology, 20:136–144, 1999. Wexler, Arnold, “Vapor Pressure Formulation for Water in Range 0 to 100 °C. A revision” in Journal of Research of the National Bureau of Standards — A. Physics and Chemistry, Vol. 80A, Nos. 5 and 6, September–December, 1976, pp. 777–785. 3 Definitions Note: In some cases, the authority having jurisdiction will define the following terms differently. However, the definitions supplied in this clause are to be used for the application of this Standard. The following definitions shall apply in this Standard: Aerosol — a particulate suspended in a gaseous medium. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 3 Z94.4-11 © Canadian Standards Association Airline respirator — a respirator and air supply hose with a hood/helmet, a tight-fitting facepiece, or a loose-fitting facepiece/visor that is supplied with compressed breathing air from a compressed breathing air system. Air-purifying respirator — a respirator with an air-purifying filter, cartridge, or canister that removes specific air contaminants by passing ambient air through the air-purifying element. Note: See Annex G for a description of subclasses of these respirators. Assigned protection factor (APF) — the anticipated level of respiratory protection that would be provided by a properly functioning respirator or class of respirators to properly fitted and trained users. Atmosphere-supplying respirator — a respirator that supplies the respirator user with breathing air/gas from a source independent of the ambient atmosphere. Note: See Annex G for a description of the subclasses of these respirators. Authority having jurisdiction — an agency established by a provincial, federal, or territorial government that has the responsibility for occupational health and safety legislation. Bioaerosol — a liquid droplet (generated, for example, by coughing, sneezing, or a medical procedure such as bronchoscopy) or a solid particle (generated, for example, by sweeping or shovelling) suspended in the air and that is living or originates from living organisms. Bioaerosols include living or dead micro-organisms, fragments, toxins, and particulate waste products from all varieties of living things. They are capable of causing infection or adverse or allergic response. Note: Bioaerosols range in size from submicroscopic particles (< 0.01 μm) to particles greater than 100 μm in diameter. Biological monitoring — analysis of exhaled air, a biological fluid (e.g., urine, blood, perspiration), or a body component (e.g., hair, nails) to assess the extent to which an individual has been exposed to a contaminant. Breathing gas — oxygen, air, or other respirable gas as defined in CSA Z180.1 and CGA G-4.3, as applicable. Buddy breathing — the use of an accessory device on a self-contained breathing apparatus or a practice that enables a second person to simultaneously share the same breathing gas supply as that of the user of such apparatus while both persons are attempting to move to a safe location. CBRN incident or event — a deliberate chemical, biological, radiological, or nuclear (CBRN) incident, including releases of contaminants and contagious outbreaks. Note: See CAN/CGSB/CSA-Z1610. Combined respirator — a respirator that is capable of operating in either air-purifying or atmosphere-supplying mode. Note: An airline respirator with air-purifying cartridges for entry is an example of a combined respirator. Compressed breathing air — air meeting the purity requirements of CSA Z180.1. Confined space — as defined by the authority having jurisdiction. All confined spaces are considered immediately dangerous to life and health (IDLH) unless proven otherwise. Note: Examples include storage tanks, process vessels, boilers, silos, tank cars, pipelines, tubes, ducts, sewers, underground utility vaults, tunnels, and pits. Controlled breathing — a method of consciously reducing air use by forcing exhalation from the mouth and allowing natural inhalation through the nose. Cylinder — a pressure vessel as defined in CSA B339 and CSA B340, forming an integral part of a respirator. Demonstration of competency — written or demonstrated performance of the necessary practices and procedures required as part of the respiratory protection program. 4 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Drill — simulated situational practice of respirator use in a timed, controlled setting to measure equipment and user readiness. End-of-service-life indicator (ESLI) — a system that warns the respirator user that the sorbent is approaching saturation or is no longer effective. Fit factor — a quantitative measure of the fit of a particular respirator to a particular individual. Fit test — the use of a qualitative or a quantitative method to evaluate the fit of a specific make, model, and size of respirator on an individual. Fumes — solid particles generated by condensation from the gaseous state, generally after volatilization from melted substances (e.g., welding) and often accompanied by a chemical reaction (e.g., oxidation). See Particulate. Gas — a substance that is in the gaseous state at ambient temperature and pressure. Hazard ratio (HR) — the estimated or measured airborne concentration of a substance divided by the occupational exposure limit. This ratio is calculated for each gas, vapour, or particulate component that poses a respiratory hazard. Hazardous atmosphere — any atmosphere that is oxygen deficient, exceeds occupational exposure limits, presents a fire or explosion hazard, or contains an airborne toxic or disease-producing contaminant in concentrations deemed to be hazardous. Health care facility — a facility designed for the provision of health care. Note: Acute care hospitals, emergency departments, rehabilitation hospitals, mental health hospitals, and infirmaries are examples of health care facilities. Health care professional — an individual who is licensed by a provincial licensing authority or equivalent to practise medicine or nursing and who possesses experience and knowledge in the field of occupational health and safety. Helmet — the part of a respirator that completely covers the head and neck and can offer head or eye protection. High-efficiency particulate air (HEPA) filter — a filter that has been tested to ensure efficiency equal to or exceeding 99.97% for removal of particles having a mean aerodynamic diameter of 0.3 μm from the air. Note: HEPA filters are equivalent to N100, R100, P100, and HE for filtration efficiency only. Highest hazard ratio (HHR) — the highest calculated hazard ratio (HR) for any gas, vapour, or particulate component that poses a respiratory hazard. Hood — the part of a respirator that completely covers the head, neck, and portions of the shoulders and can offer head or eye protection. Hydrostatic test — a calibrated expansion pressure test of the structural integrity of cylinders. Note: See CGA C-1. Hypoxia — any condition in which there is an inadequate supply of oxygen in the tissues. Note: See Annex H. Immediately dangerous to life or health (IDLH) atmosphere — an atmosphere that poses an immediate threat to life or that will cause irreversible adverse health effects or impair an individual’s ability to escape. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 5 Z94.4-11 © Canadian Standards Association Instruction — information or direction on equipment, processes, and procedures, provided and documented as part of the respiratory protection program requirements. Note: Instruction does not include a demonstration of competency by the recipient. Intrinsically safe respirator — a respirator that has been certified as not being a source of ignition. Loose-fitting facepiece/visor (LFFV) — the part of a respirator that forms a partial seal with the face, does not cover the neck and shoulders, and can offer head or eye protection. Maximum use concentration (MUC) — the maximum concentration of an airborne contaminant from which an employee is expected to be protected when wearing a respirator, determined by the assigned protection factor of the respirator or class of respirators and the occupational exposure limit for that contaminant. The MUC is usually determined mathematically by multiplying the assigned protection factor specified for a respirator by the occupational exposure limit, which can include a short-term exposure limit and a ceiling limit or any other exposure limit used for that chemical agent, as defined by the authority having jurisdiction. Mist — liquid particles in a gaseous medium. See Particulate. Mouthpiece — the part of a respirator that is held and sealed in the user’s mouth and is designed to be used in conjunction with a nose-clip. Multi-functional respirator — a respirator that is capable of operating in two modes within either air-purifying or atmosphere-supplying groups. Note: An airline respirator with a self-contained escape cylinder or a powered air-purifying respirator capable of working in silent mode (power off) are examples of multi-functional respirators. Occupational exposure limit (OEL) — the maximum concentration of airborne contaminants deemed to be acceptable (a) as defined by the authority having jurisdiction; or (b) in the absence of a regulated occupational exposure limit, by a qualified person with the approval of the authority having jurisdiction. Oil — any of numerous mineral, vegetable, and synthetic substances and animal and vegetable fats that are generally slippery, combustible, viscous, liquid or liquefiable at room temperature, and soluble in various organic solvents such as ether but not in water. Oxygen deficiency — a condition based on an oxygen concentration or partial pressure below which a person can be adversely affected. Note: See Annex H. Particulate — any liquid or solid airborne contaminant, other than a gas or vapour, but including dusts, fumes, mists, fibres, fog, pollen, smoke, spores, and bioaerosols. Pathogen — a living organism, such as bacteria, viruses, fungi, or mould, that causes disease. Pressure-demand respirator — a respirator where the pressure in the facepiece or hood remains positive with respect to the ambient pressure during both inhalation and exhalation. Program administrator — the individual designated to ensure the development, implementation, and maintenance of the respiratory protection program. Qualified person — an individual who possesses the knowledge, experience, and training to fulfill the competencies of the role(s) defined in this Standard. Qualitative fit test (QLFT) — a pass/fail test method that relies on the subject’s sensory response to detect a challenge agent in order to assess the adequacy of respirator fit. 6 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Quantitative fit test (QNFT) — a test method that uses an instrument to assess the amount of leakage into the respirator in order to assess the adequacy of respirator fit. Respirator — a device that is tested and certified by procedures established by testing and certification agencies recognized by the authority having jurisdiction and is used to protect the user from inhaling a hazardous atmosphere. Notes: (1) Examples of such agencies include NIOSH and CEN Notified Bodies. (2) See Annex G for a description of various classes of respirators. Sanitization — the use of an accepted product to clean and reduce the level of micro-organisms on the surfaces of inanimate objects in order to mitigate or prevent the transmission of disease to humans. Note: Accepted products include Health Canada DIN registered disinfectant sanitizer products. Self-contained breathing apparatus (SCBA) — a respirator that has a portable supply of breathing gas and is independent of the ambient atmosphere. SCBAs include both open-circuit and closed-circuit respirators. Series N particulate filter — a NIOSH classification for particulate filters effective against particulate aerosols free of oil. Time-use restrictions can apply to these filters. Note: Three filter efficiency levels are tested and certified: 99.97%, 99%, and 95%, referred to as classes N100, N99, and N95 respectively. Series P particulate filter — a NIOSH classification for particulate filters effective against all particulate aerosols. Notes: (1) Three filter efficiency levels are tested and certified: 99.97%, 99%, and 95%, referred to as classes P100, P99, and P95 respectively. (2) Manufacturer’s time-use restrictions can apply to these filters. Series R particulate filter — a NIOSH classification for particulate filters effective against all particulate aerosols. Time-use restrictions can apply to these filters. Note: Three filter efficiency levels are tested and certified: 99.97%, 99%, and 95%, referred to as classes R100, R99, and R95 respectively. Service life — the period of time during which a respirator provides adequate protection to the user. Sorbent — a material contained in a respirator that removes toxic gases and vapours from the inhaled air. Structural firefighting — the activities of rescue, fire suppression, and property conservation in buildings, enclosed structures, aircraft interiors, vehicles, vessels, aircraft, or similar properties that are involved in a fire. Supervisor — the employer or a person assigned by the employer having authority for the respirator user and control over the workplace. Supplied-air suit — a suit that is impermeable to specific particulate and gaseous contaminants and is provided with a supply of breathing gas that is adequate for the user and capable of maintaining a positive pressure inside the suit. Note: The use of a Vortex tube for heating or cooling supplied-air suits is deemed to be an appropriate application for the use of compressed breathing air; see Clause 1.2(d) of CSA Z180.1. Tight-fitting respirator — a respirator that is designed to form a complete seal with the face or neck. Tight-fitting respirators include half-facepiece, both elastomeric and filtering-facepiece respirators, full-facepiece, and certain hoods equipped with a tight-fitting seal. Note: Tight-fitting respirators also include adhesive sealing respirators. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 7 Z94.4-11 © Canadian Standards Association Tight-fitting sealing surface — the entire area where a respirator is designed to contact the skin, including, where present, a secondary interior flange. For tight-fitting hoods, the sealing surface is provided by the neck dam and can also include a secondary nose cup. Training — formal, defined, and documented delivery of information applicable to assigned respiratory program roles and activities that consists of (a) instruction (using learning materials or equipment); (b) facilitator demonstration (subject matter expert or training facilitator); (c) reference to the applicable clause of this Standard or respirator program requirements; and (d) participant competency demonstration. Upon successful completion of training, participants are able to apply their knowledge and demonstrate the level of practical competencies required for the roles and activities to which the training pertains. User seal check — an action conducted by the respirator user to determine if the respirator is properly seated to the face. Note: Positive- and negative-pressure user seal checks are described in Annex A. Vapour — the gaseous state of a substance that is solid or liquid at ambient temperature and pressure. 4 Respiratory protection program 4.1 General Respiratory protection shall be used to protect a user from inhaling a hazardous atmosphere when engineering or administrative control measures are not practicable or not adequate, while such controls are being instituted, or during shutdown for maintenance, repair, or emergency. 4.2 Employer responsibility 4.2.1 The employer shall be responsible for preparing and implementing, in consultation with users, a written respiratory protection program including all of the elements listed in Clause 4.3. Written procedures, as appropriate, shall also be included. 4.2.2 The employer shall ensure that (a) its respiratory protection program is effective (see Clause 13); (b) all program roles are assigned to qualified persons (see Clause 5); and (c) each individual assigned to one or more program roles shall be able to demonstrate and maintain a level of competency in the roles for which they are responsible (see Clauses 5 and 9). 4.2.3 Program roles (see Clause 5) A respiratory protection program shall include the following roles: (a) program administrator; (b) respirator user; (c) supervisor; (d) person selecting respirators; (e) fit tester; (f) issuer of respirators; (g) maintenance personnel; and (h) health care professional. 8 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 4.3 Program components A respiratory protection program shall consist of the following components: (a) roles and responsibilities (Clause 5); (b) hazard assessment (Clause 6); (c) respirator selection (Clause 7); (d) training (Clause 8); (e) respirator fit testing (Clause 9); (f) use of respirators (Clause 10); (g) cleaning, inspection, maintenance, and storage of respirators (Clause 11); (h) health surveillance (Clause 12); (i) program evaluation (Clause 13); and (j) recordkeeping (Clause 14). 5 Roles and responsibilities Note: See Clause 8 for an understanding of the competencies required for the defined roles. 5.1 Program administrator The program administrator shall be responsible for the administration of the respiratory protection program in accordance with the requirements of this Standard and CSA Z180.1 as applicable and shall ensure that (a) qualified personnel have been assigned the roles defined in this Standard; (b) assessments for respiratory hazards are conducted by qualified persons; (c) a list of respirators selected for use in the workplace is maintained for each respiratory hazard; (d) procedures are established for respirator user screening and, where required, a medical assessment (see Clause 8.1.3); (e) procedures are established for the issuance of selected respirators; (f) all persons required to use respirators (i) complete user screening; (ii) receive written instructions, training, and fit testing prior to initial use of a respirator; (iii) are able to demonstrate ongoing competency in respirator use and receive additional training where required; and (iv) are fit tested again at designated intervals or when required (see Clause 9.1.6); (g) the use of respirators is monitored, including that (i) selected equipment is being used; (ii) respirators are being worn properly and are in good working condition; (iii) problems and corrective actions are documented and implemented; and (iv) maintenance of the respirators is in accordance with manufacturer’s instructions; (h) the program is reviewed at least annually to assess its effectiveness; (i) a monitoring system and performance measures are in place to assess and document that the required procedures are demonstrated to the level of competency required by the program; (j) written instructions and records required by this Standard are maintained; (k) appropriate authorities having jurisdiction or standards organizations are consulted on interpretations of criteria affecting the use of respirators in the workplace to maintain currency of the program; (l) procedures for emergency and rescue operations are developed; Note: These procedures should address the following: (a) the consequences of equipment or power failures, uncontrolled chemical reactions, fire, explosion, or human error; (b) an analysis of emergency and rescue uses of respirators that might occur in each operation; (c) consideration of past occurrences requiring emergency or rescue uses of respirators; (d) rescue in IDLH environments; (e) the appropriate types and numbers of respirators that need to be maintained and stored so that they are readily accessible and operational when needed; and (f) if the emergency involves suspected or known terrorism, reference to CAN/CGSB/CSA-Z1610. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 9 Z94.4-11 © Canadian Standards Association (m) the program is periodically updated (e.g., to maintain consistency with regulatory criteria, consensus standards, feedback from program evaluations, investigation reports, users’ comments, and product alerts that can affect the respirators used in the workplace). 5.2 Respirator users Respirator users shall use and care for respirators in accordance with the written instructions and training received and shall (a) report to their supervisor or other responsible person when there is any condition that can impair their ability to safely use a respirator; (b) in the case of a tight-fitting respirator, maintain their respirator seal interference free, that is, refrain from having any object or material on their person that would interfere with the seal or operation of the respirator; (c) check that the respirator is clean and in good operating condition prior to each use and at intervals that will ensure that it continues to operate effectively; (d) perform user seal checks after each donning of a tight-fitting respirator (see Annex A); (e) remove from service any respirator that they determine to be defective and report it to their supervisor or other responsible person; and (f) report to their supervisor or other responsible person when there is any condition or change that could impact their ability to safely use the selected respirator. 5.3 Supervisor The supervisor shall monitor respirator use in relation to workplace conditions to ensure that respiratory protection program requirements are being met and shall ensure that (a) user screening, training, fit testing, and, where required, medical assessments are completed prior to assigning a user any task that requires the use of a respirator; (b) users demonstrate competency in the use of the respirator; (c) respirators are cleaned, sanitized, inspected, maintained, repaired, and stored in accordance with written instructions and the manufacturer’s recommendations; (d) the respirator is used in accordance with the instructions, the training received, and the safe operating procedures established for the workplace, i.e., to manage work tasks requiring the use of a respirator; (e) in the case of a tight-fitting respirator, respirator users maintain their required interference-free respirator seal and do not have any object or material on their person that would interfere with the seal or operation of the respirator. See Clauses 9.2 and 10.1.3; (f) details of the type of respirator selected and the anticipated working conditions are provided to the health care professional conducting the medical assessment of a respirator user, where required. See Clause 12; (g) the program administrator is notified of respirator users’ concerns, changes in processes, equipment, or operating procedures that have an impact on environmental conditions, and respiratory protection requirements; and (h) the program administrator is notified of investigation reports that indicate that the use of a respirator could have prevented or contributed to an incident or injury. 5.4 Person selecting respirators The person selecting respirators shall base selection on the requirements of the respiratory protection program and shall (a) review the assessments of respiratory hazards identified in the workplace and select those respirators suitable for protection against those hazards; and (b) notify the program administrator of changes in regulatory criteria, consensus standards, and technological developments that could affect the selection of respirators. Note: See Clause 7 for selection requirements. 10 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 5.5 Respirator fit tester The fit tester shall follow the protocols identified in the respiratory protection program and (a) apply program requirements regarding interference concerns; (b) verify that the user is trained and competent in respirator inspection, donning, performing user seal checks, and doffing; (c) conduct fit tests to verify the user’s ability to obtain an acceptable fit and an effective respirator seal; (d) document individual user’s competency and corresponding fit test results; (e) ensure the proper cleaning and sanitizing of fit testing equipment and respirators used for fit testing; (f) ensure and document the maintenance, calibration, and repair of fit test equipment; and (g) notify the program administrator of respirator users’ concerns. 5.6 Issuer of respirators The person issuing respirators shall, in accordance with written instructions, issue only those respirators for which the user has been qualified. 5.7 Respirator maintenance personnel The respirator maintenance personnel shall inspect, maintain, repair, and test respirators in accordance with manufacturer’s written instructions and shall ensure that (a) test equipment is in good working condition, including required calibration; and (b) maintenance and repairs are documented. 5.8 Health care professional The health care professional shall, as necessary, assess the suitability of the user to safely use the selected respirator and shall (a) have knowledge of the health effects associated with the respiratory hazards to which the user might be exposed; (b) have knowledge of the physiological and psychological stresses associated with use of the selected respirator under the anticipated working conditions; and (c) report, as required by the respiratory protection program, whether the user (i) meets medical requirements; (ii) meets medical requirements with limitations as defined in the report provided; or (iii) does not meet medical requirements to use the selected respirator. Note: See Clause 12. 6 Hazard assessment 6.1 General 6.1.1 A hazard assessment shall be performed by a qualified person to determine the respiratory hazards present and to assist in the selection of an appropriate respirator where required. 6.1.2 Where the only hazard identified is a bioaerosol, the risk assessment and the selection process in Clause 7.3.2 shall be followed. 6.1.3 Where the hazard identified includes a workplace contaminant but does not include a bioaerosol component, the hazard assessment in Clause 6.2 and the selection process in Clause 7.3.4 shall be followed. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 11 Z94.4-11 © Canadian Standards Association 6.1.4 Where the hazard identified includes a bioaerosol and other contaminants (e.g., gas, vapour, particulate), the risk or hazard assessments and the selection processes specified in Clauses 6.1.2 and 6.1.3 shall both be followed. Note: It is important to select a level of respirator protection to protect against all hazards; see Clause 7.3.2.2(b). 6.2 Steps in hazard assessment for non-bioaerosol workplace contaminants 6.2.1 Determination of hazard The nature of the hazard shall be determined as follows: (a) Identify what contaminants are present in the workplace. (b) Identify the physical states of all airborne contaminants. (c) Measure or estimate the concentration of the contaminants. (d) Determine if the atmosphere is potentially oxygen deficient. (e) Identify an appropriate occupational exposure limit for each airborne contaminant. (f) Determine if an IDLH atmosphere is present (see NIOSH 2005-149 for IDLH values for specific substances). (g) Determine if there is an applicable health regulation or a substance-specific standard for the contaminants. (h) Determine for particulate hazards if there is oil present. (i) Determine if the contaminant can be absorbed through, or is irritating to, the skin or eyes. Updated assessments shall be completed when the nature of the hazard changes. 6.2.2 Identification of contaminants The following factors concerning an operation or process shall be taken into consideration: (a) operation or process characteristics as they relate to the release of air contaminants through routine or non-routine procedures, malfunctioning of equipment or processes, or spills; (b) the period of time for which the respirator is to be used and the physical demands made on the worker; (c) work area layout, work activities, temperature, relative humidity, atmospheric pressure, escape routes, and maintenance procedures; (d) materials used, produced, or stored, including raw materials, end-products, by-products, chemical reactivity, and wastes; and (e) emergency repair, shutdown procedures, escape, and rescue operations. 6.2.3 Identification of physical state The physical states for all airborne contaminants as they are likely to be encountered shall be identified as follows: (a) gas or vapour; or (b) particulate. 6.2.4 Measurement or estimation of concentrations An estimate of the airborne concentrations of contaminants to which persons might be exposed shall be conducted by a qualified person as follows: (a) air sampling and analysis conducted in accordance with recognized occupational hygiene practices; (b) mathematical modelling or estimating based on the workplace volume and physical properties (e.g., vapour pressure); or (c) experience from similar circumstances and materials. Anticipated exposures should account for variations in process operation, rate and direction of air movement, temperature (ambient or process), and seasonal variations. 12 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 6.2.5 Determination of oxygen level Where the potential for an oxygen-deficient atmosphere exists, the oxygen concentration shall be measured. Where oxygen concentration is confirmed to be below 19.5% (at sea level), the cause of the deficiency shall be determined, and (a) ongoing monitoring shall be performed; or (b) the atmosphere shall be assumed to be IDLH. 6.2.6 Identification of occupational exposure limits Occupational exposure limits shall be identified [e.g., regulated limits, ACGIH threshold limit values (TLVs), AIHA workplace environmental exposure levels (AIHA WEELs), values based on an estimate of toxicity for each contaminant]. 6.2.7 Determination of the existence of an IDLH atmosphere An IDLH atmosphere shall be assumed in any of the following situations: (a) structural firefighting; (b) an untested confined space; (c) an area where a known hazardous contaminant is present at or above published IDLH concentrations; (d) an area where a known hazardous contaminant is present at an unknown concentration; (e) an area where a reduced oxygen concentration could produce a level of hypoxia that is IDLH. See Annex H; and (f) an area where, in the opinion of a qualified person, the condition presents a potential IDLH atmosphere. 6.2.8 Determination of an applicable substance-specific standard The workplace shall be assessed to determine if there is an applicable health regulation or substance-specific standard. Professional judgment shall be used to assess all respiratory hazards present. 6.2.9 Determination of the presence of oil If there is a particulate hazard, the potential for any oil to become airborne shall be determined. If the presence of oil is unknown, it shall be assumed to be present. Sampling and analysis are not required to make this judgment. Notes: (1) Knowledge of the presence of airborne oil is needed to properly select a particulate filter. (2) Examples of activities that are known to produce airborne oil include use of air compressor systems with oil lubricators and operation of motor vehicles. 6.2.10 Determination of skin or eye absorption and irritation characteristics If the contaminant is an eye irritant or can use the skin or eyes as a route of exposure at concentrations normally encountered in the workplace or anticipated during an emergency, any available information regarding possible systemic injury or illness resulting from absorption of the contaminant through the skin or eyes shall be identified. 6.3 Monitoring respiratory hazards The workplace atmosphere shall be assessed on a regular basis for respiratory hazards to confirm that the proper type of respirator is being used. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 13 Z94.4-11 © Canadian Standards Association 7 Respirator selection 7.1 General 7.1.1 Personnel conducting respirator selection shall understand and comply with the limitations of the selected respirators under the conditions of use. Note: See Annex G for information on respirator limitations. 7.1.2 Personnel conducting respirator selection should consider extraordinary circumstances in the operations that could adversely affect the function of a respirator (e.g., extreme cold or radiant heat, hypobaric or hyperbaric conditions). Advice should be sought from the manufacturer’s technical experts. 7.2 Classification of respirators 7.2.1 For the purpose of selection, respirators shall be grouped as follows: (a) atmosphere-supplying respirators: (i) self-contained breathing apparatus (SCBA) (pressure-demand, open- or closed-circuit); (ii) airline (pressure-demand or continuous-flow); and (iii) multi-functional (a configuration incorporating both SCBA and airline); (b) air-purifying respirators, non-powered (APR) and powered (PAPR): (i) gas- and vapour-removing; (ii) particulate-removing; (iii) gas-, vapour-, and particulate-removing; and (iv) multi-functional (a configuration incorporating both APR and PAPR); (c) combined respirator (a configuration incorporating both atmosphere-supplying and air-purifying); and (d) escape-only respirators (atmosphere-supplying or air-purifying). Note: The terms “multi-functional” and “combined” are defined in this Standard to improve clarity about the large variety of configurations now available. See Annex G for additional information on the characteristics, capabilities, and limitations of the respirators identified in this Clause. 7.2.2 Devices that are not respirators under the definition in this Standard should be selected and used based on recommendations from knowledgeable professionals. Note: These devices include supplied-air suits and radiological respirators. 7.2.3 Supplied-air suits 7.2.3.1 Selection criteria for supplied-air suits shall be based primarily on the inhalation hazard of the substance. 7.2.3.2 A supplied-air suit can provide both skin and respiratory protection from toxic substances that can be absorbed through the skin. Other impervious coverings should be used to prevent skin contact. 7.2.3.3 Supplied-air suits shall be selected, used, and maintained by qualified persons knowledgeable in their use and limitations. 14 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 7.2.4 Escape respirators Respirators chosen for escape purposes may be (a) respirators that can be used for entry; or (b) respirators designated as escape-only. Escape-only respirators shall not be used to enter into a contaminated atmosphere. Escape respirators shall be selected on the same principles as any other respirator. Precautions shall be taken to ensure that the respirator to be used for escape is a type appropriate for the conditions and duration of use. Advice should be sought from the respirator manufacturer. 7.3 Selection procedures 7.3.1 General 7.3.1.1 The respirator selection process in this Standard is based on NIOSH criteria for the testing and certification of respirators. Selection of respirators certified by other organizations is not addressed in this Standard. Respirator selection shall be based on a systematic review of the hazards and knowledge of standards, regulatory criteria, and manufacturers’ information on the types of respirators and their limitations to ensure that appropriate respirators are selected for the intended conditions of use. There can be multiple hazards present (e.g., bioaerosol and chemical). All hazards shall be considered in exposure assessments. 7.3.1.2 The program administrator shall establish procedures to ensure that only qualified persons are tasked with respirator selection. See Clause 8.1.2. 7.3.1.3 The respirator selection process for all hazards shall be as illustrated in Figure 1, and the selection shall be made from the appropriate level in the hierarchy of respiratory protection specified in Figure 4. 7.3.2 Respirator selection for protection against bioaerosols 7.3.2.1 General Infection prevention and control, occupational health, and occupational hygiene programs remain the most important means for preventing or limiting employee exposures to bioaerosols, and an effective respiratory protection program is an essential component. It is the responsibility of employers to assess this risk and decide on the acceptable level of protection as it relates to a specific use. When respirators to protect against bioaerosols are being selected, airborne transmissibility shall be confirmed and the infectivity of the bioaerosol shall be taken into consideration. Clause 7.3.2 addresses selection of respirators for bioaerosols that are capable of causing infection or adverse or allergic response but for which no occupational exposure limits (OELs) have been established. Where regulations, best practices, or infection prevention and control guidance documents exist, they shall be considered during the respirator selection process. Only exposures through inhalation are covered in this selection process, and appropriate selection of PPE for other routes of entry shall be undertaken if applicable. 7.3.2.2 Application Respirator selection for protection against bioaerosols shall be as illustrated in Figure 1 and shall be determined as follows: (a) The level of protection required shall be determined in accordance with Clauses 7.3.2.3.3 to 7.3.2.3.8 and Figures 2 and 3. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 15 Z94.4-11 © Canadian Standards Association (b) A respirator suitable for the conditions of use determined in Item (a) shall be selected from the appropriate level in the hierarchy of respiratory protection defined in Figure 4. If there are multiple exposure risks, the selection shall be based on the highest hazard level. If there are also chemical hazards present, the selection process specified in Clauses 6.2 and 7.3.4 shall be followed as well. See Clause 7.3.4 for instructions on the use of the respirator selection flow chart in Figure 1. 7.3.2.3 Control banding approach 7.3.2.3.1 Control banding (CB) was developed in Great Britain to implement safe and realistic means of control where quantitative risk information was limited (for more information, visit http://www.coshh-essentials.org.uk/). CB is a process in which risk factors are assessed using variables that are organized into ranges or bands; each variable is divided into four bands. In this model, a risk group is defined by the nature of the bioaerosol/pathogen, a generation rate is defined by the activity, and a control level is determined by the type/level of ventilation. A qualified person can use this simple and effective semi-quantitative tool to reduce the complexity and improve the applicability of respirator selection decisions for protection against bioaerosols. Because it facilitates decision making based on incomplete information, CB is an attractive option for controlling bioaerosol exposures. For more information, refer to AIHA, Guidance for Conducting Control Banding Analyses. CB is a generic technique used to guide the assessment and management of workplace risks. In this Standard, the CB approach is being adapted to tasks involving bioaerosols. The inputs and outputs have been selected to reflect expert opinion as expressed in existing research and guidance for use of respiratory protection for bioaerosols. For more information, refer to McCullough et al., “Selecting Respirators for Control of Worker Exposure to Infectious Aerosols” and Brosseau et al., “Selecting Respiratory Protection for Exposure to Pathogenic Biological Aerosols.” The general procedure is to derive an appropriate level of respiratory protection by combining ranges or “bands” representing (a) the risk group [nature of the hazard (bioaerosol type) and availability of treatment]; (b) the generation rate (from human release, activities, or equipment); and (c) the control level (e.g., ventilation). 7.3.2.3.2 A control banding approach shall be used for selection of respiratory protection against bioaerosols with no established occupational exposure limits (OELs) or in the absence of regulations or other guidance. Control banding shall be used in conjunction with health and safety practices. Notes: (1) Control banding requires input from relevant experts and ongoing risk assessment. (2) The guidance on respirator selection currently provided in infection prevention and control guidance documents should be confirmed using the control banding approach in this Standard. 7.3.2.3.3 Risk assessment A qualified person shall determine whether a known or suspected bioaerosol presents a risk associated with transmissibility, infectivity, and adverse health effects. See Annex N. Note: Infection prevention and control specialists or industrial hygienists knowledgeable in bioaerosols are examples of persons qualified to conduct the risk assessment. 7.3.2.3.4 Selection of workplace environment The appropriate workplace environment shall be selected in accordance with (a) Figure 2 for a health care facility when exposure is related to infectious bioaerosols that are communicable between humans; or Note: Annex N provides health care guidance on factors to be considered by a qualified person. 16 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators (b) Figure 3 for general workplace environments [including all settings not defined in Item (a)] for all bioaerosols. Note: Both Figures 2 and 3 provide a selection with an appropriate level of protection. In situations where it appears that either figure could apply, the qualified person should use the figure containing the descriptors that best describe the intended use conditions. See Annex K for scenarios using the selection wheels in Figures 2 and 3. 7.3.2.3.5 Risk group selection — Type of bioaerosol/pathogen (see Figures 2 and 3) The qualified person shall select a risk group for the bioaerosol based on the following criteria: Classification of biohazardous agents by risk group Risk group Health impacts (transmissibility, infectivity, and adverse health effects of the bioaerosol) Risk group 1 (R1) Agents not associated with disease or serious adverse health effects in healthy adult humans Risk group 2 (R2) Agents associated with human disease or adverse health effects that are rarely serious and for which preventive or therapeutic interventions are usually available Risk group 3 (R3) Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Risk group 4 (R4) Agents likely to cause serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions are not usually available (high individual risk and high community risk) Note: The qualified person can consult the references provided in Annex L for background information and additional guidance on determining an appropriate risk group classification. 7.3.2.3.6 Generation rate level (see Figures 2 and 3) The generation rate shall be selected based on (a) known conditions in the work environment as follows: (i) health care facilities — nature of exposure (e.g., a patient coughing or sneezing, aerosol-generating medical procedures); or (ii) general workplace environments — nature of activities (e.g., vacuuming with a HEPA filter, soaking then shovelling, misting then shovelling, dry sweeping). (b) other possible exposures and the nature of the work; and (c) additional factors that can increase pathogen airborne concentrations. 7.3.2.3.7 Control level selection (see Figures 2 and 3) The control level shall be selected based on the known conditions in the work environment as follows: (a) health care facilities — based on air changes per hour (ACH) (see CSA Z317.2); or (b) general workplace environments — based on ventilation rates indoors and wind conditions outdoors. Note: Control level descriptors may be defined more specifically by the qualified person performing the control banding for a general workplace, e.g., ventilation levels could be identified by type of ventilation or capture velocities, provided that findings are validated against Figure 3. 7.3.2.3.8 Level of respiratory protection The level of respiratory protection shall be determined as follows: Step 1 Identify the bioaerosol (known or suspected). Step 2 Confirm that a risk of transmission of disease, infection, or adverse health effects is produced from inhalation of the bioaerosol. Step 3 Select applicable control banding wheel: health care facilities or general workplace environments (see Figure 2 or 3) August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 17 Z94.4-11 © Canadian Standards Association Step 4 Determine the bioaerosol risk group (R1, R2, R3, or R4 in accordance with Clause 7.3.2.3.5) Step 5 Determine the generation rate (G1, G2, G3, or G4 in accordance with Clause 7.3.2.3.6) Step 6 Determine the control level (C1, C2, C3, or C4 in accordance with Clause 7.3.2.3.7) Step 7 Identify the number and colour of the segment selected at the intersection of the items identified in Steps 4 to 6 (e.g., R1, G2, C3). This corresponds to the range of options in the hierarchy of respiratory protection shown in Figure 4. The respirator shall be selected based on the level of protection identified in Figure 4. 7.3.3 Respirator selection for protection against non-bioaerosol workplace contaminants The respirator selection process for protection against non-bioaerosol workplace contaminants shall be as illustrated in Figure 1, and the selection shall be made from the appropriate level in the hierarchy of respiratory protection specified in Figure 4. See Clause 7.3.4 for instructions on the use of the respirator selection flow chart in Figure 1. 7.3.4 Using the respirator selection flow chart 7.3.4.1 Before using the respirator selection flow chart illustrated in Figure 1, gather all the information regarding hazard assessment as described in (a) Clause 6.2 for non-bioaerosol workplace contaminants; and (b) Clause 7.3.2.3.3 for bioaerosols. 7.3.4.2 All respirator selections using the flow chart in Figure 1 shall start in the block identified with navigation marker number 1 and end in the block identified with navigation marker number 52. Read the contents of each block in sequence and perform the task identified as defined in the legend. Record the information used and decisions taken at each step in the selection process. 7.3.4.3 The yellow rectangular shapes indicate that additional information is required. Ensure that this information is gathered before proceeding to the next block. 7.3.4.4 The red diamond shapes indicate that a decision must be made in order to proceed. Answer each question with a “Yes” or “No” response and follow the arrow to the next block. The option may be qualified by a further statement such as “Yes, or unknown”. 7.3.4.5 The green rectangular shapes with the curved base indicate that a selection has been made for a respirator style or respirator component. Record this selection before proceeding to the next block. 7.3.4.6 Refer to the definitions in Clause 3 and descriptions of respirator use and limitations in Annex G. 7.3.4.7 The following notes are provided to assist in the comprehension of Figure 1. Each note references a block in the flow chart by its navigation marker number. 18 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association 1 Selection, use, and care of respirators Initial recognition and identification of respiratory hazards according to the information requirements of Clause 6. Elimination of the respiratory hazard is not feasible. The risk assessment concludes that a respirator is required. 2 Where regulations, best practices, or infection prevention and control guidance documents exist, they shall be considered during the respirator selection process. 3 Where multiple hazards are present and a regulation prescribes a specific respirator for only one of these hazards, the process shall be repeated, starting in Block 1, for each hazard. Identify the known or suspected bioaerosol (see Clause 7.3.2.3.3 and Annexes L and N). 5 15 Type CE respirator refers to the NIOSH classification approved for protection against abrasive blasting. 16 Exposure is measured or estimated (see Clause 6.2.4). In the absence of information to evaluate the respiratory hazards, the most protective respirator selection shall be considered. 18 See the definition of Immediately dangerous to life or health (IDLH) atmosphere in Clause 3; refer also to Clause 6.2.7. 21 See the definition for Hazard ratio in Clause 3. Exposures shall be compared to relevant occupational exposure limits (e.g., time-weighted average, short term, or ceiling). 26 See the definition for Highest hazard ratio in Clause 3. When more than one contaminant is present, the possibility of synergistic effects shall be assessed by a qualified person. 29 The APF for a loose-fitting helmet/hood shall be a maximum of 25 where there is no simulated workplace protection factor (SWPF) or workplace protection factor (WPF) study supplied by the respirator manufacturer. 33 The APF for a loose-fitting helmet/hood shall be a maximum of 1000 where a simulated workplace protection factor (SWPF) or workplace protection factor (WPF) study supplied by the respirator manufacturer supports this level of protection. 34 Where the highest hazard ratio is known to be greater than 10 000, measures shall be taken to reduce the concentration of airborne contaminants. Level 5 respirators selected from Figure 4 are suitable only for a highest hazard ratio that does not exceed 10 000. See Clause 10.2 for requirements for change-out procedures, schedules, and service time. 39 46 The choice of Series R or P and 95, 99, or 100 class particulate filters should be based on regulatory requirements and operational needs. User comfort issues and acceptance should be considered. 47 The choice of Series N, R, or P and 95, 99, or 100 class particulate filters should be based on regulatory requirements and operational needs. User comfort issues and acceptance should be considered. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 19 Z94.4-11 © Canadian Standards Association The use of goggles necessitates additional criteria for the review of intended use conditions (e.g., proper integration with the respirator, fogging). 51 Some respirators identified might no longer be available, but the approval is retained for existing equipment. All limitations for the respirator at the time of testing and certification shall remain applicable. 52 The selection process is complete. Record all information used to make the selection. Record the results of the review of the limitations under the anticipated conditions of use. Then proceed to Figure 4 to identify acceptable options for the level of protection required. 20 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association 1 Risk assessment concludes that a respirator is required Note: Use this chart in conjunction with Clause 7.3 of CSA Z94.4, Selection, use, and care of respirators. Where exposure involves first responders during CBRN events, refer to CAN/CGSB/CSA Z1610. 2 Regulation prescribes specific respirator? Yes Selection, use, and care of respirators No 4 Yes Hazard is a bioaerosol? Legend: 14 No 15 Hazard involves abrasive blasting? = Process step: requires information Select airline type CE respirator or one approved for protection against abrasive blasting Yes Yes = Answer by Yes or No No No 16 Respiratory hazards evaluated? Yes 18 Identify the bioaerosol IDLH environment exists? 5 = Record selection and proceed to next step No Yes = Navigation marker = Navigation marker with guidance No 13 Complete the selection process to protect against all other respiratory hazards 19 Yes OEL exists? = Line text indicates option No 20 Yes 6 Can a workplace OEL be established? 21 Transmission of disease, infection, or adverse effects produced from inhalation of bioaerosol. Calculate and record a hazard ratio for each respiratory hazard Yes Oxygen 22 concentration below 19.5% at sea level? 17 Select any respirator from the Hierarchy of Respiratory Protection with a Level 5 No Yes 24 23 Oxygen deficiency is the only respiratory hazard? No Select any airline respirator from the Hierarchy of Respiratory Protection with a Level 2 Yes No No 26 Select Control Banding Approach for Bioaerosols in Health Care (Figure 2) or for Bioaerosols in General Workplaces (Figure 3) Cause for oxygen deficiency shall be identified and monitored 27 7 Highest hazard ratio (HHR) for any gas, vapour, or particulate <– 10? Select any respirator from the Hierarchy of Respiratory Protection with a Level 1 Yes 35 29 28 8 Select a Risk Group e.g. R1, R2, R3, or R4. HHR < – 25 Select any respirator from the Hierarchy of Respiratory Protection with a Level 2 Yes 36 Oxygen concentration below 19.5 % at sea level? No 25 Cause for oxygen deficiency shall be identified and monitored Yes No No 37 31 9 Select a Generation Rate e.g. G1, G2, G3, or G4. 30 HHR <– 50 Gas or vapour hazard ratio > 1 Select any respirator from the Hierarchy of Respiratory Protection with a Level 3 Yes 38 No or atmospheresupplying respirator selected 32 HHR <– 1000 Select any respirator from the Hierarchy of Respiratory Protection with a Level 4 Yes 11 Select any respirator from the Hierarchy of Respiratory Protection with a Level 5 Colour and number of segment selected corresponds to the range of acceptable options in Figure 4 — Hierarchy of Respiratory Protection. Follow Regulation: Use professional judgment to protect against all respiratory hazards Yes 39 Yes No 3 Gas and/or vapour purifying element available? No 33 10 Select a Control Level e.g. C1, C2, C3, or C4. Yes No Change-out schedule or ESLI available? 34 40 Select appropriate gas and/or vapour purifying element No 42 Yes 12 Other respiratory hazards are present? 43 44 Select HEPA class particulate filter Yes Particulate hazard ratio > 1 Powered airpurifying respirator style selected in Figure 4? Yes No or atmospheresupplying respirator selected 41 Air-purifying respirator is not an appropriate selection. Select a respirator from the atmospheresupplying options in the appropriate level of the Hierarchy of Respiratory Protection. No No 45 Yes or unknown Airborne oil present? 51 Review limitations of selected respirator against intended use conditions. Refer to Annex G 52 Selection complete. Record and proceed to Figure 4 No 46 Select any Series R or P particulate filter (e.g. R95, R99, R100, P95, P99, or P100) 47 Select any Series N, R, or P particulate filter (e.g. N95, N99, N100, R95, R99, R100, P95, P99, or P100) 48 Yes Select an alternative facepiece style with eye protection or add CSA Z94.3 class 2(b) non-ventilated goggles 50 Yes 49 Eye irritant or ocular absorption? Half-facepiece selected in Figure 4? No No Figure 1 Respirator selection flow chart (See Clauses 7.3.1.3, 7.3.2.2, 7.3.3, 7.3.4.1, 7.3.4.2, 7.3.4.7, and 8.1.2 and Figures 2 to 4.) August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 21 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Risk group Agents not associated with disease or serious adverse health effects in healthy adult humans R1 Agents associated with human disease or adverse health effects that are rarely serious and for which preventive or therapeutic interventions are usually available R2 Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Agents likely to cause serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions are not usually available (high individual risk and high community risk) C3 G4 1 R1 C2 2 1 2 C2 C1 G1 Patient coughing or sneezing with mouth covered G2 Patient coughing or sneezing with mouth uncovered G3 Aerosol-generating procedures G4 G4 Corridor or patient room, 3–6 ACH C2 Negative pressure, laboratory, autopsy, 6–12 ACH C3 Surgery >12 ACH C4 1 0 0 G1 1 1 1 1 1 2 C3 G1 G2 G3 1 1 G2 G3 1 G4 1 3 1 1 C1 1 1 1 1 1 C2 1 2 4 R3 0 0 1 1 C4 0 0 0 1 1 1 1 1 0 0 G1 1 C4 G1 1 1 1 1 1 1 2 G2 1 G4 C2 C1 C3 C4 23 Figure 2 Control banding approach for bioaerosols in health care facilities (See Clauses 7.3.2.2 and 7.3.2.3.4 to 7.3.2.3.8, Figure 1, and Annex K.) R2 Selection, use, and care of respirators C1 1 1 G3 G2 1 Control level Poorly ventilated, <3 air changes per hour (ACH) 3 1 1 2 4 R4 C3 1 1 2 R3 G3 1 3 Generation rate Patient not coughing or sneezing C1 C4 R4 © Canadian Standards Association August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Health care facilities Risk group Agents not associated with disease or serious adverse health effects in healthy adult humans Agents associated with human disease or adverse health effects that are rarely serious and for which preventive or therapeutic interventions are usually available Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Agents likely to cause serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions are not usually available (high individual risk and high community risk) C1 C4 R4 C3 R1 G4 2 R1 C2 2 1 3 C2 R2 3 4 1 2 G2 1 1 G1 1 3 R4 1 1 1 0 1 1 G1 G1 1 0 0 C4 1 0 2 G3 G2 1 1 2 4 G4 C3 1 2 2 C1 G3 2 R3 Z94.4-11 24 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. General workplace environments G2 G3 G4 Generation rate Low release of bioaerosol / pathogen — vacuuming with a HEPA filter G2 High release of bioaerosol / pathogen — misting then shovelling 1 1 C4 1 1 C1 Indoor — ventilation 1 < ACH < –4 Outdoor — no wind C2 Indoor — ventilation 4 < ACH < –6 Outdoor — low wind C3 Indoor — ventilation > 6 Outdoor — moderate wind C4 3 C3 G1 G2 G3 1 1 1 3 1 1 C1 1 1 1 1 1 C2 1 2 4 R3 2 1 G4 C2 C1 C3 C4 August 2011 Figure 3 Control banding approach for bioaerosols in general workplace environments (See Clauses 7.3.2.2 and 7.3.2.3.4 to 7.3.2.3.8, Figure 1, and Annex K.) R2 © Canadian Standards Association Indoor — poorly ventilated ACH < –1 1 2 Control level 1 2 G3 G4 1 1 1 1 1 1 1 Medium release of bioaerosol / pathogen — soaking then shovelling Very high release of bioaerosol / pathogen — dry sweeping G1 0 1 2 3 4 5 Air-purifying options APF Atmosphere-supplying options SCBA (pressure-demand) full-facepiece 5 No air-purifying option available 10000 SCBA (pressure-demand) tight-fitting hood Multi-functional SCBA/airline Airline (continuous-flow) full-facepiece Powered air-purifying full-facepiece 4 to 5 Powered air-purifying helmet/hood with SWPF study Powered air-purifying half-facepiece 3 to 5 2 to 5 1 to 5 Air-purifying (negative-pressure) full-facepiece 1000 Airline (continuous-flow) helmet/hood with SWPF study 50 Airline (pressure-demand) half-facepiece Airline (continuous-flow) half-facepiece Airline (continuous-flow) loose-fitting facepiece/visor Powered air-purifying loose-fitting facepiece/visor Powered air-purifying helmet/hood without SWPF study Airline (pressure-demand) full-facepiece © Canadian Standards Association August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Acceptable level 25 Airline (continuous-flow) helmet/hood without SWPF study Air-purifying (negative-pressure) half-facepiece (including filtering facepieces) 10 No atmosphere-supplying option available No respiratory protection required <1 No respiratory protection required Figure 4 Hierarchy of respiratory protection (See Clauses 7.3.1.3, 7.3.2.2, 7.3.2.3.8, 7.3.3, 7.3.4.7, 9.3.3, 9.4.2, and 9.4.3, Tables 1 and 2, Figure 1, and Annex K.) 25 Selection, use, and care of respirators Notes: (1) See Tables 1 and 2 for fit test pass/fail criteria for tight-fitt ng respirators. (2) Fit testing is not required for loose-fitt ng respirators. Z94.4-11 © Canadian Standards Association 8 Training 8.1 Competencies 8.1.1 General Table 3 provides a matrix summarizing the training requirements for a respiratory protection program; the table references the clause numbers in this Standard applicable to each defined role. Because communication with other role-holders in the program will be essential, each person fulfilling a defined role should understand how that role relates to the other defined roles. Note: The summary of training matrix in Table 3 is intended to describe the training competencies required to fulfill the roles and responsibilities listed in Clause 5. In many organizations, one person can fulfill more than one defined role and will therefore require multiple competencies. 8.1.2 Respirator selection process The selection process shall include a detailed review of factors such as workplace conditions, hazardous materials and exposures, and relevant standards in order to specify a range of appropriate respirator options. Accurate records shall be maintained to support this activity. See Clauses 6 and 7 and Figure 1. 8.1.3 Respirator user screening and medical assessment This activity requires an understanding of the health assessment process, physiological and psychological conditions that could require reassessment, and individual accountabilities. An initial assessment of user suitability may be performed by someone who is not a health care professional but is working under the direction of a health care professional. A respirator user screening form is a tool to identify user suitability or flag any health concerns that warrant a medical assessment by a health care professional. For a sample of a respirator user screening form, see Figure E.1. A medical assessment shall consist of a review and written opinion by a health care professional as to the suitability of the worker to safely use a respirator. Accurate records, excluding personal medical information, shall be maintained. See Parts 6 and 7 of the sample respirator user screening form provided in Figure E.1. 8.1.4 Fit testing The fit tester shall be competent in the applicable fit test methods and be able to verify a user’s ability to obtain an effective respirator seal, comfort, and fit for a tight-fitting respirator. The fit tester shall also be able to manage the overall fit testing process, including the transition between sensitivity screening and fit testing where applicable, interpret test results, and document user, respirator, and instrument performance. See Annex J for a checklist that can be used as a supplement to the summary of training matrix provided in Table 3 to determine the competency of fit testers. 8.1.5 Instruction Provision of instruction to program participants requires a practical understanding of the respiratory protection program requirements. A qualified person shall provide instruction regarding the requirements of the respiratory protection program, including (a) policies, procedures, roles, and responsibilities; (b) the respiratory hazards encountered in the workplace, their potential health effects on the worker, and the means to control them; (c) the rationale for the respirators selected and where to find more information about them; and (d) procedures to follow in case of an emergency. Note: Documentation of all program instruction should be maintained. 26 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 8.1.6 Care and practical use Training in the care and practical use of respirators shall consist of instruction, facilitator demonstration, participant practice and demonstration of competency in procedures and practices relating to (a) the choice of the appropriate respirator for the anticipated hazard; and (b) the operation of each respirator, including (i) donning and doffing (avoiding contamination) and, where required, redonning of respirators; (ii) user seal checks; (iii) care; (iv) cleaning; (v) inspection; (vi) end-of-service recognition; (vii) change-out of filter elements; (viii) replacement of air cylinders; (ix) identification of problems; (x) use under failure or emergency modes; (xi) storage; (xii) removal from service; (xiii) basic maintenance; and (xiv) familiarity with and adherence to the manufacturer’s instructions. 8.1.7 Limitations Limitations are the restrictions, cautions, warnings, and prohibitions imposed by manufacturers, testing and certification agencies, authorities having jurisdiction, and employers on the use, care, and maintenance of the respirator. See Annex G. 8.1.8 Repair and maintenance Repair and maintenance consist of those activities related to restoring a respirator to the manufacturer’s original operating condition, including (a) operation of the respirator; (b) care, cleaning, and inspection; (c) end-of-service recognition; (d) change-out of filter elements; (e) replacement of air cylinders; (f) identification of problems; (g) storage; (h) removal from service; and (i) familiarity with and adherence to the manufacturer’s instructions. This function requires that the individual maintain appropriate records. These activities can require a periodic proficiency review to the manufacturer’s standards. 8.2 Provision of training 8.2.1 Training shall be provided by a qualified person or persons with a practical understanding of the respiratory protection program roles, responsibilities, and requirements and the ability to coordinate the multiple training requirements of the program. 8.2.2 Provision of role-specific training, as applicable for each assigned respiratory protection program role or activity, requires task-specific qualification and expertise. Note: Depending on the requirements of the program, complexity of respiratory protection requirements, and the training needs of the program participants, more than one trainer might be required. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 27 Z94.4-11 © Canadian Standards Association 8.2.3 Role-specific training shall include the following: (a) instruction for program participation (see Clause 8.1.5); (b) reference to the applicable sections of the respiratory protection program; (c) exercise of required practices and procedures, including the following where applicable: (i) care and practical use of respirators (see Clause 8.1.6); (ii) limitations and their impact on respirator use (see Clause 8.1.7); (iii) repair and maintenance (see Clause 8.1.8); and (iv) drills for controlled practice of respirator use under the conditions to be expected in the workplace to maintain a standing level of competency; and (d) demonstration of the level of competency as defined in the assigned respiratory protection program role(s) (see Clause 5). 8.2.4 The employer shall provide additional training for the respirator user or other individual assigned one or more roles in the respiratory protection program where (a) a review cannot confirm that the individual remains qualified; (b) the program administrator indicates that additional training is required [see Clause 13.2(i)]; or (c) a review indicates that additional training is needed to meet the required level of competency. Where such training is required, it shall be designed, delivered, evaluated, and documented to ensure that it meets the requirements of this Standard. 8.3 Training records Accurate records shall be maintained in accordance with Clause 14.5 so that documentation of training is available for all individuals with assigned roles in the respiratory protection program. 9 Respirator fit testing 9.1 General 9.1.1 The purpose of a qualitative or quantitative fit test is to verify a user’s ability to obtain an effective seal and an acceptably comfortable fit for a selected tight-fitting respirator. The fit test process also verifies that a user is able to demonstrate the required level of competency in donning and doffing the respirator, as well as inspecting it and performing a user seal check. 9.1.2 No person shall use or be assigned to use a tight-fitting respirator until a satisfactory fit has been verified by a qualitative or quantitative fit test. 9.1.3 The fit test shall be used to verify the selection of the specific make, model, and size of a tight-fitting respirator for individual users. A sufficient variety of respirators shall be provided to ensure that each user has an opportunity to obtain a satisfactory fit because no single make, model, or size can be expected to fit all persons. The fit tester shall not force fit a respirator being fit tested. Note: Force fitting is the practice of repeating a failed fit test with the same respirator by redonning or otherwise adjusting it (e.g., overtightening the straps) until a fit test pass is finally obtained. The user may adjust the respirator but comfort should be maintained. Offering a reasonable array of respirator types and sizes should eliminate the inclination to force fit. 28 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 9.1.4 When respirators used for fit testing are not individually assigned, cleaning and sanitizing shall be performed before the next use. Respirators that cannot be sanitized (e.g., filtering facepieces) shall not be used by more than one person in fit testing. See Annex F. 9.1.5 At a minimum, when fit testing hoods are employed, they shall be cleaned and sanitized between each person being fit tested. 9.1.6 A fit test shall be carried out (a) after completion of user screening (see Clause 12.1); (b) after or during training (see Clause 8); (c) prior to initial use of a tight-fitting respirator; (d) when changes to a user’s physical condition (e.g., significant weight change or changes to facial or dental features) could affect the respirator fit; (e) when there is a change in respirator (e.g., make, model, size); (f) when a respirator user experiences continued significant discomfort during use or difficulty in completing a successful user seal check; (g) when there is a change in PPE use that could affect the respirator; and (h) at least every 2 years. 9.1.7 Tight-fitting respirators shall be tested only in the negative-pressure mode regardless of the mode of operation in which the respirator is to be used. Note: This can be accomplished by temporarily converting the user’s facepiece into negative-pressure mode or by using a surrogate negative-pressure air-purifying respirator with identical sealing surface. 9.2 Respirator interference concerns 9.2.1 General The program administrator shall ensure that potential interferences to the fit and function of the respirator are effectively managed according to the requirements described in Clause 9.2. Fit testers shall follow the requirements of the program and shall not perform a fit test if they observe that the person is not free from interference where the respirator seals to the skin of the face or neck. Individuals who are unwilling or otherwise unable to comply with the interference-free requirement, or who are unable to obtain an acceptable fit, shall be prohibited from using a tight-fitting respirator. 9.2.2 Facial hair Individuals shall present themselves for fit testing free from interference of hair where the respirator seals to the skin of the face or neck. Although the rate of hair growth varies (see examples of acceptable and unacceptable facial hair in Annex M), for many this requires being clean-shaven within the previous 24 or preferably 12 h to ensure that hair neither infringes on the sealing surface of the respirator nor interferes with valve or respirator function. A “clean-shaven” policy is best implemented through emphasis on its importance during training, through regular reminders, and ongoing verification of conformance. 9.2.3 Personal conditions Individuals shall present themselves for fit testing in the same personal condition they would expect to be in when using the respirator. This includes hair styles (e.g., hair buns) and wearing or not wearing dentures, eyeglasses, or contact lenses. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 29 Z94.4-11 © Canadian Standards Association 9.2.4 Personal effects or accessories Individuals shall present themselves for fit testing in such a way that personal accessories such as head coverings, garments, facial jewellery, or other items shall not come between the skin and the sealing surface of the respirator. Note: Such accessories can impair respirator effectiveness by interfering with valve function, respirator adjustability, and proper secure positioning. Makeup, creams, or lotions can also interfere with effective respirator function. 9.2.5 PPE integration When PPE such as eye, face, head, or hearing protectors or protective garments are required to be worn during respirator use, they shall be worn during respirator fit testing to ensure that the respirator seal is not compromised. 9.3 Pass criteria 9.3.1 A satisfactory fit using QLFT shall be verified when the fit test results satisfy the criteria specified in Table 1. 9.3.2 A satisfactory fit using QNFT shall be verified when the fit test results satisfy the criteria specified in Table 2. 9.3.3 The applicable assigned protection factor listed in Figure 4 shall be used subject to the applicable limitations of the QLFT or QNFT method. Note: Fit factor criteria in Tables 1 and 2 are derived as follows: A safety factor of 10 is applied to the assigned protection factors of all tight-fitting facepiece respirators operating in air-purifying (negative-pressure) mode. The relationship between “assigned protection factor”, “safety factor”, and “fit factor” can be expressed as APF × safety factor = minimum fit factor to demonstrate a pass Because QLFT test methods have been validated only for a fit factor of 100, a tight-fitting respirator operated in air-purifying (negative-pressure) mode can be tested by QLFT methods to validate a maximum APF of 10. Therefore, the maximum APF that can be used for all tight-fitting respirators operated in air-purifying (negative-pressure) mode is 10 where a QLFT method is used. See Table 1 and Figure 4. 9.4 Qualitative fit testing (QLFT) 9.4.1 Qualitative fit testing shall be conducted in accordance with one of the procedures described in Annex B. Only QLFT methods that are appropriate for the respirator as referenced in Table 1 shall be used. QLFT shall not be used for SCBA and multi-functional SCBA airline applications. 9.4.2 With the exception of full-face negative-pressure respirators (see Clause 9.4.3), the assigned protection factors listed in Figure 4 for the type of respirator chosen shall be applied subject to a satisfactory fit using QLFT. 9.4.3 For full-face negative-pressure respirators, the assigned protection factors listed in Figure 4 shall be applicable subject to a satisfactory fit test using QLFT only under the limitations specified in Table 1, i.e., where the highest hazard ratio (HHR) is less than or equal to ten. 30 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 9.5 Quantitative fit testing (QNFT) Quantitative fit testing shall be conducted in accordance with one of the procedures described in Annex C. Only QNFT methods that are appropriate for the respirator as referenced in Table 2 shall be used. 9.6 Fit test records The program administrator shall ensure that procedures are established to maintain fit test records in accordance with Clause 14.4. 10 Use of respirators 10.1 General 10.1.1 User requirements Before being assigned any task that requires the use of a respirator, the user shall meet all the health screening, training, and fit testing requirements in this Standard. 10.1.2 Breakthrough detection Workers shall exit a contaminated work area whenever they detect the odour of the contaminant or experience any irritation symptoms caused by it; see Clause 10.2.1.1. 10.1.3 Tight-fitting respirator seal with skin 10.1.3.1 To promote the safety of persons using tight-fitting respirators, the seal to the face or neck shall be effectively maintained in accordance with the requirements of Clause 9.2 throughout the period during which respirator use is required. If during the course of work, a person develops any condition that degrades the respirator seal to the face or neck, the person shall restore the required interference-free condition in a non-hazardous environment. 10.1.3.2 Respirators requiring a tight fit in order to perform effectively shall not be worn when an effective seal to the face or neck of the person cannot be achieved and maintained. 10.1.3.3 When using tight-fitting respirators, persons shall wear or not wear dentures according to the conditions under which a successful fit test was obtained. 10.1.3.4 Temples on eyeglasses or any other materials such as hair, cloth, tissue, straps, or jewellery shall not come between the skin and the sealing surface of the facepiece or interfere with the operation of the respirator. Potential interferences shall be managed in accordance with Clause 9.2. 10.1.3.5 The use of contact lenses may be approved by the program administrator after consideration of those factors inside and outside the tight-fitting respirator that could affect the eyes of the user. See Annex E. 10.1.3.6 Where other personal protective devices or equipment are required to be worn in conjunction with a respirator, potential incompatibilities shall be managed according to Clause 9.2. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 31 Z94.4-11 © Canadian Standards Association 10.1.3.7 Persons who cannot achieve and maintain an effective closure of the nose or a seal around a respirator mouthpiece shall not be permitted to use a mouthpiece and nose-clip type of respirator. 10.1.4 User seal check of face-to-facepiece seal The user of a respirator shall check the seal of the facepiece immediately after donning the respirator, by procedures recommended in Annex A or by other procedures recommended by the respirator manufacturer. A user seal check shall not be used as a substitute for a qualitative or quantitative fit test. 10.2 Change-out procedures, schedules, and service time 10.2.1 General 10.2.1.1 A qualified person shall establish a change-out schedule for the replacement of air-purifying filters or cartridges of respirators before their useful service life is ended. Warning properties of the contaminant shall not be relied on for cartridge/canister change-out. Should workers detect odour or experience any irritation symptoms of the contaminant before the end of the change-out schedule, the respirator program administrator shall be informed and shall re-evaluate this respirator use, i.e., the change-out schedule, the workplace concentrations, or other conditions of use [relative humidity (RH), work rate, etc.]. Note: Change-out can include end-of-service-life indicators, maximum use time, and breathing resistance as appropriate. 10.2.1.2 The useful service life of a gas/vapour cartridge or canister or a particulate filter is affected by several factors, including (a) the contaminant’s chemical properties, physical state, and concentration; (b) the environment, temperature, humidity, and atmospheric pressure; (c) the physical/chemical characteristics of the air-purifying element; surface area, volume, and the mechanism used to remove the contaminant; filtration, electrostatic charge, and absorption or adsorption; (d) the effectiveness of the air-purifying element against the contaminants; (e) the breathing rate and volume of the respirator user; and (f) the pattern of use, whether continuous or intermittent. 10.2.2 Gas/vapour-removing cartridges or canisters 10.2.2.1 Gas/vapour-removing cartridges or canisters equipped with an end-of-service-life indicator shall be replaced when the indicator dictates. 10.2.2.2 Gas/vapour-removing cartridges or canisters not equipped with an end-of-service-life indicator shall be replaced based on an established procedure or schedule that ensures that the cartridge is changed before the service life has ended. 10.2.2.3 The selection of air-purifying respirators shall include a change-out schedule calculated by a qualified person using the manufacturer’s product information or estimated based on knowledge of the effectiveness of the cartridge or canister to remove the contaminant. The respirator manufacturer should be consulted for guidance on the effectiveness of any specific respirator or air-purifying element against the contaminant for which protection is needed. (See Clause G.4.) 32 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 10.2.2.4 Particulate filters 10.2.2.4.1 Particulate filters shall be replaced (a) if they become damaged or unhygienic; or (b) based on the employer’s change-out schedule. 10.2.2.4.2 Particulate filters (N, P, and R filters) shall be replaced when breathing becomes difficult or as recommended by the manufacturer. In the case of powered air-purifying respirators (PAPRs), particulate filters shall be replaced when the air flow does not meet the manufacturer’s requirements. 10.2.2.4.3 If used in atmospheres where oil is present, R filters shall be replaced after 8 h of use or after the respirator has been exposed to 200 mg of the contaminant. R filters shall be used for more than 8 h only if a change-out schedule is calculated by a qualified person based on representative airborne particulate concentrations and estimated breathing rate (tidal volume). 10.2.2.4.4 The change-out schedule for combination gas/vapour and particulate cartridges or canisters with non-separable air-purifying elements shall be based on the lesser service time for either the gas/vapour or the particulate constituent. 10.2.2.5 Self-contained breathing apparatus service time 10.2.2.5.1 Structural firefighting For structural firefighting, pressure-demand SCBA with a rated service time of 30 min or more shall be used. Note: The requirements of NFPA Standard 1981 should be consulted for additional performance requirements for SCBAs for firefighting. 10.2.2.5.2 Entry into an IDLH atmosphere Pressure-demand SCBA or a multi-functional SCBA/airline respirator with auxiliary self-contained air supply, with a minimum rated service time of 15 min, shall be used for entry into IDLH atmospheres. Where a multi-functional SCBA/airline respirator is used for entry using the auxiliary air supply, no more than 20% of the auxiliary air shall be used before connection is made to an airline. 10.2.2.5.3 Escape from an IDLH atmosphere For escape from IDLH atmospheres, the SCBA or escape SCBA shall have a rated service time in excess of the anticipated time needed to escape. 10.3 Breathing gas 10.3.1 Only compressed breathing air meeting the requirements of CSA Z180.1 shall be used in open-circuit SCBAs, airline respirators, and supplied-air suits. Compressed oxygen shall never be used in respirators manufactured for use with compressed breathing air. Note: Compressed breathing air can contain low concentrations of oil. Oxygen forms explosive mixtures with organic materials such as oil and grease. Gaseous oxygen is a powerful oxidizer and can constitute a considerable fire hazard. 10.3.2 Compressed breathing oxygen shall meet the purity requirements of CGA G-4.3. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 33 Z94.4-11 © Canadian Standards Association 10.4 Communications 10.4.1 The respirator face-to-facepiece seal shall not be broken to communicate. Note: Verbal communication while using a respirator is often necessary to perform specific tasks; however, movement of facial features while talking can adversely affect the seal of the facepiece. The use of various types of mechanical and electronic speech transmission devices can minimize the possibility of facepiece leakage when the user is speaking. 10.4.2 Respirators for use in a hazardous atmosphere that requires intrinsic safety and that are equipped with electronic speech transmission devices having an electrical power supply shall be intrinsically safe. Note: In extremely cold weather, battery power can be unreliable. 10.5 Buddy breathing Buddy breathing shall not be permitted. See Annex I. 10.6 Special requirements for general industrial use 10.6.1 Use in high- and low-temperature environments Respirators used in high- and low-temperature environments can undergo adverse functional changes that affect apparatus performance and, in turn, the safety and health of the user. Strict adherence to good maintenance and repair procedures shall be maintained, and users shall be trained in the use and limitations of respirators at these extreme temperatures. See Annexes D and G. 10.6.2 Use of respirators in IDLH atmospheres 10.6.2.1 Respirator users shall not remove their facepieces at any time while working in an IDLH atmosphere. 10.6.2.2 For additional requirements where respirators are used during firefighting, hazmat response, mine rescue, or confined space entry, reference shall be made to legislation, regulations, standards, and guidelines. Note: For example, see NFPA 1404, NFPA 1500, and CSA Z1006. 10.6.2.3 Respirator selection shall be carried out for both non-emergency and emergency use. The respirator selected in both instances may be the same, but respirators approved for escape only shall be used only for escape. 11 Cleaning, inspection, maintenance, and storage of respirators 11.1 General 11.1.1 Each respirator shall be properly maintained to retain its original effectiveness. An acceptable program of care and maintenance shall include (a) cleaning and sanitizing; (b) inspection, testing, and repair; (c) storage; and (d) recordkeeping. 34 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 11.1.2 Defective or nonfunctioning respirators shall be identified as out of service or the equivalent (e.g., by being tagged) and shall be replaced or removed from service until repaired. 11.2 Cleaning and sanitizing 11.2.1 Respirators shall be cleaned and sanitized according to the respirator manufacturer’s instructions or according to procedures authorized by the program administrator in consultation with the respirator manufacturer. Respirators designed not to be cleaned shall be disposed of after use as directed by the manufacturer. Note: See Annex F for cleaning and sanitizing procedures. 11.2.2 When the respirator is not individually assigned, cleaning and sanitizing shall be performed before the next use. 11.3 Inspection 11.3.1 General Users shall inspect their respirators before and after each use. 11.3.2 Inspection coverage 11.3.2.1 Respirator inspection shall include, where applicable, the following: (a) condition of component parts (e.g., facepiece, helmet, hood, suit, head harness, valves, connecting tubes, harness assemblies, filters, cartridges, canisters, cylinders); (b) tightness of connections; (c) end-of-service-life indicator; (d) shelf-life dates; and (e) proper functioning of regulators, alarms, and other warning systems. 11.3.2.2 Pressure gauges of all breathing gas cylinders in service shall indicate that the cylinders are within the “Full” range. Cylinders with gauges indicating less than the “Full” range shall be recharged in accordance with the manufacturer’s instructions. 11.3.2.3 Oxygen-generating canisters and CO2 sorbent in closed-circuit apparatus shall be new and capable of providing full rated service. 11.3.2.4 Respirators shall be inspected in accordance with the manufacturer’s instructions. If they do not pass the inspection, the respirator shall be tagged and removed from service. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 35 Z94.4-11 © Canadian Standards Association 11.3.3 Inspection of SCBA cylinders 11.3.3.1 General requirements for inspection of steel, aluminum, and fibre-reinforced cylinders 11.3.3.1.1 A qualified person shall inspect cylinders externally and internally according to (a) CSA B339 and CSA B340; (b) CGA C-6, C-6.1, or C-6.2 as applicable; (c) applicable transport regulations; and (d) the manufacturer’s instructions. Notes: (1) Visual internal inspections are required for all cylinders at the time of their hydrostatic testing; see Clause 11.6.2 for hydrostatic testing requirements. (2) In Canada, applicable transport regulations are issued by Transport Canada under the Transportation of Dangerous Goods Act. 11.3.3.1.2 All composite SCBA cylinders (e.g., fibreglass, Kevlar, carbon-wrapped, or hoop-wound) shall be removed from service no later than 15 years from their date of manufacture. 11.3.3.1.3 Steel and aluminum cylinders over 15 years old shall have the interior of the cylinder inspected at least annually by a qualified person when these cylinders are in current use. Note: This Clause does not extend the service life of cylinders. 11.3.3.1.4 After each use of a cylinder and before it is refilled, a qualified person shall inspect its exterior for signs of external damage. 11.3.3.1.5 Cylinders showing signs of external damage shall be immediately depressurized and removed from service and, prior to return to service, inspected in accordance with the requirements of Clause 11.3.3.1.1. 11.3.3.1.6 Cylinders showing damage to the paint shall be inspected. If the damaged cylinders require repairs, they shall be carried out as soon as possible by a qualified person in accordance with the manufacturer’s instructions and specifications. 11.3.3.1.7 Cylinders stored in accordance with the requirements of Clause 11.5.4 shall be checked to ensure that the hydrostatic test date is current before the cylinders are returned to service. 11.3.3.2 Special inspection requirements for emergency-use SCBA 11.3.3.2.1 SCBA shall be inspected on a schedule to ensure readiness for emergency use. 11.3.3.2.2 The program administrator shall establish procedures for keeping a record of all inspections and service performed on an emergency-use SCBA and cylinder in accordance with Clause 14.6.2. 36 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 11.4 Repair and test 11.4.1 Any used oxygen-generating canister shall be disposed of in accordance with the manufacturer’s instructions. The spent CO2 sorbent in a closed-circuit apparatus shall be replaced or refilled after each use. 11.4.2 Where inspections specified in Clauses 11.3.1 and 11.3.3 indicate that repairs or rebuilding, or both, of a respirator or cylinder are required, such repairs and subsequent tests and checks shall be carried out in accordance with the manufacturer’s instructions. Used respirators shall be reconditioned to accepted manufacturer’s standards, and used SCBAs shall be reconditioned by the manufacturer or authorized service agents prior to use after ownership is transferred. 11.4.3 Qualified persons shall repair and test respirators and cylinders, using original manufacturer’s replacement parts and repair procedures. 11.4.4 The frequency with which the pressure-regulating system of a respirator is rebuilt shall be governed by the manufacturer’s recommendations and as inspection and performance require. SCBA shall not be modified to accommodate a resuscitator nor shall it be used as such. 11.4.5 Facilities where repairs or tests on cylinders are performed shall be registered to meet the requirements of CSA B339 and CSA B340. 11.5 Storage 11.5.1 Respirators shall be stored in a manner that will protect them against dust, ozone, sunlight, heat, extreme cold, excessive moisture, vermin, damaging chemicals, oils, greases, or any other potential hazard that can have a detrimental effect on the respirator. 11.5.2 Respirators shall be stored in a manner that will prevent deformation of rubber or other elastomeric parts. 11.5.3 Emergency- and rescue-use respirators placed in work areas shall be quickly accessible at all times and the storage cabinet, container, or holder shall be clearly marked. 11.5.4 Storage of cylinders not in current use 11.5.4.1 Cylinders not in current use and those in long-term storage should be stored at reduced pressure in the vertical position (valve up) and never inverted. Notes: (1) The reduction in pressure is important because corrosion attack is reduced in decreased-oxygen partial pressures. Vertical storage reduces the extent of corrosion by minimizing the interface between metal and water. (2) Because steel cylinders are more prone to corrosion activity, vertical storage of them at reduced pressure is especially important. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 37 Z94.4-11 © Canadian Standards Association 11.5.4.2 Whenever possible, cylinders should be stored indoors in a warm, dry environment. 11.5.4.3 Unpressurized cylinders should be stored with the main valve closed. 11.5.5 Rotation of cylinders in current use 11.5.5.1 Cylinders should be numbered, colour-coded, or arranged in a manner that ensures that all of them are used on a regular basis. Note: Protective caps should be used to prevent physical damage to the cylinder valve threads and prevent dirt and moisture from entering the valve body. 11.5.5.2 Prior to using an SCBA cylinder that has not been used in any 12-month period, the air shall be discarded by slowly depressurizing the cylinder to the atmosphere and refilling it with compressed breathing air meeting the requirements of CSA Z180.1. 11.6 Hydrostatic testing and marking of SCBA cylinders 11.6.1 General SCBA cylinders that are transported shall comply with applicable transport regulations. Note: In Canada, applicable transport regulations are issued by Transport Canada under the Transportation of Dangerous Goods Act. 11.6.2 Hydrostatic test 11.6.2.1 Cylinders shall be hydrostatically tested at a frequency and in the manner described in CSA B339 and CSA B340. Note: Hydrostatic tests are required every 5 years for all SCBA cylinders. 11.6.2.2 Hydrostatic testing shall be performed by a registered facility according to the requirements of CSA B339 and CSA B340. 11.6.2.3 Hydrostatic retest data and a statement about the condition of the cylinder shall be forwarded by the hydrostatic testing organization to the owner of the cylinder or an agent of the owner. 11.6.2.4 A cylinder that fails hydrostatic testing shall be returned to the owner, who shall ensure that the cylinder is taken out of service and rendered unusable. 11.6.2.5 Hydrostatic test records shall be kept by the program administrator. 11.6.3 Cylinder markings 11.6.3.1 Cylinders shall bear the markings required in CSA B339. 38 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators 11.6.3.2 No person shall apply any markings to cylinders unless they are registered as required in CSA B339. 11.7 Filling of cylinders 11.7.1 Filling of cylinders shall be carried out at an average rate not exceeding 2 MPa/min (300 psi/min) unless the respirator manufacturer provides written instructions for a different fill rate. Filling of a cylinder while it is being worn by a person shall be permitted only in life-threatening emergencies where the SCBA user is physically unable to leave a hazardous atmosphere and shall be done in accordance with the respirator manufacturer’s instructions and written procedures. Note: This is particularly important when filling older cylinders where corrosion and other structural damage could have occurred over a long period of use. Rapid filling can also destroy the fusible plug or frangible rupture disc, causing malfunction and loss of air. 11.7.2 Cylinders shall be filled to a pressure not to exceed the maximum cylinder pressure shown on the cylinder. Note: See Transport Canada or US Department of Transportation requirements. CAUTION: It is hazardous to exceed this maximum pressure even when the pressure gauge on the cylinder could be calibrated for a pressure range greater than the maximum working pressure inscribed on it. 12 Health surveillance Note: See Annex E for guidelines, references, and documentation tools for health surveillance activities. 12.1 Prior to fit testing and respirator use, the program administrator shall ensure that documentation is completed that confirms that individuals are free from any physiological or psychological condition that could preclude them from using the selected respirator. All health information shall be treated as medically confidential. Note: A screening form for respirator users can assist in identifying such conditions. See the sample respirator user screening form in Figure E.1. 12.2 Where the program administrator or respirator user is concerned that a physiological or psychological condition exists that could preclude the use of a respirator, an opinion from a health care professional shall be obtained regarding that person’s ability to use a respirator. This opinion shall be obtained before the person is permitted to use a respirator or if a change in conditions warrants an additional opinion. 12.3 The program administrator shall establish procedures to provide documented information to the health care professional regarding the work activity, the workplace environment, and the type of respirators required. Note: See Annex E. 12.4 The program administrator shall ensure that a respirator user obtains the opinion from a health care professional who is informed about the job and the working conditions of that person. The written opinion shall indicate whether the user (a) meets medical requirements; (b) meets medical requirements with limitations; or (c) does not meet medical requirements to use the selected respirator. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 39 Z94.4-11 © Canadian Standards Association Where limitations are imposed, these shall be explicitly stated in the written opinion. Note: This opinion can be based on information provided on a respirator user screening form such as the one provided in Figure E.1 and through consultation with the user. 12.5 The program administrator shall ensure that documentation of health surveillance confirming the user’s ability to use a respirator is maintained in accordance with Clause 14.7. 13 Program evaluation 13.1 General Respirator selection, use, and care should be effectively managed within the boundaries of an appropriate respiratory protection program. A program should include mechanisms to routinely review the effectiveness of the program by verifying compliance with regulatory requirements and company standards, identifying weaknesses, and implementing appropriate corrective actions. A program review can range from an informal evaluation to a formal audit and accompanying report, depending on the level of workplace risk present and the scope and depth of the evaluation desired. The review can be performed by either internal or external resources knowledgeable in the relevant aspects of the respiratory protection program under review. 13.2 The program administrator shall ensure that the respiratory protection program is reviewed annually to ensure that it is being managed effectively and that respirator users are being adequately protected. Key elements for review can include (a) a review of program elements against regulatory requirements; (b) identification of management processes, including the clear definition of roles and responsibilities and adequate resources; (c) a review of documented program procedures; (d) examination of records to verify that documented procedures are being followed; (e) confirmation that workplace practices comply with program requirements; (f) documentation of performance problems and subsequent resolution or corrective action plans; (g) stakeholder input to verify worker acceptance (e.g., regarding comfort, ease of breathing, fatigue, vision, mobility, job interference, utility); (h) proper selection, use, and maintenance of respirators; (i) effective training of all stakeholders as evidenced by ongoing demonstration of competencies; (j) proper inspection of respirators; and (k) proper storage and maintenance of respirators. 13.3 The program administrator shall review summary information derived from the medical and biological monitoring performed, if available, to evaluate the effectiveness of the respiratory protection program. 14 Recordkeeping 14.1 General The program administrator shall ensure that appropriate records are kept of all respiratory protection program activities as required by applicable legislation, employer policy, or as outlined in this Standard. Recordkeeping should include documentation on (a) the individuals fulfilling the roles and responsibilities of the program, including corresponding with users, qualified persons, and regulators (see Clause 5); (b) hazard assessment, including periodic monitoring of the workplace atmosphere (see Clause 6); 40 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association (c) (d) (e) (f) (g) (h) Selection, use, and care of respirators selection of the appropriate respirator (see Clause 7); training (see Clause 8); respirator facial fit (see Clause 9); cleaning, maintenance, and storage of respirators (see Clause 11); health surveillance of respirator users (see Clause 12); and program evaluation (see Clause 13). Note: Records should be maintained for the duration of employment of the person trained or for a minimum of 10 years. 14.2 Records of hazard assessments 14.2.1 Records of hazard assessments shall be maintained to document the initial and ongoing need for respirators. 14.2.2 Records of hazard assessments shall be retained for the period of time required in the applicable legislation or as directed in the employer’s policy. 14.3 Records of respirator selection The selection of the appropriate respirators for the hazards identified and evaluated shall be documented. Should the respiratory hazards change, the respirator selection process shall be repeated and documented. 14.4 Records of respirator fit testing Fit test records shall be retained for respirator users and shall meet all the following requirements: (a) the name of the person tested; (b) the date of the tests; (c) the specific make, model, and size of respirator; (d) the type of fit test and test agent used; (e) pass/fail criteria for the fit test; (f) a list of additional PPE worn during the fit test; (g) notes on restrictions related to facial hair, use of dentures and corrective eyewear, or any particular fitting difficulties such as unusual facial features or use of facial jewellery or cosmetics; (h) the name of the person conducting the fit test; (i) documentation of the individual user’s competency and corresponding fit test results; and (j) documentation of the maintenance, calibration, and repair of fit test equipment. 14.5 Records of training The following training records shall be maintained: (a) training records of respirator users, specifying the content and type of training provided, the dates when the training occurred, and a record of completion; and (b) qualifications and training records of persons in other respirator program roles. The program administrator shall ensure that training records are kept for at least the duration of employment of the person trained. 14.6 Records of inspection, maintenance, and storage 14.6.1 General Records of inspection, maintenance, and storage of respirators shall be retained as required by the manufacturer’s instructions. Records for the repair and calibration of respirator maintenance tools shall also be kept. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 41 Z94.4-11 © Canadian Standards Association 14.6.2 Inspection records for emergency-use SCBA The inspection records for emergency-use SCBA shall include (a) the date of use of the respirators and cylinders; (b) the date of inspection; (c) the physical condition of the respirators and cylinders; (d) the cleaning and sanitizing of respirators; (e) the repairs done to respirators and cylinders; and (f) the tests performed on respirators and cylinders and remedial actions taken. 14.7 Records of health surveillance Records of health surveillance confirming the user’s ability to use a respirator, including any specified limitations of use, shall be retained. All health information shall be treated as medically confidential and shall be controlled and maintained by the health care professional. 14.8 Records of program evaluations Records of periodic program evaluations shall be retained to ensure that the program is being managed effectively and that respirator users are being adequately protected. 42 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Table 1 Applicable qualitative fit test (QLFT) methods and pass criteria for tight-fitting respirators (See Clauses 9.3 and 9.4, Figure 4, and Annex J.) QLFT method (all passing results for QLFT are assumed to be a fit factor of 100) Respirator type Negative-pressure air-purifying particulate (refer to Clause 9.3.3) Inlet covering type Bitter or sweet aerosol Filtering facepiece Isoamyl acetate Irritant smoke (stannic chloride) No for filtering facepiece respirators. No for filtering facepiece Type N or R respirators. Half-mask Full-facepiece (limited for use where HHR 10) Negative-pressure air-purifying gas/vapour (refer to Clause 9.3.3) Half-mask Full-facepiece (limited for use where HHR 10) Powered air-purifying particulate and gas/vapour (tested in a negative-pressure mode, i.e., without the blower activated) Half-mask Airline, continuous-flow or pressure-demand, including combination air-purifying devices (tested in negativepressure mode, i.e., without the air source, and with a surrogate facepiece converted to negative-pressure air-purifying respirators using cartridges or filters appropriate for the fit test method) Half-mask SCBA including multi-functional SCBA airline Full-facepiece Yes, when the respirator is fitted with a particulate filter and there shall be no interference with the test hood when the exercises are being performed. Yes, when the respirator is fitted with a cartridge capable of removing organic vapours. Yes for all P100 particulate filters. Full-facepiece or tight-fitting hood Full-facepiece or tight-fitting hood No August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. No No 43 (See Clauses 9.3 and 9.5, Figure 4, and Annex J.) Respirator type Negative-pressure air-purifying particulate (refer to Clause 9.3.3) Inlet covering type QNFT method Minimum Generated fit factor aerosol 100 Half-mask 100 Full-facepiece 500 Half-mask 100 Full-facepiece 500 Powered air-purifying particulate and gas/vapour (tested in a negative-pressure mode, i.e., without the blower activated) Half-mask 100 Full-facepiece 100 Airline, continuous-flow or pressure-demand, including combination air-purifying devices (tested in negative-pressure mode, i.e., without the air source, and with a surrogate facepiece converted to negative-pressure air-purifying respirators using cartridges or filters appropriate for the fit test method) Half-mask 100 Full-facepiece or tight-fitting hood 100 Full-facepiece or tight-fitting hood 1000 August 2011 SCBA including multi-functional SCBA airline (tested in negative-pressure mode, i.e., without the air source, and with a surrogate facepiece converted to negative-pressure air-purifying respirators using cartridges or filters appropriate for the fit test method) Particle counter Controlled negative pressure No for filtering facepiece respirators Yes, when the respirator is fitted with a filter that removes the generated aerosol. Consult the test equipment manufacturer. Yes Yes, when the respirator is fitted with a model-specific surrogate filter/ cartridge adapter from the fit test equipment manufacturer © Canadian Standards Association Filtering facepiece Negative-pressure air-purifying gas/vapour (refer to Clause 9.3.3) Z94.4-11 44 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Table 2 Applicable quantitative fit test (QNFT) methods and pass criteria for tight-fitting respirators (See Clauses 8.1.1 to 8.1.8.) Respirator selection process Respirator user screening Clauses 6, 7, Annexes G, K, L Clause 12 Annex E Care and practical use Limitations Repair and maintenance Clause 9, Clauses 1, 8 Annexes A, B, C, F, J, M Clause 10 Annex G Clause 11 Position Roles and responsibilities Employer Clause 4.2 Program administrator Clause 5.1 Respirator user Clause 5.2 Clause 12 Annex E Clause 9, Annexes A, B, C, F, M Clauses 1, 8 Clause 10 Annex G Clause 11 Supervisor of respirator user Clause 5.3 Clause 12 Annex E Clause 9, Annexes A, B, C, F, M Clauses 1, 8 Clause 10 Annex G Clause 11 Person selecting respirator Clause 5.4 Fit tester Clause 5.5 Issuer Clause 5.6 Respirator maintenance personnel Clause 5.7 Health care professional Clause 5.8 Clauses 6, 7, Annexes G, K, L Fit testing Instruction Clauses 1, 8 Annex G Clause 9, Clauses 1, 8 Annexes A, B, C, F, J, M Clause 11 Clauses 1, 8 Clause 11 Clauses 1, 8 45 Selection, use, and care of respirators Clause 12 Annex E © Canadian Standards Association August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Table 3 Summary of training matrix Z94.4-11 © Canadian Standards Association Annex A (informative) User seal checks Notes: (1) This Annex is not a mandatory part of this Standard but is written in mandatory language to accommodate its adoption by anyone wishing to do so. (2) For filtering-facepiece respirators, consult the manufacturers’ recommendations on specific user seal check procedures. A.1 Negative-pressure user seal check using tight-fitting elastomeric facepieces A.1.1 A negative-pressure user seal check can be conducted on air-purifying respirators and atmosphere-supplying respirators equipped with tight-fitting facepieces. This check can be difficult or impossible to conduct on respirators incorporating air-purifying elements that do not allow the inhalation inlets to be temporarily sealed. A.1.2 The procedure for conducting the negative-pressure user seal check shall be as follows: (a) The user seal check consists of closing off the inlet opening(s) of the respirator air-purifying elements so that upon inhalation, passage of air into the facepiece will not occur. In the case of atmosphere-supplying respirators, the user seal check consists of closing off the air supply hose. (b) To avoid possible disruption of the facial seal, a non-permeable, flexible plastic wrap may be used to seal the air inlets instead of attempting to maintain a seal with the hands. (c) The user shall inhale gently and hold a breath for at least 5 s. The facepiece will collapse slightly on the face and shall remain collapsed while the breath is held. (d) During this period, the facepiece shall not be disturbed by the user attempting to maintain a seal on the inlet opening of the air-purifying elements. (e) If the facepiece remains collapsed while a breath is being held, the user seal check is successful. (f) If the facepiece does not remain collapsed while a breath is being held, the user shall verify that nothing obstructs the sealing surface, adjust the facepiece and harness, and repeat the user seal check. (g) If the facepiece still does not remain collapsed while a breath is being held, then the user shall remove the respirator, inspect the components for the cause of the leakage, correct any problems discovered, or obtain a replacement respirator and repeat the user seal check. (h) Users shall not use a respirator for which a user seal check cannot be completed successfully. A.2 Positive-pressure user seal check using tight-fitting elastomeric facepieces A.2.1 A positive-pressure user seal check can be conducted on respirators equipped with tight-fitting facepieces that contain both inhalation and exhalation valves. 46 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators A.2.2 The procedure for conducting the positive-pressure user seal check shall be as follows: (a) Don the respirator facepiece, closing off the exhalation valve or breathing tube, or both, and exhaling gently. Note: For some respirators, the positive-pressure user seal check requires that the exhalation valve cover be removed, then replaced following completion of the user seal check. (b) During this period, the facepiece shall not be disturbed by the user attempting to maintain a seal on the exhalation valve. (c) If a slight positive pressure can be maintained inside the facepiece without detection of any outward leakage of air, the user seal check is successful. (d) If a slight positive pressure cannot be maintained inside the facepiece for 5 s, the user shall verify that nothing obstructs the sealing surface, adjust the facepiece and harness, and repeat the user seal check. (e) If a slight positive pressure still cannot be maintained inside the facepiece, the user shall remove the respirator, inspect the components for the cause of the leakage, correct any problems discovered, or obtain a replacement respirator and repeat the user seal check. (f) Users shall not use a respirator for which a user seal check cannot be completed successfully. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 47 Z94.4-11 © Canadian Standards Association Annex B (mandatory) Qualitative respirator fit tests (QLFT) Notes: (1) This Annex is a mandatory part of this Standard. (2) This Annex sets out currently recognized fit test methods. If other methods are developed, their use is subject to approval by the authority having jurisdiction. B.1 Acceptable QLFT methods (see Clause 9.4.1) The following QLFT methods shall be acceptable: (a) QLFT using isoamyl acetate (banana oil) as a challenge agent in a test chamber following threshold screening, with non-detection of its odour by a test subject wearing a respirator serving as an indication of acceptable fit; (b) QLFT using saccharin solution aerosol as a challenge agent in a test chamber following threshold screening, with non-detection of its sweet taste by a test subject wearing a respirator serving as an indication of acceptable fit; (c) QLFT using bitter aerosol (denatonium benzoate) as a challenge agent in a test chamber following threshold screening, with non-detection of its bitter taste by a test subject wearing a respirator serving as an indication of acceptable fit; and (d) QLFT using irritant smoke (stannic chloride) as a challenge agent following threshold screening, with non-detection of it by a test subject wearing a respirator serving as an indication of acceptable fit. B.2 General B.2.1 Health and safety issues Specific issues associated with each challenge agent are addressed in the respective QLFT protocols below. Refer to the manufacturer’s MSDS for appropriate handling and disposal procedures for the challenge agents. Diligence in adhering to the protocols will ensure that the respirator user is fitted with and assigned a respirator that is protective within the specifications and limitations defined or referenced in this Standard. B.2.2 Introduction of QLFT to respirator users The person conducting the QLFT shall provide the test subject with an introduction to QLFT. In this introduction, the fit tester shall (a) explain what the QLFT procedure is, why it is required, and the importance of using a respirator that provides an effective, reproducible face-to-facepiece seal; (b) explain why the test is important, in order to convince the test subject to co-operate fully in the QLFT; (c) describe the challenge agent used in the QLFT and how to identify it; (d) describe how the test subject selects a properly fitting and comfortable respirator from those that are appropriate to the application; (e) explain that the respirator is equipped with the appropriate filters or chemical cartridges for the challenge agent being used; (f) explain that the test subject is required to successfully complete the positive- or negative-pressure user seal check with the selected respirator without physical or verbal assistance prior to proceeding with the QLFT; (g) explain that the test subject is required to don the respirator properly, without physical or verbal assistance, in accordance with the manufacturer’s instructions; (h) explain that the test subject is required, during the QLFT, to wear other PPE that he/she could be required to use in the workplace and that could affect the face-to-facepiece seal; 48 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators (i) (j) describe the QLFT exercises and how to perform them during the QLFT; explain why it is important to use, in the workplace, the specific brand, model, and size of facepiece that is used to pass the QLFT; and (k) emphasize that the user must always inspect a respirator before using it to ensure that it is in proper working condition. B.2.3 Common basic steps B.2.3.1 Each facepiece represents a different model and size. The test subject shall select the most comfortable facepiece from a variety of appropriate models and sizes. B.2.3.2 The test subject shall hold each facepiece against his/her face and shall choose one that he/she feels will provide the best fit and comfort. The test subject shall be shown how to don a respirator, how to position it on the face, how to set strap tension, and how to assess a comfortable fit. A mirror shall be available to assist the subject in evaluating the fit and positioning of the respirator. If the appropriate facepiece for the application cannot be found, a protective alternative shall be made available. A small percentage of users will not be able to use any tight-fitting facepiece. B.2.3.3 The more comfortable facepieces shall be recorded and the most comfortable facepiece shall be donned and worn for at least 5 min to assess comfort. Assistance in assessing comfort shall be given by discussing the points in Clause B.2.3.4. B.2.3.4 Assessment of comfort shall include reviewing the following points with the test subject: (a) proper placement of the chin; (b) fit and position of the facepiece on the nose (if a half-facepiece); (c) strap tension; (d) accommodation of spectacles or eye protection, without adversely affecting face-to-facepiece seal; (e) intelligible speech without an obvious break in the face-to-facepiece seal; (f) tendency for the facepiece to slip (stability); (g) full contact of the sealing surface of the facepiece to the face; (h) self-observation in the mirror; and (i) time for assessment of comfort in relation to the face-to-facepiece seal. B.2.3.5 The respirator configuration to be worn in the test subject’s workplace, including other required PPE, shall be worn for the fit test to confirm compatibility (see Clause 9.2.5). B.2.3.6 The test subject shall perform the positive- or negative-pressure user seal checks (see Annex A). Failure of the user seal check shall be cause to select an alternative respirator. B.2.3.7 When a successful user seal check is achieved, the subject shall be deemed ready for fit testing. B.2.3.8 After passing the fit test, the test subject shall be questioned again regarding the comfort of the respirator. If it has become uncomfortable, another model of respirator shall be tried. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 49 Z94.4-11 © Canadian Standards Association B.2.3.9 The user shall be given the opportunity to select a different facepiece and be retested if, during on-the-job use, the chosen facepiece becomes increasingly uncomfortable. B.2.4 Sensitivity screening test The sensitivity screening test area shall be ventilated to prevent general room contamination with the challenge agent. Fit testing shall be conducted so that it does not interfere with the sensitivity screening test. B.2.5 Fit testing B.2.5.1 After selecting, donning, and properly adjusting a respirator unassisted, the test subject shall wear it to the fit testing area. B.2.5.2 Fit test exercises The following exercises shall be performed while the person conducting the QLFT challenges the respirator seal with the test agent. Each exercise described shall be performed for at least 30 s: (a) normal breathing; (b) deep breathing. Be certain breaths are deep and regular; (c) turning head from side to side. Be certain movement is complete, within the test subject’s comfortable range of motion. Alert the test subject to inhale and exhale when the head is at either side and to avoid bumping on the shoulder; (d) nodding head up and down. Be certain that the test subject’s movements are complete, within a comfortable range of motion. Alert the test subject to inhale when the head is in the fully up position, to exhale when the head is in the fully down position, and to avoid bumping the respirator on the chest; (e) talking. Talk loud enough to be understood and slowly for the duration of this exercise. The person being tested should be instructed to count, recite the alphabet, talk about a subject that is relevant to work activities, or, if he/she prefers, read the Rainbow Passage: “When the sunlight strikes raindrops in the air, they act like a prism and form a rainbow. The rainbow is a division of white light into many beautiful colours. These take the shape of a long round arch, with its path high above, and its two ends apparently beyond the horizon. There is, according to legend, a boiling pot of gold at one end. People look, but no one ever finds it. When people look for something beyond reach, their friends say they are looking for the pot of gold at the end of the rainbow”; (f) bending over, except where the test method will not permit it because of space limitations. The test subject bends at the waist and tries to keep the head and back parallel to the floor, repeating the movement at a comfortable pace and pausing long enough to inhale twice at each extreme position; and (g) normal breathing again. B.3 Qualitative fit test (QLFT) protocols B.3.1 Isoamyl acetate QLFT protocol B.3.1.1 General The entire screening and testing procedures shall be explained to the test subject prior to the screening test. The fit test shall be conducted immediately after the threshold screening, but in a separate area (i.e., in a different room). 50 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators B.3.1.2 Isoamyl acetate odour threshold screening Odour threshold screening, performed without using a respirator, is intended to determine if the individual tested can detect the odour of isoamyl acetate (CAS# 123-92-2) at low levels. The apparatus and test method shall be as follows: (a) Three 1 L glass jars with metal lids are required. (b) Odour-free water (e.g., distilled or spring water) at approximately 25C (77F) shall be used for the solutions. (c) The isoamyl acetate (IAA; also known as isopentyl acetate) stock solution shall be prepared by adding 1 mL of pure IAA to 800 mL of odour-free water in a 1 L jar, closing the lid, and shaking for 30 s. Stock solutions more than 1 week old shall not be used. (d) The screening test shall be conducted in a room separate from the room used for actual fit testing. The two rooms shall be well ventilated to prevent the odour of IAA from becoming evident in the general room air where testing takes place. (e) The mixtures used in the IAA odour detection test shall be prepared in an area separate from where the test is performed, in order to prevent olfactory fatigue in the subject. The odour test solution shall be prepared in a second jar by placing 0.4 mL of the stock solution into 500 mL of odour-free water using a clean dropper or pipette. The solution shall be shaken for 30 s and allowed to stand for 2 to 3 min so that the IAA concentration above the liquid can reach equilibrium. This solution shall be used for only 1 day. (f) A test blank shall be prepared in a third jar by adding 500 mL of odour-free water. (g) The odour test and test blank jar lids shall be labelled 1 and 2, for jar identification. Labels shall be placed on the lids so that they can be peeled off periodically and switched to maintain the integrity of the test. (h) The following instruction shall be typed on a card and placed on the table in front of the two test jars: “The purpose of this test is to determine if you can smell banana oil at a low concentration. The two bottles in front of you contain water. One of these bottles also contains a small amount of banana oil. Be sure the covers are on tight, then shake each bottle for two seconds. Unscrew the lid of each bottle, one at a time, and sniff at the mouth of the bottle. Indicate to the test conductor which bottle contains banana oil.” (i) If the test subject is unable to correctly identify the jar containing the odour test solution, the IAA qualitative fit test shall not be performed. (j) If the test subject correctly identifies the jar containing the odour test solution, the test subject shall proceed to respirator selection and fit testing. B.3.1.3 Isoamyl acetate odour threshold fit test The procedure for conducting the IAA QLFT shall be as follows: (a) The fit test chamber shall be a clear 240 L (65 gal) drum liner suspended inverted over a 600 mm (2 ft) diameter frame so that the top of the chamber is about 150 mm (6 in) above the test subject’s head. If no drum liner is available, a similar chamber shall be constructed using plastic sheeting. The inside top centre of the chamber shall have a small hook attached. (b) Each respirator used for the fitting and fit testing shall be equipped with organic vapour cartridges or offer protection against organic vapours. (c) After selecting, donning, and properly adjusting a respirator, the test subject shall wear it to the fit testing room. This room shall be separate from the room used for odour threshold screening and respirator selection and shall be well ventilated, by an exhaust fan or lab hood, to prevent general room contamination. (d) A copy of the test exercises and any prepared text from which the subject is to read shall be taped to the inside of the test chamber. (e) Upon entering the test chamber, the test subject shall be given a 150 × 125 mm (6 × 5 in) piece of paper towel, or other porous, absorbent, single-ply material, folded in half and wetted with 0.75 mL of pure IAA. The test subject shall hang the wet towel on the hook at the top of the chamber. An IAA test swab or ampoule may be substituted for the IAA wetted paper towel provided that it has been demonstrated that the alternative IAA source will generate an IAA test atmosphere with a concentration equivalent to that generated by the paper towel method. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 51 Z94.4-11 © Canadian Standards Association (f) Allow 2 min for the IAA test concentration to stabilize before starting the fit test exercises. This is an appropriate time to talk with the test subject about the fit test, the importance of his/her co-operation, and the purpose of the test exercises or to demonstrate some of the exercises. (g) If at any time during the test, the subject detects the banana-like odour of IAA, the fit test has failed. The subject shall quickly exit from the test chamber and leave the test area to avoid olfactory fatigue. (h) If the test has failed, the subject shall return to the selection room and remove the respirator. The test subject shall repeat the odour sensitivity test, select and put on another respirator, return to the test area, and again begin the fit test procedure above. The process shall continue until a respirator that fits well has been found. Should the odour sensitivity test fail, the subject shall wait at least 5 min before retesting. Odour sensitivity will usually return by this time. (i) If the subject passes the test, the reliability of the test procedure shall be verified by having the subject break the respirator face seal and confirm the presence of IAA odour before exiting the chamber. (j) When the test subject leaves the chamber, he/she shall remove the saturated towel and return it to the person conducting the test so that there is no significant IAA concentration buildup in the chamber during subsequent tests. The used towels shall be kept in a self-sealing plastic bag to keep the test area from being contaminated. B.3.2 Saccharin solution aerosol QLFT protocol B.3.2.1 The entire screening and testing procedure shall be explained to the test subject prior to the screening test. The fit test shall be conducted in a well-ventilated area or a separate room immediately after the threshold screening. Note: Fit testers should make the user aware that wearing a respirator with a fit test hood will elevate inspired carbon dioxide levels and decrease inspired oxygen levels, which can cause discomfort. If this occurs, the user should notify the fit tester to interrupt the test and remove the hood and respirator. B.3.2.2 Saccharin taste threshold screening The saccharin taste threshold screening, performed without using a respirator, is intended to determine whether the individual being tested can detect the taste of saccharin. The procedure shall be as follows: (a) The test subject shall not eat, drink (except plain water), smoke, or chew gum for 15 min before the test. Note: If the test subject eats or drinks something sweet before the screening test, he/she might be unable to taste the weak saccharin solution. (b) During threshold screening as well as during fit testing, subjects shall wear an enclosure about the head and shoulders that is approximately 300 mm (12 in) in diameter and 350 mm (14 in) tall. The front portion of the enclosure shall be clear from the respirator and allow free movement of the head when a respirator is worn. (c) The test enclosure shall have a 19 mm (3/4 in) hole in front of the test subject’s nose and mouth area to accommodate a nebulizer/atomizer nozzle. (d) The test subject shall don the test enclosure. Throughout the threshold screening test, the test subject shall breathe through his/her slightly open mouth with the tongue extended. The subject is instructed to report when he/she detects a sweet taste. (e) The threshold screening solution shall be prepared by dissolving 0.83 g of sodium saccharin USP in 100 mL of warm water or by putting 1 mL of the fit test solution in 100 mL of distilled water. Alternatively, a commercially available pre-mixed fit testing solution may be used. (f) A small amount of the taste screening solution (~ 3 mL) shall be added into a nebulizer. This nebulizer shall be clearly marked to distinguish it from the fit test solution nebulizer. (g) Using the nebulizer, the test conductor shall spray the threshold screening solution into the enclosure. The nozzle shall be directed away from the nose and mouth of the test subject. (h) To produce the aerosol, the nebulizer bulb shall be firmly squeezed so that it collapses completely, then released, and allowed to fully expand. 52 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association (i) (j) (k) (l) (m) (n) (o) (p) Selection, use, and care of respirators Ten squeezes shall be repeated rapidly and the test subject shall then be asked whether the saccharin can be tasted. If the test subject reports tasting the sweet taste during the ten squeezes, the screening test is complete. The taste threshold shall be noted as ten regardless of the number of squeezes actually completed. If the first response is negative, ten more squeezes shall be repeated rapidly and the test subject shall again be asked whether the saccharin is tasted. If the test subject reports tasting the sweet taste during the second ten squeezes, the screening test is complete. The taste threshold shall be noted as 20 regardless of the number of squeezes actually completed. If the second response is negative, ten more squeezes shall be repeated rapidly and the test subject shall again be asked whether the saccharin is tasted. If the test subject reports tasting the sweet taste during the third set of ten squeezes, the screening test is complete. The taste threshold shall be noted as 30 regardless of the number of squeezes actually completed. The test conductor shall record the number of squeezes required to solicit a taste response. If the saccharin is not tasted after 30 squeezes [see Item (k)], the saccharin fit test shall not be used. If a taste response is elicited, the test subject shall be asked to take note of the taste for reference in the fit test. Correct use of the nebulizer means that approximately 1 mL of liquid is used at a time in the nebulizer body. The nebulizer shall be thoroughly rinsed in water, shaken dry, and refilled at least each morning and periodically checked and maintained free of clogs. B.3.2.3 Saccharin solution aerosol QLFT protocol The protocol for the saccharin solution aerosol QLFT shall be as follows: (a) The fit test shall use the same enclosure described in Clause B.3.2.2(b). (b) The test subject shall don the enclosure while using the selected respirator [see Clause B.2.2(d)]. The respirator shall be properly adjusted and equipped with a particulate filter(s). (c) A second nebulizer/atomizer shall be used to spray the fit test solution into the enclosure. This nebulizer shall be clearly marked to distinguish it from the screening test solution nebulizer. (d) The fit test solution shall be prepared by adding 83 g of sodium saccharin USP to 100 mL of warm water. Alternatively, a commercially available pre-mixed fit testing solution may be used. (e) A small amount of the fit test solution (~ 3 mL) shall be added into the nebulizer. (f) As before, the test subject shall breathe through a slightly open mouth with tongue extended and report if he/she tastes the sweet taste of saccharin. (g) The nebulizer shall be inserted into the hole in the front of the enclosure and an initial concentration of saccharin fit test solution shall be sprayed into the enclosure using the same number of squeezes (either 10, 20, or 30 squeezes) required to elicit a taste response as noted during the screening test. A minimum of ten squeezes is required. (h) After the aerosol has been generated, the test subject shall be instructed to perform the exercises described in Clause B.2.5.2. (i) Every 30 s the aerosol concentration shall be replenished using one-half the number of squeezes recorded initially (i.e., 5, 10, or 15). (j) The test subject shall indicate to the test conductor if at any time during the fit test the taste of saccharin is detected. If the taste of saccharin is detected, the fit shall be deemed unsatisfactory and the test has failed. A different respirator shall be tried and the entire test procedure shall be repeated (taste threshold screening and fit testing). (k) If the test subject does not report tasting the saccharin, the test has passed. (l) Prior to removing the enclosure following a satisfactory fit test, the test conductor shall ask the test subject to break the face-to-facepiece seal. Having the test subject detect the test agent confirms the validity of the fit test and the effectiveness of the respirator. (m) The test conductor shall make periodic checks of the nebulizer to ensure that it is not clogged. If clogging is found at the end of the test session, the test shall be deemed invalid and shall be repeated. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 53 Z94.4-11 © Canadian Standards Association B.3.3 Bitter aerosol (denatonium benzoate) protocol B.3.3.1 The entire screening and testing procedure shall be explained to the test subject prior to the screening test. The fit test shall be conducted in a well-ventilated area or a separate room immediately after the threshold screening. Note: Fit testers should make the user aware that wearing a respirator with a fit test hood will elevate inspired carbon dioxide levels and decrease inspired oxygen levels, which can cause discomfort. If this occurs, the user should notify the fit tester to interrupt the test and remove the hood and respirator. B.3.3.2 Bitter aerosol (denatonium benzoate) taste threshold screening The bitter aerosol taste threshold screening, performed without using a respirator, is intended to determine whether the individual being tested can detect the taste of bitter aerosol. The screening method shall be as follows: (a) The test subject shall not eat, drink (except plain water), smoke, or chew gum for 15 min before the test is conducted. (b) The fit test shall use the same enclosure as that described in Clause B.3.2.2(b). (c) The test enclosure shall have a 19 mm (3/4 in) hole in front of the test subject’s nose and mouth area to accommodate a nebulizer/atomizer nozzle. (d) The test subject shall don the test enclosure. Throughout the threshold screening test, the test subject shall breathe through his/her slightly open mouth with the tongue extended. The subject is instructed to report when he/she detects a bitter taste. (e) The threshold screening solution shall be prepared by adding 13.5 mg of bitter aerosol to 100 mL of 5% salt (NaCl) by weight solution in distilled water. Alternatively, a commercially available pre-mixed fit testing solution may be used. (f) A small amount of the taste screening solution (~ 3 mL) shall be added into a nebulizer. This nebulizer shall be clearly marked to distinguish it from the fit test solution nebulizer. (g) Using the nebulizer, the test conductor shall spray the threshold check solution into the enclosure. (h) To produce the aerosol, the nebulizer bulb shall be firmly squeezed so that the bulb collapses completely, then released, and allowed to fully expand. (i) An initial ten squeezes shall be repeated rapidly and the test subject shall then be asked whether the bitter aerosol can be tasted. If the test subject reports tasting the bitter taste during the ten squeezes, the screening test is complete. The taste threshold shall be noted as ten regardless of the number of squeezes actually completed. (j) If the first response is negative, ten more squeezes shall be repeated rapidly and the test subject shall again be asked whether the bitter aerosol is tasted. If the test subject reports tasting the bitter taste during the second ten squeezes, the screening test is complete. The taste threshold shall be noted as 20 regardless of the number of squeezes actually completed. (k) If the second response is negative, ten more squeezes shall be repeated rapidly and the test subject shall again be asked whether the bitter aerosol is tasted. If the test subject reports tasting the bitter taste during the third set of ten squeezes, the screening test is complete. The taste threshold shall be noted as 30 regardless of the number of squeezes actually completed. (l) The test conductor shall take note of the number of squeezes required to solicit a taste response. (m) If the bitter aerosol is not tasted after 30 squeezes [see Item (k)], the test subject is unable to taste bitter aerosol and the bitter aerosol fit test shall not be used. (n) If a taste response is elicited, the test subject shall be asked to take note of the taste for reference in the fit test. (o) Correct use of the nebulizer means that approximately 1 mL of liquid is used at a time in the nebulizer body. (p) The nebulizer shall be thoroughly rinsed in water, shaken to dry, and refilled at least each morning and afternoon or at least every 4 h. 54 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators B.3.3.3 Bitter aerosol (denatonium benzoate) QLFT protocol The protocol for the bitter aerosol QLFT shall be as follows: (a) The test subject shall not eat, drink (except plain water), smoke, or chew gum for 15 min before the test. (b) The fit test shall use the same enclosure as that described in Clause B.3.2.2(b). (c) The test subject shall don the enclosure while using the selected respirator [see Clause B.2.2(d)]. The respirator shall be properly adjusted and equipped with any type of particulate filter. (d) A second nebulizer/atomizer shall be used to spray the fit test solution into the enclosure. This nebulizer shall be clearly marked to distinguish it from the screening test solution nebulizer. (e) The fit test solution shall be prepared by adding 337.5 mg of bitter aerosol to 200 mL of a 5% salt (NaCl) solution in warm water. Alternatively, a commercially available pre-mixed fit testing solution may be used. (f) A small amount of the fit test solution (~ 3 mL) shall be added into the nebulizer. (g) As before, the test subject shall breathe through his/her slightly open mouth with tongue extended and be instructed to report if he/she tastes the bitter aerosol. (h) The nebulizer shall be inserted into the hole in the front of the enclosure and an initial concentration of the fit test solution shall be sprayed into the enclosure using the same number of squeezes (either 10, 20, or 30 squeezes) required to elicit a taste response as noted during the screening test. (i) After the aerosol is generated, the test subject shall be instructed to perform the exercises described in Clause B.2.5.2. (j) Every 30 s the aerosol concentration shall be replenished using one half the number of squeezes used initially (i.e., 5, 10, or 15). (k) The test subject shall indicate to the test conductor if at any time during the fit test the taste of bitter aerosol is detected. If the test subject does not report tasting the bitter aerosol, the test has passed. (l) If the taste of bitter aerosol is detected, the fit shall be deemed unsatisfactory and the test has failed. A different respirator shall be tried and the entire test procedure repeated (taste threshold screening and fit testing). (m) Prior to removing the enclosure following a satisfactory fit test, the test conductor shall ask the test subject to break the face-to-facepiece seal. Having the test subject detect the test agent confirms the validity of the fit test and the effectiveness of the respirator. B.3.4 Irritant smoke (stannic chloride) QLFT protocol B.3.4.1 Health and safety issues B.3.4.1.1 The sensitivity screening test and the QLFT procedure for the stannic chloride irritant smoke protocol requires very brief exposure of the test subjects to challenge concentrations of irritant smoke containing hydrogen chloride possibly in excess of regulated occupational exposure limits and maximum use concentrations for certain types of respiratory protective equipment unless the area is adequately ventilated. The person conducting the QLFT might also be exposed. The person conducting the QLFT and the test subject shall be made aware of this fact. The fit tester shall advise the test subject that the smoke can be irritating to the eyes, lungs, and nasal passages and shall instruct the subject to keep his/her eyes closed while the test is being performed. The fit tester conducting the test should wear a respirator. The test subject shall not be placed in a hood or enclosure at any time during the irritant smoke fit testing. The irritant smoke sensitivity screening test and the QLFT shall be performed in a location with exhaust ventilation sufficient to prevent contamination of the testing area or contamination of the ventilation system. B.3.4.1.2 The person conducting the QLFT shall ensure that the test subject has successfully completed a positive- or negative-pressure user seal check. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 55 Z94.4-11 © Canadian Standards Association B.3.4.1.3 The prescribed QLFT protocol shall be used to ensure a controlled exposure to the challenge agent. Avoid continuing to expose the test subject as soon as it is evident that he/she does not react to the test agent. B.3.4.2 Preparation of the QLFT stannic chloride irritant smoke tube The QLFT stannic chloride irritant smoke tube shall be prepared as follows: (a) Use the tool provided by the manufacturer to break both ends of a glass stannic chloride irritant smoke tube. (b) Attach a short length of rubber tubing to the outlet end of the irritant smoke tube. (c) Attach the other end of the irritant smoke tube to the tubing and aspirator bulb provided by the manufacturer. (d) To produce smoke for the fit test, gently squeeze the aspirator bulb to force air through the stannic chloride irritant smoke tube. Note: Appropriate hand and eye protection should be worn while breaking the tube. B.3.4.3 Sensitivity screening test The test subject shall be exposed in the following manner to a weak concentration of the stannic chloride irritant smoke to become familiar with its characteristic odour: (a) By squeezing the aspirator bulb to create positive-pressure air flow through the stannic chloride irritant smoke tube, the person conducting the irritant smoke sensitivity check generates a weak concentration of the irritant smoke within approximately 1 m of the test subject. (b) The test subject then brings a handful of the smoke to within approximately 20 cm of his/her nose and inhales gently. The result should be a slight involuntary cough or verbal acknowledgement of the odour of the smoke. B.3.4.4 Respirator selection Respirators shall be selected as described in Clauses B.2.3.1 to B.2.3.3 except that each respirator shall be equipped with a P100 rated particulate filter for removing irritant smoke. B.3.4.5 Fit test — General B.3.4.5.1 When conducting QLFT on subjects using half-facepiece respirators, the fit tester shall advise the test subjects that the smoke can be irritating to the eyes. The fit tester shall instruct the QLFT subject to keep his/her eyes closed throughout the complete test and until the conductor of the QLFT indicates that the test has been completed. When QLFT is conducted on subjects using full-facepiece respirators, the test subjects may keep their eyes open throughout the QLFT. B.3.4.5.2 QLFT using the irritant smoke method shall be conducted as follows: (a) Remind the test subject to ensure that his/her eyes remain closed if he/she is using a quarter- or half-facepiece respirator for the test. (b) Obtain verbal confirmation from the test subject that this instruction is understood. (c) Using the aspirator bulb provided with the irritant smoke kit, direct the stream of irritant smoke from the tube towards the respirator face-to-facepiece seal area on the test subject. Start from a distance at least 300 mm from the facepiece and gradually move to within approximately 50 mm, moving around the entire perimeter of the facepiece while continuing to generate only sufficient irritant smoke to challenge the periphery of the facepiece seal. (d) Gradually direct the smoke around the entire perimeter of the face-to-facepiece seal of the respirator, paying particular attention to the areas under the chin and in the area of the bridge of the nose if half-facepiece respirators are involved. (e) Avoid directing the irritant smoke directly into the air-purifying elements of the respirator. 56 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators B.3.4.5.3 The exercises described in Clause B.2.5.2 shall be performed while the person conducting the fit test challenges the respirator seal with the test agent. Each exercise shall be performed for 30 s. The person conducting the QLFT shall control the stream of smoke as described in Clause B.3.4.5.2 Items (c) to (e). B.3.4.5.4 If the test subject detects the irritant smoke, the person conducting the QLFT shall stop the test and attempt to determine the reason for and the location of the leak. If possible, the test subject should attempt to correct the cause of the leak and repeat the test. If the repeated fit test is unsuccessful, the test respirator shall be rejected and another respirator shall be selected and the fit test repeated. B.3.4.5.5 When a test subject passes the stannic chloride irritant smoke fit test without evidence of a response, the person conducting the fit test shall repeat the sensitivity screening test using the smoke from the same irritant smoke tube used in the QLFT to confirm the subject’s reaction to the smoke. If the test subject fails to recognize the characteristic odour, the result of this QLFT shall be considered void. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 57 Z94.4-11 © Canadian Standards Association Annex C (mandatory) Quantitative respirator fit tests (QNFT) Notes: (1) This Annex is a mandatory part of this Standard. (2) This Annex sets out currently recognized fit test methods. If other methods are developed, their use is subject to approval by the authority having jurisdiction. C.1 Acceptable QNFT methods (see Clause 9.5) The following QNFT methods shall be acceptable: (a) QNFT using a nonhazardous test aerosol (such as corn oil, polyethylene glycol 400, di-2-ethyl hexyl sebacate, or sodium chloride) generated in a test chamber, and employing instrumentation to quantify the fit of the respirator; (b) QNFT using ambient aerosol as the test agent and appropriate instrumentation (condensation nuclei counter) to quantify the respirator fit; and (c) QNFT using controlled negative pressure and appropriate instrumentation to measure the volumetric leak rate of a facepiece to quantify the respirator fit. C.2 General C.2.1 The employer shall ensure that persons administering QNFT are able to calibrate equipment, perform tests, recognize invalid tests, calculate fit factors, and ensure that test equipment is in working order. The employer shall ensure that QNFT equipment is maintained, calibrated, and operated according to the manufacturer’s instructions. C.2.2 Introduction of QNFT to respirator users The person conducting the QNFT shall provide the test subject with an introduction to QNFT. In this introduction, the fit tester shall (a) explain what the QNFT procedure is, why it is required, and the importance of using a respirator that provides an effective, reproducible face-to-facepiece seal; (b) explain why the test is important, in order to convince the test subject to co-operate fully in the QNFT; (c) describe the challenge agent (e.g., ambient dust, generated aerosol, negative pressure) used in the QNFT; (d) describe how the test subject selects a properly fitting and comfortable respirator from those that are appropriate to the application; (e) explain that the respirator is equipped with the appropriate adapters or filters for the QNFT being used; (f) explain that the test subject is required to successfully complete the positive- or negative-pressure user seal check with the selected respirator without physical or verbal assistance prior to proceeding with the QNFT; (g) explain that the test subject is required to don the respirator properly, without physical or verbal assistance, in accordance with the manufacturer’s instructions; (h) explain that the test subject is required, during the QNFT, to wear other PPE that he/she could be required to use in the workplace and that could affect the face-to-facepiece seal; (i) describe the QNFT exercises and how to perform them during the QNFT; (j) explain why it is important to use, in the workplace, the specific brand, model, and size of facepiece that is used to pass the QNFT; and 58 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators (k) emphasize that the user must always inspect a respirator before using it to ensure that it is in proper working condition. C.2.3 Common basic steps C.2.3.1 Each facepiece represents a different model and size. The test subject shall select the most comfortable facepiece from a variety of appropriate models and sizes. C.2.3.2 The test subject shall hold each facepiece against his/her face and shall choose one that he/she feels will provide the best fit and comfort. The test subject shall be shown how to don a respirator, how to position it on the face, how to set strap tension, and how to assess a comfortable fit. A mirror shall be available to assist the subject in evaluating the fit and positioning of the respirator. If the appropriate facepiece for the application cannot be found, a protective alternative shall be made available. A small percentage of users will not be able to use any tight-fitting facepiece. C.2.3.3 The more comfortable facepieces shall be recorded and the most comfortable facepiece shall be donned and worn for at least 5 min to assess comfort. Assistance in assessing comfort shall be given by discussing the points in Clause C.2.3.4. C.2.3.4 Assessment of comfort shall include reviewing the following points with the test subject: (a) proper placement of the chin; (b) fit and position of the facepiece on the nose (if a half-facepiece); (c) strap tension; (d) accommodation of spectacles or eye protection, without adversely affecting face-to-facepiece seal; (e) intelligible speech without an obvious break in the face-to-facepiece seal; (f) tendency for the facepiece to slip (stability); (g) full contact of the sealing surface of the facepiece to the face; (h) self-observation in the mirror; and (i) time for assessment of comfort in relation to the face-to-facepiece seal. C.2.3.5 The respirator configuration to be worn in the test subject’s workplace, including other required PPE, shall be worn for the fit test to confirm compatibility (see Clause 9.2.5). C.2.3.6 The test subject shall perform the positive- or negative-pressure user seal checks (see Annex A). The fit test probe in the facepiece shall be blocked during the user seal check. Failure of the user seal check shall be cause to select an alternative respirator. C.2.3.7 When a successful user seal check is achieved, the subject shall be deemed ready for fit testing. C.2.3.8 After passing the fit test, the test subject shall be questioned again regarding the comfort of the respirator. If it has become uncomfortable, another model of respirator shall be tried. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 59 Z94.4-11 © Canadian Standards Association C.2.3.9 The user shall be given the opportunity to select a different facepiece and be retested if, during on-the-job use, the chosen facepiece becomes increasingly uncomfortable. C.2.3.10 Sampling adapters used with the user’s respirator for QNFT shall be completely removed and the facepiece restored to its original configuration before the respirator is returned for use in the workplace. C.2.3.11 Permanently probed facepieces used for QNFT shall not be used for respiratory protection in the workplace. C.3 Generated aerosol photometer QNFT procedure C.3.1 Operating principles An aerosol, usually an oil, shall be generated and blown into a test chamber that surrounds the head and shoulders or the entire body of the respirator user. Photometers shall simultaneously measure the scattered light from a large number of particles to indicate a relative aerosol concentration. As used for QNFT, the concentration of the challenge aerosol (Cout) and the concentration inside the respirator (Cin) shall be measured consecutively while the test subject performs a series of exercises designed to stress the facepiece seal in ways that approximate anticipated workplace conditions. The method generally requires an exposure chamber to confine the generated aerosol around the test subject. The respirator shall be equipped with particulate filters that do not allow the challenge aerosol to penetrate significantly so that it can be assumed that all particles sampled from inside the respirator have entered through a face seal leak. The fit factor (FF) shall be calculated from the two concentration measurements as follows: Fit factor = Cout/Cin C.3.2 Equipment needed The following equipment shall be used: (a) aerosol generation and distribution system. The aerosol shall have an MMAD less than 1 m; (b) photometric detection system; (c) strip chart recorder or computer for permanent record; (d) test chamber; (e) respirator facepieces equipped with probes or special adapters and appropriate filters as specified by the QNFT instrument manufacturer; and (f) other accessories and supplies as required by the equipment manufacturer. C.3.3 Equipment setup The equipment shall be set up in accordance with the manufacturer’s instructions and in compliance with the following requirements: (a) Verify that all components of the QNFT system are assembled according to the manufacturer’s instructions. This includes the hoses supplying the aerosol to the test chamber and returning exhaust air from the chamber, sample lines, and electrical connections. (b) Perform necessary maintenance, including filling the generator with oil to the proper level, draining water filters, and fixing deficiencies detected in a visual inspection, such as loose hose connections. (c) Power up the system and allow for a warm-up. (d) Perform any preliminary adjustments, e.g., sample flow, generator pressure, dilution airflow. (e) Allow time for the aerosol concentration to become stabilized in the test chamber. 60 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators C.3.4 Performing the fit test The procedure for performing the fit test shall be as follows: (a) Do not initiate the test if the worker has smoked within the last 30 min. (b) Enter all pertinent data into the test record. (c) Instruct the test subject to don the respirator as trained (see Clause C.2.3.2). (d) Have the test subject enter the test chamber and connect his/her respirator to the respirator sample line. (e) Sample the challenge aerosol agent and adjust the controls for the correct initial challenge level (usually 100%). If a strip chart is used, mark “100%” on the paper. (f) Connect the instrument to a filter to establish the zero baseline. For some instruments, Items (d) and (e) may be reversed. If a strip chart is used, mark “0” on the paper. (g) Begin the test. If a strip chart recorder is being used, be sure to note on the chart the beginning and end of each exercise. Mark the range switch setting on the paper. (h) The series of exercises specified in Clause B.2.5.2 shall be performed for at least 30 s. (i) At the conclusion of the fit test, the person conducting the test shall resample the aerosol challenge. This step shows the final challenge aerosol concentration and confirms that it has not changed substantially during the test. If a strip chart is used, mark “100%” on the paper. (j) Have the test subject disconnect the respirator sample line and exit the test area or chamber. (k) Reconnect the instrument to a filter to verify that the zero baseline has not drifted significantly. If a strip chart is used, mark “0” on the paper. (l) If necessary, data reduction shall be done on the strip chart. The test results shall be recorded and preserved. C.3.5 Interpretation of results When a computer is used, the computer reports for each exercise an average percent penetration (Pen), calculated by summing each value measured during the exercise and dividing by the total number of points collected. The overall penetration is the arithmetic mean of the penetration for each exercise. When a strip chart is used, the Pen for each exercise is estimated by drawing a line through the midpoint of the trace of that exercise. The midpoint of this line represents the percent penetration, taking into account the range to which the instrument is set. The overall fit factor (Overall FF) shall be calculated as follows: Overall FF = 1/Average overall penetration A person shall be considered to have passed the fit test if the overall fit factor equals or exceeds the minimum required fit factor. C.4 Particle-counting instrument QNFT procedure C.4.1 Operating principles Particle-counting instruments are capable of measuring the number concentration of particles in a given aerosol sample by counting single particles. When used for QNFT, the particle concentration of the challenge aerosol (Cout) and the particle concentration inside the respirator (Cin) are both measured while the test subject performs a series of exercises designed to stress the face seal in ways that approximate anticipated workplace conditions. Particle-counting instruments typically use the particles in the ambient air as the challenge aerosol. This eliminates the need for aerosol generators and test chambers. The respirator shall be equipped with particulate filters that do not allow the challenge aerosol to penetrate significantly. Refer to the fit testing equipment manufacturer for filter requirements. It is assumed that all particles sampled from inside the respirator have entered through a face seal leak. The fit factor shall be calculated from the two concentration measurements as follows: Fit factor = Cout/Cin August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 61 Z94.4-11 © Canadian Standards Association Care shall be taken to ensure that particles are not generated by the test subject’s body inside the facepiece. Because the system cannot differentiate between subject-generated particles and the ambient aerosol penetration, erroneously low fit factors can result. For example, particles are released from the lungs for 30 min after smoking a cigarette. C.4.2 Equipment needed The following equipment shall be used: (a) a particle-counting QNFT instrument; (b) a high-efficiency particulate filter for diagnostic checks recommended by the instrument manufacturer; (c) other accessories and supplies required by the instrument manufacturer; and (d) respirator facepieces equipped with probes or special adapters and appropriate filters as specified by the QNFT instrument manufacturer. C.4.3 Diagnostic checks The following diagnostic checks shall be performed at least daily. The instrument shall pass all three checks before fit testing can begin. Refer to the manufacturer’s instructions for specifications and guidance. (a) Particle check — Measure the concentration of particles in the environment where fit testing will be performed to make sure that the instrument is working and that the concentration is high enough and stable enough to permit reliable measurements. (b) Zero check — After the particle check is successfully completed, with the instrument in particle-counting mode, attach the high-efficiency filter to the sample hose. Watch the particle concentration display to make sure that it drops to zero within the time specified by the manufacturer. This confirms there are no leaks in the system. (c) System check — After the zero check is successfully completed, leave the filter on the sample hose and perform a fit factor measurement on the filter. The result shall comply with the manufacturer’s instructions and specifications. This confirms that high fit factors can be measured. C.4.4 Preparation for fit testing Preparation of equipment shall be as follows: (a) Follow the manufacturer’s instructions to set the instrument to perform the required fit test exercise protocol. (b) Connect the instrument sample hose to the respirator facepiece to be tested. In-mask aerosol sampling devices shall be situated and used such that the in-mask sample is drawn at a point midway between the nose and mouth. The sample probe location shall follow the recommendations of the fit test equipment manufacturer. The sample probe should extend into the respirator cavity, but not close enough to be blocked by the face. The in-mask sampling point shall not be isolated from the nose or mouth by a physical partition. For example, if a nose cup is used on a full-facepiece, the sample point shall be inside the nose cup. (c) Instruct the test subject to don the respirator as trained (see Clause C.2.3.2). (d) Allow the test subject’s breathing to purge ambient particles trapped inside the respirator during donning. A half-facepiece will usually purge in a few breaths while a full-facepiece can take a full minute. C.4.5 Fit testing Initiate the instrument’s fit test cycle. Instruct the test subject to begin and follow through with the exercise protocol specified in Clause B.2.5.2 for at least 30 s. C.4.6 Interpretation of results At the completion of the fit test, the instrument provides a pass/fail indication or a numeric overall fit factor result, or both, for the entire test. The person shall be considered to have passed the fit test if the overall fit factor result equals or exceeds the minimum required fit factor criteria. 62 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators C.5 Controlled negative-pressure (CNP) QNFT procedure C.5.1 Operating principle The CNP fit test method is based on exhausting air from a temporarily sealed respirator. Measurement of the exhaust air stream that is required to hold the pressure constant in the temporarily sealed respirator yields a direct measure of leakage air into the respirator. The rate of exhaust is controlled so that a constant negative pressure is established and maintained in the respirator during the fit test. Air molecules are the challenge agent for a CNP fit test. The amount of air that leaks through the face seal is assumed to represent the amount of contaminant leakage through the face seal. The rate of air leakage is directly related to the pressure differential created inside the facepiece during inspiration. The primary determinants of in-mask inspiratory pressure include work rate and air-purifying cartridge resistance. CNP challenge pressures are designed to approximate inspiratory pressure differentials associated with low to moderate work rates rather than resting conditions. The CNP fit factor shall be calculated from the ratio of modelled inspiratory flow rate (function of work rate and cartridge resistance) and measured leakage flow rate. C.5.2 Equipment needed The following equipment shall be used: (a) a controlled negative-pressure (CNP) fit test instrument; and (b) CNP fit test adapters. Filter cartridges shall be replaced with leak-tight adapters to seal the normal air pathways into the respirator. The adapters are equipped with a breathing valve as well as air exhaust and pressure-monitoring ports. The inhalation valve downstream from the test adapter containing the air exhaust port shall be either propped open or removed during the fit test. C.5.3 System calibration and operational checks The following system calibration and operational checks shall be conducted: (a) Calibrate the pressure and flow rate transducers on a periodic (e.g., annual) basis. (b) The pressure/flow rate relationship of the bypass orifice should be checked on a daily basis. C.5.4 Preparation for fit testing Preparation for the fit test shall consist of the following: (a) Equip the test respirator with the appropriate CNP test adapter. (b) Tell the person being fit tested to don the respirator as trained. (c) Select the appropriate fit test protocol from the instrument’s fit test menu: (i) Redon for all air-purifying respirators; or (ii) SCBA for all atmosphere-supplying respirators. C.5.5 Fit tests Fit tests shall consist of the following: (a) Tell the person being fit tested to take a breath and hold it for the duration of the test (about 10 s). The person shall remain motionless in the specified head position during the fit test. (b) When the breath hold is initiated, tell the person being tested to pause for 1 s and then close the adapter breathing valve with the trigger switch. This allows the in-mask pressure to equilibrate to ambient pressure before the test is started. (c) The CNP test system shall be activated to establish and maintain a negative challenge pressure in the temporarily sealed respirator. The exhaust flow rate required to maintain a constant challenge pressure shall be averaged over the duration of the test and represents a direct measure of respirator leakage flow rate. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 63 Z94.4-11 © Canadian Standards Association C.5.6 CNP test exercises All of the following exercises shall be conducted: (a) Face forward — The test subject shall face forward, hold a comfortable breath, press the trigger switch to initiate the test measurement, and remain still for the duration of the test. (b) Bend over — The test subject shall bend at the waist and face the floor, hold a comfortable breath while looking at the floor, press the trigger switch to initiate the test measurement, and remain still for the duration of the test. (c) Shake head — The test subject shall shake his/her head vigorously from side to side while exhaling forcefully or shouting for 3 to 5 s. He/she shall then face forward, hold a comfortable breath, press the trigger switch to initiate the test measurement, and remain still for the duration of the test. (d) Redon 1 — The test subject shall remove the respirator, let out the straps, redon the respirator, face forward, hold a comfortable breath, press the trigger switch to initiate the test measurement, and remain still for the duration of the test. (e) Redon 2 — The test subject shall remove the respirator, let out the straps, redon the respirator, face forward, hold a comfortable breath, press the trigger switch to initiate the test measurement, and remain still for the duration of the test. C.5.7 Interpretation of CNP test results Interpretation of CNP test results shall be based on the following: (a) A CNP fit factor shall be calculated as the ratio of modelled inspiratory flow rate to measured leakage flow rate. (b) The person shall be considered to have passed the fit test if the overall fit factor equals or exceeds the minimum required fit factor criteria. 64 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Annex D (informative) Use of SCBA in low-temperature environments Notes: (1) This Annex is not a mandatory part of this Standard. (2) See CSA Z180.1 for additional information on dew point. D.1 Dew point D.1.1 Dew point is the temperature at which condensation of water vapour in the air takes place. The dew point of a compressed air sample is normally determined by measuring the concentration of water vapour in the air at normal atmospheric pressure. The water vapour concentration at this point can be expressed in v/v or ppm. D.1.2 From Table D.1, it can be seen that an air sample having an atmospheric dew point of –53 C (–63°F) contains 27 mL/m3 (27 ppm) by volume of water vapour. D.1.3 If the temperature of the compressed breathing air were reduced below the pressure dew point temperature, water vapour would begin to condense. Reduction of the air temperature can result from exposure to cold ambient temperatures or cooling from adiabatic expansion during demand. D.1.4 The minimum operating temperature is marked on all SCBA. Users should be cautioned that higher pressures such as 31.0 MPa can aggravate rather than alleviate the problems of regulator freeze-up. In an air sample having an atmospheric dew point of –53 C (–63F), water vapour condensation at 31.0 MPa would begin at the pressure dew point temperature of –8 C (18F). D.1.5 Compressed breathing air purification systems should be capable of consistently producing low dew point air to meet requirements in low-temperature operations (see CSA Z180.1). D.2 Regulator malfunction D.2.1 Regulator freeze-up can occur at ambient temperatures of 5 C (41F) or below. Cooling of the supply air results from exposure to cold ambient temperatures, as well as during demand, when the air undergoes an adiabatic expansion from high to low pressure. If the air is cooled below its dew point, water vapour can condense and ice can form in the flow system. Continued buildup of ice crystals in the flow system can cause malfunction of the regulator. D.2.2 Storage of the apparatus in warm, dry environments and filling SCBA cylinders with compressed air having a pressure dew point temperature of 5 C (9F) below the lowest expected operating ambient temperature, whenever possible, should reduce the incidence of regulator freeze-up. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 65 Z94.4-11 © Canadian Standards Association D.3 Facepiece and breathing tube D.3.1 Some elastomeric parts can become stiff when stored at cold ambient temperatures and distort to a degree that prevents an acceptable face-to-facepiece seal. An acceptable facepiece seal can sometimes be obtained if the facepiece softens when warmed through contact with the user’s skin. Whenever possible, avoid pre-cooling by storing the apparatus in a warm, dry environment. D.3.2 Certain breathing tubes and facepieces can, in sufficiently cold temperatures, become brittle to the point of shattering if dropped or accidentally bumped. Metal fasteners, buttons, or buckles can cause frostbite if permitted to touch the user’s face. D.3.3 Fogging occurs when moist, exhaled air condenses on the facepiece lens. Anti-fog preparations can alleviate fogging in temperatures down to about 0 C (32°F), but they are increasingly ineffective at lower temperatures. Facepieces fitted with nose cups that are in proper working condition and provide an effective face-to-facepiece seal will direct the moist air through the exhalation valve to the ambient atmosphere. This action significantly reduces fogging. D.3.4 Moisture from exhaled air can cause the facepiece exhalation valve to freeze shut when the facepiece is removed in low-temperature environments. Thawing with a warm air source and drying of the exhalation valve prior to re-exposure to low temperature will alleviate this problem. Caution: Attempts to free the valve using mechanical force can result in damage to the valve or valve seat. D.3.5 Harness Shoulder harnesses and waist belts made from plastic or from rubberized or plastic webbing can become stiff and unmanageable in cold weather. Nylon webbing or other materials recommended for cold weather should be used. D.3.6 Cylinder low-air warning device Audible alarms, normally set to actuate at 20 to 25% of the remaining service life of the apparatus, can malfunction at low temperatures. The user is therefore advised to check the pressure gauge at frequent intervals during operations. D.4 Pressure demand Low-temperature operations can affect the facepiece pressure characteristics during both the inhalation and exhalation phase. Users should be trained to recognize any abnormal pressures that might cause leaks or discomfort and should immediately evacuate to a fresh-air base if these problems occur. D.5 Compressed air cylinder pressure The pressure in a cylinder of compressed air drops by about 20% when the cylinder temperature is lowered from 21 C (70°F) to –32 C (–26°F). The service life, however, is not lowered significantly because the air, when used, warms to body temperature. The average loss in service life is actually less than 5%. Notes: (1) Never add additional air to a cylinder in which the pressure has decreased because of equilibration with a lower temperature. (2) Because it is very difficult to differentiate between a leaking cylinder and a cylinder in which the pressure has decreased due to low-temperature exposure, cylinders should be pressurized and stored in a warm environment prior to use. 66 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators D.6 Inspection of SCBA after use Following each use in cold environments, all equipment should be thoroughly checked for distortion and then leak tested. D.7 Atmospheric dew point D.7.1 Table D.1 is provided to assist the user in determining the atmospheric dew point required to protect cylinders and receivers against the problems associated with excessive moisture content, e.g., regulator freeze-up in cold weather operations and internal corrosion in the compressed breathing air cylinders. To determine the atmospheric dew point temperature required to achieve this protection, proceed as follows: (a) Select from Table D.1 the pressure dew point temperature column representing the pressure of the user’s SCBA. (b) Determine the lowest temperature to which the SCBA can be exposed. (c) Locate the temperature closest to this in the column headed “Pressure dew point temperature” for the appropriate cylinder pressure. (d) Select the temperature 5 C (9F) below this temperature, as a safety factor. (e) The temperature directly opposite this in the column with the heading “Atmospheric dew point temperature” is the required dew point expressed in C or F. The corresponding water vapour content in mL/m3 (ppm) is shown in the column “Water vapour content at atmospheric dew point temperature and pressure”. D.7.2 Example A firefighter using a 15.3 MPa (2216 psig) air supply is working in a geographical location where the lowest temperature to which the SCBA is exposed is –25 C (–13F). Proceed as follows: (a) Select from Table D.1: 15.3 MPa (2216 psig). (b) Locate the temperature closest to the lowest temperature to which the SCBA is exposed in the column headed “Pressure dew point temperature” for the appropriate cylinder pressure: –25 C (–13F). (c) Select a temperature 5 C (9F) below this temperature: –30C (–22F). (d) The dew point opposite in Column 1, “Atmospheric dew point”, is –65 C (–85F) and corresponds to a water vapour content of 5 mL/m3 (ppm). The required atmospheric dew point for air used by the firefighter is, therefore, –65 C (–85F), corresponding to a water vapour content at atmospheric dew point temperature and pressure of 5 mL/m3 (ppm). August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 67 Z94.4-11 68 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. Table D.1 Approximate moisture content in compressed breathing air (operating pressures at or above 15.3 MPa (2216 psig) (See Clauses D.1.2 and D.7.) Pressure dew point temperature at 15.3 MPa (2216 psig) (2230.7 psia or 151 atm) Pressure dew point temperature at 20.7 MPa (3000 psig) (3014.7 psia or 204 atm) Pressure dew point temperature at 31.0 MPa (4500 psig) (4514.7 psia or 306 atm) C F mL/m3 (ppm) C C C –53 –63 27 –12 10 –11 13 –10 13 –54 –65 24 –13 9 –12 10 –12 10 –55 –67 21 –15 6 –14 8 –14 7 –56 –69 18 –16 3 –15 5 –15 5 –57 –71 15 –18 1 –17 2 –17 2 –58 –72 14 –19 –2 –18 –1 –19 –1 –59 –74 12 –21 –5 –20 –4 –20 –4 –60 –76 11 –22 –8 –21 –6 –22 –7 –61 –78 9 –24 –10 –23 –9 –23 –10 –62 –80 8 –25 –13 –24 –12 –25 –13 –63 –81 7 –27 –16 –26 –14 –27 –16 –64 –83 6 –28 –18 –27 –17 –28 –19 –65 –85 5 –29 –21 –29 –20 –30 –22 –66 –87 5 –31 –24 –30 –23 –31 –25 –67 –89 4 –32 –26 –32 –25 –33 –27 –68 –90 4 –34 –29 –34 –28 –35 –30 –69 –92 3 –35 –32 –35 –31 –36 –33 –70 –94 3 –37 –34 –37 –34 –38 –36 –71 –96 2 –38 –37 –38 –36 –39 –39 Note: This Table is based on Table 5 from CSA Z180.1. F F F © Canadian Standards Association August 2011 Atmospheric dew point temperature at 101.3 kPa (14.7 psia or 1 atm) Water vapour content at atmospheric dew point temperature and pressure © Canadian Standards Association August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. References: (1) Arnold Wexler, “Vapour Pressure Formulation for Water in Range 0 to 100 °C. A Revision”, Journal of Research of the National Bureau of Standards — A. Physics and Chemistry, Vol. 80A, Nos. 5 and 6 (September–December 1976), pp. 777–778, equation 16A, Table 1, Column 2. (2) R.W. Hyland and A. Wexler, “Formulations for the Thermodynamic Properties of the Saturated Phases of H2O from 173.15K to 474.1K”, ASHRAE Transactions, Part 2A. (3) Lewis Greenspan, “Functional Equations for the Enhancement Factors for CO2 — Free Moist Air”, Journal of Research of the National Bureau of Standards — A. Physics and Chemistry, Vol. 80A, No. 1 (January–February, 1976), p. 41, equation 3; p. 42, equations 5 and 6, Table 1. (4) See the National Building Code of Canada for temperature conditions in Canada. Selection, use, and care of respirators 69 Z94.4-11 © Canadian Standards Association Annex E (informative) Health surveillance Note: This Annex is not a mandatory part of this Standard. E.1 Health surveillance is important to ensure that a person is able to use a respirator without serious difficulty. The use of a respirator can place a physiological or psychological burden on a person, depending on (a) the health of the person; (b) the type of respirator worn; and (c) the job and workplace conditions in which the respirator is used. Figure E.1 provides a sample user screening form to assist in assessing the respirator user’s ability to safely use a respirator. E.2 The following is a list of references that provide guidance for physicians on determining the type of medical examination to be conducted for various working conditions and jobs: (a) American Journal Respir. Crit. Care Med.: Respiratory Protection Guidelines, American Thoracic Society, Medical Section of the American Lung Association, Vol. 154, pp. 1153–1165, 1996. (b) National Fire Protection Agency, NFPA 1582, Standard on Medical Requirements for Fire Fighters, 1997 Edition, 1582-1–1582-36, Chapter 3. (c) National Institute for Occupational Health and Safety (NIOSH) Respirator Decision Logic, Publication 87-108. (d) Occupational Health and Safety Agency (OHSA) — Health Canada — Revised Occupational Health Assessment Guide (OHAG), June 1998. (e) American Journal of Industrial Medicine, Vol. 37, pp. 142–157, Medical Evaluation for Respirator Use by Szeinuk, et. al., 2000 Wiley-Liss, Inc. (f) Journal of Occupational and Environmental Medicine, Vol. 41, pp. 989–994, Medical Surveillance for Respirator Users, J. Michael Muhm. (November 1999). 70 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators RESPIRATOR USER SCREENING FORM For initial and periodic screening of respirator users in conjunction with CSA Z94.4, Clause 12 PART 1: EMPLOYER INFORMATION Employer name: Employer #: Date: Worksite address: Supervisor name: Email: Telephone: ( Facsimile: ( ) ) PART 2: RESPIRATOR USER INFORMATION Name: Employee #: Title/Occupation: Telephone: ( Email: ) Facsimile: ( ) PART 3: CONDITIONS OF USE ACTIVITIES requiring respirator use: FREQUENCY of respirator use: ❏ Daily ❏ Weekly ❏ Monthly ❏ Yearly ❏ Other EXERTION level during use: ❏ Light ❏ Moderate ❏ Heavy ❏ Other DURATION of respirator use per shift: ❏ < 1/4 h ❏ > 1/4 h ❏ >2h ❏ Variable ❏ Other TEMPERATURE during use: ❏ < 0° C ❏ > 0 and < 25° C ❏ > 25° C ATMOSPHERIC PRESSURE during use: ❏ Reduced ❏ Normal/ambient ❏ Increased SPECIAL WORK CONSIDERATIONS Uncontrolled hostile environment: ❏ Emergency escape ❏ Firefighting ❏ Riot/Police activity ❏ Rescue operations ❏ Oxygen deficiency ❏ Confined spaces ❏ IDLH ❏ Hazardous materials (emergency) ❏ Other _______________________________ Other personal protective equipment: ❏ Additional types of personal protective equipment required (specify): _______________________________________ ❏ Estimated total weight of tools/equipment carried during respirator use: Maximum: _______ Average: _________ PART 4: TYPES OF RESPIRATORS USED (check all that apply) ❏ Tight-fitting ❏ Non-tight-fitting (e.g., hood) ❏ SCBA — open-circuit ❏ Mouth bit ❏ SCBA — closed-circuit ❏ Air-purifying, non-powered ❏ Airline, continuous-flow ❏ SCBA — escape ❏ Air-purifying, powered ❏ SCBA — closed-circuit escape ❏ Airline, pressure-demand ❏ Multi-functional pressure-demand/Airline with escape ❏ Supplied-air suit ❏ Combined airline with air-purifying elements ❏ Other (specify): ______________ Figure E.1 Sample respirator user screening form (See Clause E.1.) August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 71 Z94.4-11 © Canadian Standards Association PART 5: RESPIRATOR USER’S HEALTH CONDITIONS Check Yes or No box only. DO NOT specify Note: Medical information is NOT to be offered on this form. (a) Some conditions can seriously affect your ability to safely use a respirator. Do you have or do you experience any of the following or any other condition that could affect respirator use? ❏ Yes ❏ No Shortness of breath Breathing difficulties Chronic bronchitis Emphysema Lung disease Chest pain on exertion Heart problems Allergies Hypertension Cardiovascular disease Thyroid problems Diabetes Neuromuscular disease Fainting spells Dizziness/Nausea Seizures Temperature susceptibility Claustrophobia/Fear of heights Hearing impairment Pacemaker Panic attacks Colour blindness Asthma Vision impairment Reduced sense of smell Reduced sense of taste Back/Neck problems Unusual facial features/Skin conditions Dentures Other condition(s) affecting respirator use Prescription medication to control a condition (b) Have you had previous difficulty while using a respirator? ❏ Yes ❏ No (c) Do you have any concerns about your future ability to use a respirator safely? ❏ Yes ❏ No A “YES” answer to (a), (b), or (c) indicates further assessment by a health care professional is required prior to respirator use. Signature of respirator user: Supervisor’s initials: Date: PART 6: HEALTH CARE PROFESSIONAL PRIMARY ASSESSMENT (if required) Assessment date: Respirator use permitted: ❏ Yes ❏ No Referred to medical assessment: ❏ Yes ❏ No ❏ Uncertain Comments: Reassessment date: Name of health care professional (HCP): Title: Signature of HCP: PART 7: MEDICAL ASSESSMENT (if required) Assessment date: ❏ Class 1. No restrictions ❏ Class 2. Some specific restrictions apply (specify): ________________________________________________________ ❏ Class 3. Respirator use is NOT permitted. Name of physician: Signature of physician: 72 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Annex F (informative) Procedures for cleaning and sanitizing respirators Notes: (1) This Annex is not a mandatory part of this Standard but is written in mandatory language to accommodate its adoption by anyone wishing to do so. (2) Design suggestions for a respirator cleaning and maintenance area are included in NIOSH Publication No. 87-116. F.1 Procedures for cleaning respirators Respirators shall be cleaned as follows: (a) Remove filters, cartridges, or canisters. Disassemble facepieces by removing speaking diaphragms, pressure-demand valve assemblies, hoses, and any other components as recommended by the manufacturer. Discard or repair any defective parts. (b) Wash components in warm [43° C (110°F) maximum] water with a mild detergent or with a cleaner recommended by the manufacturer. A stiff bristle (not wire) brush may be used to facilitate the removal of dirt. (c) Rinse components thoroughly in clean, warm [43° C (110°F) maximum], preferably running water. Drain. (d) When the cleaner used does not contain a disinfecting agent, respirator components should be immersed for 2 min in one of the following: (i) hypochlorite solution (50 ppm of chlorine), made by adding approximately 1 mL of laundry bleach (5 to 6% chlorine) to 1 L of water at 43° C (110°F); (ii) aqueous solution of iodine (50 ppm of iodine), made by adding approximately 0.8 mL of tincture of iodine (6 to 8 g ammonium or potassium iodide/100 cc of 45% alcohol) to 1 L of water at 43° C (110°F); or (iii) other commercially available cleansers of equivalent disinfectant quality when used as directed, if their use is recommended or approved by the respirator manufacturer. (e) Rinse components thoroughly in clean, warm [43° C (110°F) maximum], preferably running water. Drain. The importance of thorough rinsing cannot be overemphasized. Detergents or disinfectants that dry on facepieces can result in adverse skin reactions (e.g., dermatitis). In addition, some disinfectants can cause deterioration of rubber or corrosion of metal parts if not completely removed. (f) Components should be hand-dried with a clean, lint-free cloth or air-dried. (g) Reassemble the facepiece, replacing filters, cartridges, and canisters where necessary. (h) Ensure that all components work properly in accordance with the manufacturer’s instructions. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 73 Z94.4-11 © Canadian Standards Association Annex G (informative) Respirator classification, characteristics, and limitations Notes: (1) This Annex is not a mandatory part of this Standard but is written in mandatory language to accommodate its adoption by anyone wishing to do so. (2) All of the classifications and limitations included in this Annex refer to NIOSH testing and certification criteria. Some authorities having jurisdiction recognize other agencies’ testing and certification criteria, e.g., CEN. G.1 The physical characteristics, the functional capabilities, and the performance limitations of the various types of respirators shall be considered in respirator selection. G.2 For the purpose of selection, respirators shall be grouped as specified in Clause 7.2.1. G.3 Atmosphere-supplying respirators G.3.1 General G.3.1.1 Characteristics Atmosphere-supplying respirators provide compressed breathing air that is independent of the atmospheric conditions. G.3.1.2 Limitations Atmosphere-supplying respirators provide no protection to exposed skin from contaminants such as ammonia and hydrogen chloride or against the skin absorption of materials such as hydrogen cyanide, tritium oxide, or organic phosphate pesticides. Refer to approval label and instruction and maintenance manuals for additional information on use and maintenance of these respirators. This type of respirator shall be selected, fitted, used, and maintained in accordance with this Standard and other applicable regulations of the authority having jurisdiction. After each use, thorough cleaning and sanitizing of the respirator shall be done in accordance with the manufacturer’s instructions. G.3.2 Self-contained breathing apparatus (SCBA), open-circuit G.3.2.1 General G.3.2.1.1 Characteristics The supply of compressed breathing air is carried by the user. Open-circuit pressure-demand SCBA are equipped with a full-facepiece or tight-fitting hood and pressure-demand valve. The pressure-demand valve maintains a slightly positive pressure inside the 74 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators facepiece and permits air flow only during inhalation. Exhaled air passes through exhalation valves in the facepiece to the ambient atmosphere. A manually operated bypass system shall be required if the mode of failure of the regulator cuts off the breathing air supply. This bypass can have an adjustable flow valve to conserve the air during escape, or a fixed flow valve. Either configuration permits the user to breathe. G.3.2.1.2 Limitations In addition to the limitations in Clause G.3.1.2, the period over which the device will provide protection is limited by the amount of compressed breathing air in the apparatus, the ambient atmospheric pressure (e.g., service life is cut in half by a doubling of the atmospheric pressure), and the degree of physical activity. The actual service time is usually less than the NIOSH rated service time. SCBA devices are typically heavy and bulky. Their use requires more physical exertion and more training, and they require more maintenance than most other respirators. Prior to use, NIOSH approval can be maintained only if the SCBA compressed air cylinder is fully charged to the rated cylinder air pressure with compressed breathing air. The compressed breathing air shall meet or exceed the requirements of Table 1 in CSA Z180.1. SCBA devices shall be used only in the atmospheric temperatures that are listed on the approval label. The SCBA cylinder shall meet Transport Canada (TC) specifications and approval. After each use, thorough cleaning and sanitizing of the respirator shall be done in accordance with the manufacturer’s instructions. Applicable respirators shall be flow tested at least once a year, using an approved dynamic flow tester. In making renewals and repairs, parts identical with those furnished by the manufacturer under the pertinent approval shall be maintained. Some SCBA devices have a short rated service life (less than 15 min) and are suitable only for escape, including from IDLH atmospheres. G.3.2.2 Self-contained breathing apparatus (SCBA), closed-circuit G.3.2.2.1 Characteristics Closed-circuit SCBA are typically available in the following configurations and types: (a) compressed gaseous oxygen; (b) chemical oxygen generation; and (c) a combination of compressed gaseous oxygen and chemical oxygen generation. All types are equipped with either a tight-fitting facepiece, or for escape only, a mouthpiece with nose-clip and goggles. Compressed oxygen systems use a cylinder of high-pressure gaseous oxygen that passes through a pressure-reducing valve to a reservoir. Compressed oxygen systems use pressure-relief valves, bypass systems, and saliva traps. In both compressed gaseous oxygen and chemical oxygen generation systems, the user inhales and the oxygen is delivered from the reservoir to the facepiece or mouthpiece through tubing, check valves, and demand regulators. Exhaled breathing gas is directed into a carbon dioxide removal medium, and the breathing gas then recirculates through the system. Makeup oxygen can enter the reservoir on a continuous basis or when the volume of breathing gas in the reservoir is reduced sufficiently to activate an oxygen admission valve. Some types of oxygen closed-circuit SCBA use both a continuous flow as well as a demand system to supply gaseous oxygen to the reservoir. Chemical oxygen systems generate gaseous oxygen by a chemical reaction. Water vapour and carbon dioxide in the exhaled breath react with the chemical in the canister, causing gaseous oxygen to be generated. The gaseous oxygen passes into a breathing bag reservoir from which the user of the SCBA inhales. The exhaled breathing gas is returned to the canister where carbon dioxide and moisture contained in the exhaled breath react with the chemical to generate gaseous oxygen. The process is continuous until the oxygen-generating chemical is consumed. The volume of oxygen generated by this system is directly proportional to the volume of moisture and carbon dioxide in the exhalation breath of the user of the SCBA. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 75 Z94.4-11 © Canadian Standards Association The oxygen closed-circuit SCBA operation conserves oxygen and permits longer rated service life at a reduced weight when compared with the open-circuit compressed breathing air SCBA. Oxygen SCBAs are available with up to 4 h rated service time. Long-service oxygen SCBAs use a coolant component to control breathing air temperature. After each use, thorough cleaning and sanitizing of the respirator shall be done in accordance with the manufacturer’s instructions. G.3.2.2.2 Limitations In addition to the applicable limitations in Clause G.3.1.2, closed-circuit devices provide an elevated temperature of the breathing air because of the chemical reactions inherent in their operation. The closed-circuit pressure-demand oxygen breathing apparatus shall not be used where there is direct exposure to open flames or in high radiant heat. This limitation applies to 100% oxygen apparatus only. G.3.3 Airline respirators G.3.3.1 General G.3.3.1.1 Characteristics The air supply is not limited to the quantity of breathable air a person can carry. A variety of configurations of air sources are available (e.g., compressor, cascade cylinder system, portable air supply, ambient air system). Respirable air is supplied through an approved flexible air supply hose from a breathing airline source (see CSA Z180.1). The approved operating air supply pressure is maintained by an adjustable regulator. The air supply hose is attached to the user by a belt and can be detached rapidly in an emergency by means of a quick disconnect fitting. A flow control valve or orifice is provided to govern the rate of airflow to the user. The breathing air passes up to the tight-fitting facepiece, loose-fitting hood, or helmet by means of a flexible breathing tube. Exhaled air passes to the ambient atmosphere through valves or openings in the enclosure (facepiece, loose-fitting facepiece, helmet, or hood). Airline respirators are available in the following configurations: (a) pressure-demand; and (b) continuous-flow. Pressure-demand types are equipped with a tight-fitting facepiece or tight-fitting hood, a spring-loaded pressure-demand exhalation valve, and a regulator, all of which are configured to contribute to maintaining a positive pressure in the facepiece when a proper face-to-facepiece seal is maintained by the user. Continuous-flow types are generally equipped with a tight- or loose-fitting facepiece, hood, or helmet. The respirators require at least 115 L/min (4 ft3/min) of air to tight-fitting facepieces and 170 L/min (6 ft3/min) of air to loose-fitting facepieces, helmets, or hoods. Continuous-flow and pressure-demand types are designed to maintain a positive pressure in the facepiece and are less apt to permit inward leakage of contaminants. Note: Changes in breathing rates can result in system increased/decreased airflow sensed by the pressure regulator, which maintains positive pressure in pressure-demand respirators. In order to maintain positive pressure in continuous-flow respirators at higher breathing rates, the airflow can be changed by manually adjusting the control valve. An instantaneous negative pressure can be created in continuous-flow airline respirators if the respirator is overbreathed at a given setting. Similarly, an instantaneous negative pressure can be created in pressure-demand airline respirators at very high flow rates. G.3.3.1.2 Limitations Airline respirators provide no protection if the air supply fails and shall therefore not be used in IDLH atmospheres. In addition to the limitations in Clause G.3.1.2, airline respirators are limited to use in atmospheres in which the user can remove the facepiece, loose-fitting facepiece, helmet, or hood and 76 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators escape unharmed without the aid of the respirator (i.e., in non-IDLH atmospheres), should the air supply fail. Maximum use concentrations based on contaminant toxicity shall apply. The user is restricted in movement by the air supply hose and must return to a respirable atmosphere. Airline respirators shall have a minimum quantity and pressure of breathing air meeting the requirements of CSA Z180.1. The demand-type respirator develops a negative pressure in the facepiece on inhalation and therefore can be used only in an atmosphere where a non-powered air-purifying respirator is suitable. Continuous-flow types require a higher volume of breathing air than demand or pressure-demand because the air is flowing at a constant rate independent of breathing rate. An instantaneous negative pressure can be created in pressure-demand and continuous-flow airline respirators if the respirator is overbreathed. Airline hoses other than those approved by NIOSH can be permeable to substances such as aromatic hydrocarbons. The NIOSH-approved respirator includes the air supply hoses and male/female quick disconnect fittings; therefore, substitution of other hose or other respirator manufacturers’ air supply hoses or fittings voids the approval, and the respirator is no longer considered acceptable. To maintain NIOSH approval, the approved air supply hose shall not exceed a maximum of 90 m (300 ft) in length, but some are approved only for shorter lengths; refer to limitations associated with the specific approval number. G.3.4 Multi-functional atmosphere-supplying respirators G.3.4.1 Characteristics These are airline respirators that have an auxiliary self-contained air supply The auxiliary self-contained air supply on this type of device allows the user to enter and work in an IDLH atmosphere. The worker uses the airline mode for normal work. To escape from an IDLH atmosphere in the event that the primary air supply fails to operate, the user switches to the auxiliary self-contained air supply and disconnects the air supply hose using a quick disconnect fitting. G.3.4.2 Limitations The escape route shall be planned such that the time needed to escape does not exceed the rated service time of the auxiliary air supply. The auxiliary air supply shall be used to enter the hazardous atmosphere before connection is made to an air supply line only if the rated service time is at least 15 min, and the time for entry does not exceed 20% of the rated service time of the auxiliary air supply. G.4 Air-purifying respirators G.4.1 General G.4.1.1 Characteristics Ambient air, prior to being inhaled, is passed through a filter, cartridge, or canister that removes particles, vapours, gases, or a combination of these contaminants. Air-purifying respirators are available in two modes of operation: (a) non-powered (APR); and (b) powered (PAPR). The breathing action of the user operates the non-powered types. The powered types contain a blower carried by the user that passes ambient air through an air-purifying component and then supplies purified air to the facepiece. Non-powered types are equipped with a facepiece or mouthpiece and nose-clip. Powered types are equipped with a facepiece, loose-fitting facepiece, helmet, or hood. G.4.1.2 Limitations Air-purifying respirators shall not be used where the oxygen content of the air is less than the equivalent of 19.5% at sea level. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 77 Z94.4-11 © Canadian Standards Association Air-purifying respirators shall not be used in IDLH atmospheres. Maximum use concentrations based on contaminant toxicity shall apply. The appropriate type of canister, cartridge, or filter shall be selected for the particular atmosphere and conditions. The time period over which protection is provided is dependent on the canister, cartridge, or filter type, the concentration of the contaminant, humidity levels in the ambient atmosphere, and the user’s respiratory rate. A canister, cartridge or filter change-out schedule shall be established unless the respirator is equipped with an end-of-service-life indicator. Non-powered air-purifying respirators can cause discomfort due to a noticeable resistance to inhalation. This problem is minimized in powered respirators. Powered respirators are limited by battery life in addition to canister, cartridge, or filter life and shall be checked for flow before each use. Fit testing is required for users of all tight-fitting facepiece respirators. Some respirator facepieces can present special problems to individuals required to wear corrective lenses. G.4.2 Vapour- and gas-removing respirators G.4.2.1 Characteristics Vapour- and gas-removing respirators are equipped with cartridges or canisters to remove a single vapour or gas, a single class of vapours or gases (e.g., organic vapour), or a combination of two or more classes of vapours and gases from the air. Vapour- and gas-removing respirators are available in the following respiratory inlet configurations: (a) half-facepiece respirator; (b) loose-fitting facepiece for powered air; (c) full-facepiece respirator that provides protection against eye irritation in addition to respiratory protection. These respirators can also provide eye and face impact protection; (d) tight-fitting hood; and (e) helmet or hood for powered air. G.4.2.2 Limitations Breakthrough warning properties of vapour- and gas-removing respirators (e.g., odour, taste, or irritation) shall not be used to identify change-out schedules. Unless the cartridges contain an end-of-service-life indicator for the contaminant, a change-out schedule shall be established that ensures that the cartridge is changed before the service life has ended. The respirator manufacturer should be consulted for guidance on the effectiveness of any specific respirator or air-purifying element against the contaminant for which protection is needed. At any time, should workers detect odour or experience any irritation symptoms of the contaminant before the end of the change-out schedule, the respirator program administrator shall be informed and shall re-evaluate the use of this respirator, i.e., the change-out schedule, the workplace concentrations, or the other use conditions [relative humidity (RH), work rate, etc.]. No protection is provided against particulate contaminants. A rise in the canister or cartridge temperature indicates that a gas or vapour is being removed from the inhaled air. An uncomfortably high temperature indicates a high concentration of gas or vapour and requires an immediate return to fresh air. See Clause G.4.1.2 for additional limitations. G.4.3 Particulate-removing respirator G.4.3.1 Characteristics G.4.3.1.1 Particulate-removing respirators are equipped with filters to remove particulate matter from the air. The filter may be a replacement part or a permanent part of the respirator. The filter may be of the single-use or reusable type. 78 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Particulate filters for non-powered respirators are available in three minimum efficiencies and three series, Series N, Series R, and Series P, as follows: (a) N100, R100, and P100 filters shall demonstrate a minimum efficiency level of 99.97%. (b) N99, R99, and P99 filters shall demonstrate a minimum efficiency level of 99%. (c) N95, R95, and P95 filters shall demonstrate a minimum efficiency level of 95%. Series N filters are suitable for any non-oil based particulates. Series R and P filters are suitable for any particulate, including oil-based particulates. G.4.3.1.2 Particulate filters for powered air-purifying respirators are available in one efficiency only (99.97%). These filters are designated as high efficiency (HEPA). G.4.3.1.3 Particulate-removing respirators are available in the following respiratory inlet configurations: (a) half-facepiece respirator, both elastomeric and filtering facepiece; (b) loose-fitting facepiece for powered air; (c) full-facepiece respirator that provides protection against eye irritation in addition to respiratory protection. These respirators can also provide eye and face impact protection; (d) tight-fitting hood; and (e) helmet or hood for powered air. G.4.3.2 Limitations Protection is provided against non-volatile particulates only, i.e., those that cannot release or evaporate contaminant vapours or gases at room temperature. No protection is provided against gases and vapours. All particulate filters will increase in resistance with use and shall be changed when breathing becomes difficult or, for powered devices, when the air flow is not sufficient. Series N, R, and P filters shall be replaced for hygienic reasons if damaged or soiled or if breathing becomes difficult. The following specific limitations shall apply: (a) Series N and R filters have a maximum total particulate load of 200 mg for the respirator, characterized by increased breathing resistance. (b) Series N filters are not suitable for particulates where oil is present. (c) Series R filters are restricted to a maximum of 8 h use or total respirator particulate load of 200 mg. (d) Series N, P, and HEPA filters can also have time restrictions on their service life; the manufacturer’s instructions should be consulted. (e) HEPA filters used in PAPR systems can require replacement when the air flow falls below the required level. See Clause G.4.1.2 for additional limitations. G.4.4 Combination gas-, vapour-, and particulate-removing respirators G.4.4.1 Characteristics Combination gas-, vapour-, and particulate-removing respirators are equipped with cartridges or canisters to remove gases and vapours and a particulate filter(s) to remove particles from the air. The filter may be a permanent or replaceable part of a cartridge or canister. G.4.4.2 Limitations The limitations of both gas-, vapour-, and particulate-removing air-purifying respirators shall apply. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 79 Z94.4-11 © Canadian Standards Association G.4.5 Multi-functional air-purifying respirators G.4.5.1 Characteristics A multi-functional air-purifying respirators is a PAPR that is also approved to operate as a non-powered respirator for use in the event that the motor fails or there is a need for clandestine operation. G.4.5.2 Limitations All of the limitations of Clause G.4.1.2 shall apply except the limitations associated with battery life. G.5 Combined atmosphere-supplying and air-purifying respirators G.5.1 Characteristics A combination atmosphere-supplying and air-purifying respirator is (a) an atmosphere-supplying pressure-demand respirator with an auxiliary air-purifying attachment that provides protection in the event that the compressed breathing air supply fails. The respirator consists of a tight-fitting facepiece with or without a manually switchable spring-loaded exhalation valve to take the respirator from a compressed air pressure demand to an air-purifying demand type; or (b) an atmosphere-supplying continuous-flow respirator with an auxiliary air-purifying attachment that provides protection in the event that the compressed breathing air supply fails. The respirator consists of a tight-fitting facepiece to take the respirator from a continuous-flow to an air-purifying respirator. G.5.2 Limitations A combination atmosphere-supplying respirator with an auxiliary air-purifying element shall be used only when the concentration of airborne contaminants in the workplace does not exceed the maximum use concentration of the respirator when used in the air-purifying mode. The mode of operation in use will dictate the assigned protection factor to be applied when airline respirators are equipped with an air-purifying filter (combined respirator). G.6 Escape-only self-rescue respirators G.6.1 Characteristics Emergency escape respirators are typically available in the following configurations and types: (a) air-purifying self-rescue respirator; (b) chemical oxygen generation self-rescue respirator; and (c) compressed breathing air self-rescue apparatus. These devices are available in a variety of sizes and weights. Consideration should be given to the weight the wearer must carry. The air-purifying escape respirator typically consists of a tight-fitting facepiece or tight-fitting hood assembly with neck collar and adjustable straps and cartridges or with a mouthpiece, nose-clip, goggles, and cartridges. The respirator comes in a sealed protective container and is either worn on the belt of the user or cached ready for distribution to the user. The chemical oxygen escape respirator consists of a mouthpiece, nose-clip, and goggles and is generally worn by the user or cached in a protective container. The atmosphere-supplying escape respirator comes with a compressed breathing air cylinder, a pressure-reduction regulator, and constant flow valve with a tube and loose-fitting hood. 80 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators G.6.2 Limitations This type of respirator is intended for emergency escape purposes only and can have a limited shelf life, depending on the type. Escape-only respirators shall not be used for entry into contaminated atmospheres. Escape-only air-purifying respirators shall not be used for escape from IDLH atmospheres. Maximum use concentrations shall apply. APFs are not applicable for escape-type respirators. Selection and application of respirators for escape purposes only shall be conducted in close consultation with the manufacturer of the device and the authority having jurisdiction. In addition to the limitations in Clauses G.3 and G.4, the following additional limitations apply to the use of escape-only respirators: (a) Atmosphere-supplying escape-only respirators do not have alarms that warn of the pending end of the air supply. (b) Air-purifying escape-only respirators shall be used where there is at least 19.5% oxygen (sea level) and be applicable to the anticipated contaminant type and concentration. (c) Smoke or fire escape-only air-purifying respirators shall have a carbon monoxide removing mechanism. (d) When the respirator is equipped with a mouth bit, the nose-clip shall be secured in place to prevent breathing through the nose. (e) Specialized, frequent training is needed for many escape-only respirators. G.7 Supplied-air suits G.7.1 Characteristics Supplied-air suits are impermeable to specific particulate, vapour, and gaseous contaminants and, when provided with a supply of compressed breathing air that is adequate for the user, can maintain a positive pressure inside the suit. These devices are not respirators for the purpose of this Standard. G.7.2 Limitations Supplied-air suits are not currently tested or certified by NIOSH. The manufacturer’s instructions shall be consulted for device limitations. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 81 Z94.4-11 © Canadian Standards Association Annex H (informative) Reduced oxygen concentration Note: This Annex is not a mandatory part of this Standard. H.1 Reduced oxygen concentration (hypoxia) H.1.1 Hypoxia is any condition in which there is an inadequate supply of oxygen to the tissues. Three types of tissue hypoxia relevant to this Standard are described in Clauses H.1.2, H.1.3, and H.1.4. H.1.2 Arterial hypoxia Arterial hypoxia is characterized by a lower-than-normal partial pressure of oxygen (pO2) in arterial blood and, therefore, in the capillary blood. The causes are (a) low pO2 in inspired air (e.g., at high altitude); or (b) breathing air in a confined space or other environment where the pO2 is lower than that found in normal atmospheric air. H.1.3 Anaemic hypoxia (hypoxemia) Anaemic hypoxia (hypoxemia) results when the oxygen capacity of the blood is reduced. The oxygen content falls more rapidly than normal as it flows through the capillary beds and becomes inadequate in maintaining the required oxygen tension throughout the tissues. The causes of this type of oxygen deficiency include (a) less-than-normal haemoglobin content (anaemias); (b) haemoglobin rendered ineffective, as in carbon monoxide poisoning; and (c) alteration of haemoglobin to methaemoglobin following poisoning with chlorates, nitrates, ferricyanides, etc., which prevents haemoglobin from combining with oxygen. H.1.4 Histotoxic hypoxia Histotoxic hypoxia is a condition in which the cells are not able to utilize oxygen that is available at normal partial pressure in the arterial blood. Cyanide poisoning is known to affect the cells in this manner. H.2 Minimal oxygen content Minimal oxygen content occurs when, for any reason, the oxygen partial pressure of inspired air falls to approximately 17.5 kPa or less. This corresponds to breathing air (a) in which the oxygen content has been reduced from the normal 20.95% to approximately 17.2% (17.2% × 101.3 kPa = 17.5 kPa oxygen partial pressure); or (b) having a normal oxygen content (20.95%) at altitudes where the pressure is approximately 84 kPa (20.95% × 84 kPa = 17.5 kPa oxygen partial pressure). H.3 Hypoxia immediately dangerous to life or health When, for any reason, the oxygen partial pressure of inspired air falls to approximately 16.2 kPa or less, there exists an oxygen deficiency considered immediately dangerous to life or health. This corresponds to breathing air (a) in which the oxygen content has been reduced from the normal 20.95% to approximately 16.0% (16.0% × 101.3 kPa = 16.2 kPa oxygen partial pressure); or 82 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators (b) having a normal oxygen content (20.95%) at altitudes where the pressure is approximately 77 kPa (20.95% × 77 kPa = 16.2 kPa oxygen partial pressure). H.4 Effects of oxygen deficiency The effects of oxygen deficiency are described in Table H.1. Table H.1 Effects of oxygen deficiency Stage % O2 at 101.3 kPa Partial pressure of O2 in arterial blood (kPa) Partial pressure of O2 in lung (kPa) Effects 0 21 13.3 18.7 Normal 17.2 Minimal oxygen content; no physiological effects in healthy adults I 16 10.0 15.0 Increased pulse and breathing rates; some lack of coordination; some impairment in attention and thinking II 14 8.0 13.3 Abnormal fatigue upon exertion; emotional upset; faulty coordination; impaired judgment III 12 6.3 11.3 Very poor judgment and coordination; impaired respiration that can cause permanent heart damage; vomiting and nausea IV Less than 10 Less than 4.4 Less than 9.5 Nausea; vomiting; inability to perform vigorous movement; loss of consciousness, convulsions, and death Note: ACGIH Chemical Substances TLV Appendices — Appendix F: Minimal Oxygen Content (2007). August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 83 Z94.4-11 © Canadian Standards Association Annex I (informative) Buddy breathing Note: This Annex is not a mandatory part of this Standard. I.1 Excerpt from NFPA 1500-2007, Standard on Fire Department Occupational Safety and Health Program A.7.11.1.2 Manufacturers of fire service SCBA that are NIOSH-certified and that also meet requirements of NFPA 1981 provide SCBA with a reasonable level of dependability, if correctly used and maintained. In those cases where there is a reported failure of SCBA, a before-use check, a more thorough user inspection program, or a preventive maintenance program most likely would have eliminated the failure. Fire fighters should be thoroughly trained in emergency procedures that can reverse problems encountered with their SCBA. Use of the regulator bypass valve, corrective action for facepiece and breathing tube damage, and breathing directly from the regulator (where applicable) are basic emergency procedures that should be taught to and practiced by the individual user. Fundamental to all emergency procedure training is the principle of not compromising the integrity of the user’s SCBA, with particular emphasis on not removing the facepiece for any reason. The danger of compromising the integrity of the SCBA by removing the facepiece in atmospheres where the quality of air is unknown should be reinforced throughout the SCBA training program. It is natural that this same philosophy be adopted when dealing with the subject of “buddy breathing.” The buddy breathing addressed herein is a procedure that requires compromising the rescuer’s SCBA by either removal of the facepiece or disconnection of the breathing tube, as these actions place the rescuer in grave danger. The subject of buddy breathing is always a highly emotional one. Training should stress that fire fighters should not remove the facepiece of the SCBA in a hazardous atmosphere to assist a civilian fire victim, thereby exposing themselves to the toxic atmosphere, but instead rely on the rapid removal of the victim to a safe atmosphere or to a place of refuge where the rescuer can obtain further assistance in removing the victim to fresh air and treatment. However, when a fire fighter becomes the victim due to exhaustion of the breathing air supply or other impairment, some fire departments or fire service personnel insist upon engaging in procedures that are extremely difficult at best, even with consistent training in relatively ideal conditions. Virtually all buddy breathing procedures require compromising the rescuer’s SCBA and, for this reason, cannot be condoned. Positive-pressure SCBA has made certain methods of buddy breathing more complicated, if not impossible. A key disadvantage in buddy breathing is that it is extremely difficult for two people to leave the hazardous atmosphere quickly while engaged in buddy breathing, simultaneously consuming air at a faster rate. The risk that both individuals will inhale sufficient products of combustion to cause impairment or death is a very distinct possibility. It is difficult to understand why buddy breathing advocates believe that an atmosphere that is deadly for one fire fighter and causes that fire fighter to become a victim can safely be breathed by another fire fighter (the would-be rescuer) while using a buddy breathing procedure. A scenario involving two fire fighters working at a warehouse fire provides a graphic example of how buddy breathing can be more hazardous than beneficial to both the rescuer and the victim. While working in an interior operation at a warehouse fire, one fire fighter suffered depletion of his breathing air supply. The other fire fighter commenced buddy breathing while both attempted to move out of the building. Unable to make sufficient progress as the first fire fighter was being overcome, the rescuer left the victim and attempted to leave the area for help. But because the rescuer had inhaled sufficient products of combustion during the attempted buddy breathing operation, he collapsed before he could exit the building. He was rescued by other fire fighters and removed to a hospital before he could relate the circumstances regarding the first fire fighter. The first fire fighter was found dead some time later. 84 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators If the fire fighter had been trained to remove the victim completely from the building or from immediate physical danger if possible, a number of things would have been accomplished without endangering the rescuer’s life and with less risk to the victim fire fighter. If the rescuer had not compromised his SCBA, he would not have been affected by the products of combustion, he would have retained a greater air supply, and he would have either removed the victim fire fighter by himself or exited the area for additional assistance and alerted medical help. The risk of both victim and rescuer exhausting their air supplies is another scenario associated with buddy breathing. In this case, what starts out as a rescuer-victim relationship ends up a victim-victim relationship, as the shared air supply is exhausted before exiting is possible. The one scenario that does not allow exiting is that in which two or more persons are trapped and share air supplies by buddy breathing. In this case, survival is based upon the time it takes those outside to realize that persons are trapped, initiate rescue operations, and accomplish rescue. Unfortunately buddy breathing might only provide a simultaneous ending of multiple lives. SCBA emergency procedures should be an integral part of any respiratory protection SCBA program, with written policies for the removal of victims, both civilian and fire service, from hazardous atmospheres without compromising the rescuer’s respiratory protection SCBA for any reason. Factors that can limit the need for buddy breathing include the following: (1) A strong, well-administered respiratory protection SCBA program (2) Emphasis on user testing and inspection of respiratory protection SCBA (3) Required before-use and after-use testing and maintenance (4) Functional preventive maintenance program (5) Fireground management based upon safe operations with knowledge of fire development, building construction, and coordinated fire-fighting operations (6) Air management training based upon the type of structure the user is entering, which requires the user to be aware of the distance to exit the structure when the low-air alarm activates or when necessary to leave the structure (7) Quality breathing air (8) Personal alert safety system (PASS) devices and portable radios for interior fire-fighting teams Thorough training in survival techniques, controlled breathing, and stress management (9) (10) Accountability for interior fire-fighting crews (11) Physical fitness of firefighters (12) Use of positive-pressure SCBA that are NIOSH-approved and that meet the requirements of NFPA 1981 NFPA, ANSI, IAFF, and most SCBA manufacturers do not recommend buddy breathing because it compromises one or more SCBA and can result in the needless impairment or death of either the rescuer or the victim, or both. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 85 Z94.4-11 © Canadian Standards Association Annex J (informative) Checklist of competency for respirator fit testers Note: This Annex is not a mandatory part of this Standard. Proficient Improvement required ❑ ❑ (b) Limitations on the use of respiratory protection (see Annex G of CSA Z94.4-11) ❑ ❑ (c) ❑ ❑ ❑ ❑ ❑ ❑ (b) CSA Z94.4-11 regarding fit testing, interference concerns, user screening, training, inspection, use, cleaning, maintenance, and storage ❑ ❑ (c) Applicable regulatory requirements ❑ ❑ 3 Respirators identified in the respiratory protection program (RPP) (a) Types of respirators required as determined in the RPP ❑ ❑ (b) Make, model, and size of selected respirator inlet covering types ❑ ❑ (c) Respirator components and their functions ❑ ❑ 4 Pre-use requirements for the selected respirator(s) (a) Respirator assembly, pre-use inspection, cleaning and sanitizing, and maintenance ❑ ❑ ❑ ❑ ❑ ❑ ❑ ❑ (b) Placement of fit test equipment ❑ ❑ (c) Orderly management of the fit test process ❑ ❑ 7 Operational aspects and issues in fit test method(s) being used (a) Knowledge of fit test procedures, requirements, and limitations ❑ ❑ ❑ ❑ Areas of fit tester competency (see Clauses 4, 5, 8, 9, and 14) 1 Respiratory protection and fit testing fundamentals (a) Requirements for the use of respiratory protection Purpose and applicability of respirator fit testing (see Tables 1 and 2 of CSA Z94.4-11) (d) Specific roles and responsibilities of the respirator fit tester 2 Respiratory protection requirements (a) Specific requirements as outlined in the organization’s respiratory protection program (b) Donning, user seal check procedures, doffing, and redonning 5 Verification of respirator user’s competency Verification of user’s competency to perform pre-use inspection, donning, and user seal check procedures, doffing, and redonning without assistance from the fit tester 6 Organization of fit testing workspace, equipment, and activity (a) Room layout and management of ventilation (b) Description of QLFT challenge agent and how to identify it (Continued) 86 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Areas of fit tester competency (see Clauses 4, 5, 8, 9, and 14) Proficient Improvement required (c) ❑ ❑ ❑ ❑ ❑ ❑ (b) Choose the appropriate canisters/cartridges/filters for the fit test method ❑ ❑ (c) ❑ ❑ (d) Prepare, inspect, and perform operational checks of fit test equipment and supplies ❑ ❑ (e) Create and maintain records of fit test equipment maintenance, diagnostic checks, calibration, and repair ❑ ❑ 9 Conduct respirator fit tests (a) Confirm user pre-qualifications for fit testing (i.e., completion of user screening, training, freedom from interference concerns due to facial hair and other personal conditions, effects, or accessories) ❑ ❑ (b) Oversee the matching up of a respirator (make, model, and size) with user’s physical characteristics ❑ ❑ (c) ❑ ❑ (d) Verify through observation and questioning, without coaching or ❑ assistance, that donning, a user seal check, doffing, and redonning are performed successfully ❑ Identification, knowledge, and understanding of erroneous fit test results (d) Awareness of health and safety issues associated with chemicals and equipment used in fit testing 8 Use selected respirators and fit testing equipment (a) Select, set up, and use QNFT or QLFT equipment and accessories Set up respirator facepiece assembly, use of probes, QNFT adapters and, where required, software application Identify a poorly fitting respirator through observation and questioning about comfort and fit (for QLFT, see Clauses B.2.3.3, B.2.3.4, and B.2.3.8 of CSA Z94.4-11; for QNFT, see Clauses C.2.3.3, C.2.3.4, and C.2.3.8 of CSA Z94.4-11) (e) Confirm compatibility of other personal protective equipment during the fit test ❑ ❑ (f) Conduct the chosen procedure (QLFT or QNFT) in accordance with Annex B or C ❑ of CSA Z94.4-11 ❑ (g) Confirm fit tester and user adherence to the entire fit test procedure ❑ ❑ (h) Apply problem-solving solutions (for the user, equipment, and environment) before, during, and after the fit test process, addressing fit test failures if they occur ❑ ❑ (i) Interpret and document results of the fit test ❑ ❑ (j) Communicate the need to use only the specific respirator make, model, and size with which the user passed the fit test ❑ ❑ (k) Ensure that cleaning and sanitizing of respirators and fit testing equipment is carried out according to the manufacturer’s instructions and the organization’s infection control program ❑ ❑ Comments: Action plan for areas requiring improvement: Evaluator: August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 87 Z94.4-11 © Canadian Standards Association Annex K (informative) Scenarios using selection wheels in Figures 2 and 3 Note: This Annex is not a mandatory part of this Standard. K.1 Scenario 1: Histoplasmosis A worker is directed to go into a warehouse that has been occupied by pigeons for many years. Piles of pigeon excrement about a metre deep are found under roosting locations. The cleanup will be done indoors with no additional ventilation. Step 1 Identify the bioaerosol. Histoplasma capsulatum Step 2 Transmission of disease, infection, or adverse effects produced from inhalation of bioaerosol. Yes (histoplasmosis) Step 3 Select applicable control banding wheel: health care facility or general workplace environment (see Figure 2 or 3) General workplace environment — Figure 3 Step 4 Determine the bioaerosol risk group (R1, R2, R3, or R4 in accordance with Clause 7.3.2.3.5) R3: Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Step 5 Determine the generation rate (G1, G2, G3, or G4 in accordance with Clause 7.3.2.3.6) G3 — Misting then shovelling Step 6 Determine the control level (C1, C2, C3, or C4 in accordance with Clause 7.3.2.3.7) C1 — Indoor — Poorly ventilated ACH 1 Step 7 Identify the number and colour of the segment selected at the intersection of the variables identified in Steps 4 to 6: R3, G3, C1 = Orange/No. 3. See Figure 4 to determine the assigned protection factor corresponding to Orange/No. 3 — APF 50. • Air-purifying (negative-pressure) full-facepiece; • Powered air-purifying half-facepiece; • Airline (pressure-demand) half-facepiece; or • Airline (continuous-flow) half-facepiece 88 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators K.2 Scenario 2: Hantavirus exposure Utility worker performing maintenance in a rural shed with windows and door open. Visual inspection of area shows mouse droppings throughout the area. Unknown if these are white foot deer mouse droppings. Step 1 Identify the bioaerosol. Suspected pathogen — hantavirus Step 2 Transmission of disease, infection, or adverse effects produced from inhalation of bioaerosol. Yes, hantavirus pulmonary syndrome Step 3 Select applicable control banding wheel: health care facility or general workplace environment (see Figure 2 or 3) General workplace environment — Figure 3 Step 4 Determine the bioaerosol risk group (R1, R2, R3, or R4 in accordance with Clause 7.3.2.3.5) R3: Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Step 5 Determine the generation rate (G1, G2, G3, or G4 in accordance with Clause 7.3.2.3.6) G2 — Soaking then shovelling or G4 — Dry sweeping Step 6 Determine the control level (C1, C2, C3, or C4 in accordance with Clause 7.3.2.3.7) C2 — Indoor — Ventilation 1 < ACH 4 Step 7 Identify the number and colour of the segment selected at the intersection of the variables identified in Steps 4 to 6: Cleanup by soaking then shovelling R3, G2, C2 = Green/No. 1. See Figure 4 to determine the assigned protection factor corresponding to Green/No. 1 — APF 10 • Air-purifying (negative-pressure) half-facepiece or Cleanup by dry sweeping R3, G4, C2 = Yellow/No. 2. See Figure 4 to determine the assigned protection factor corresponding to Yellow/No. 2— APF 25. • Powered air-purifying loose-fitting facepiece/visor; • Powered air-purifying helmet/hood without SWPF study; • Airline (continuous-flow) loose-fitting facepiece/visor; or • Airline (continuous-flow) helmet/hood without SWPF study August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 89 Z94.4-11 © Canadian Standards Association K.3 Scenario 3: Tuberculosis exposure A registered nurse (RN) is looking after a patient who has been diagnosed with pulmonary mycobacterium tuberculosis. The patient has a productive cough and is currently in airborne isolation in a negative-pressure room. The RN is changing the patient’s abdominal dressing. Step 1 Identify the bioaerosol. Mycobacterium tuberculosis Step 2 Transmission of disease, infection, or adverse effects produced from inhalation of bioaerosol. Yes, pulmonary mycobacterium tuberculosis Step 3 Select applicable control banding wheel: health care facility or general workplace environment (see Figure 2 or 3) Health care facility — Figure 2 Step 4 Determine the bioaerosol risk group (R1, R2, R3, or R4 in accordance with Clause 7.3.2.3.5) R3: Agents associated with serious or lethal human disease or adverse health effects for which preventive or therapeutic interventions might be available (high individual risk but low community risk) Step 5 Determine the generation rate (G1, G2, G3, or G4 in accordance with Clause 7.3.2.3.6) G3 — Patient coughing or sneezing with mouth uncovered Step 6 Determine the control level (C1, C2, C3, or C4 in accordance with Clause 7.3.2.3.7) C3 — 6–12 ACH (negative-pressure room) Step 7 Identify the number and colour of the segment selected at the intersection of the variables identified in Steps 4 to 6: R3, G3, C3 = Green/No. 1. See Figure 4 to determine the assigned protection factor corresponding to Green/No. 1 — APF 10 • Air-purifying (negative-pressure) half-facepiece 90 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators K.4 Scenario 4: Agriculture — Peat moss packaging Workers packaging peat moss could be exposed to a very high concentration of non-infectious bioaerosols (mould spores). Step 1 Identify the bioaerosol. Non-infectious bioaerosols — mould spores Step 2 Transmission of disease, infection, or adverse effects produced from inhalation of bioaerosol. Yes, hypersensitivity pneumonitis Step 3 Select applicable control banding wheel: health care facility or general workplace environment (see Figure 2 or 3) General workplace environment — Figure 3 Step 4 Determine the bioaerosol risk group (R1, R2, R3, or R4 in accordance with Clause 7.3.2.3.5) R2: Bacterial agents: mycobacterium xenopi and mycobacterium fortuitum R2: Fungal agent: sporothrix schenckii Step 5 Determine the generation rate (G1, G2, G3, or G4 in accordance with Clause 7.3.2.3.6) G4 — Very high release of bioaerosol/pathogen Step 6 Determine the control level (C1, C2, C3, or C4 in accordance with Clause 7.3.2.3.7) C1 — Indoor — Poorly ventilated ACH 1 Step 7 Identify the number and colour of the segment selected at the intersection of the variables identified in Steps 4 to 6: R2, G4, C1 = Orange/No. 3. See Figure 4 to determine the assigned protection factor corresponding to Orange/No. 3 — APF 50 • Air-purifying (negative-pressure) full-facepiece; • Powered air-purifying half-facepiece; • Airline (pressure-demand) half-facepiece; or • Airline (continuous-flow) half-facepiece References Duchaine, C. et. al. (2004). Santé respiratoire des travailleurs et qualité de l’air des tourbières du Québec possédant des systèmes de dépoussiérage. Études et recherches, Rapport R-363, IRSST. Lavoie J., Cloutier, Y., Lara, J., Marchand, G., (2007). Guide on Respiratory Protection against Bioaerosols. Recommendations on its Selection and Use. Studies and Research projects, technical guide R-501, IRSST. IICRC (Institute of Inspection, Cleaning and Restoration Certification) S520, Standard and Reference Guide for Professional Mold Remediation, 2003. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 91 Z94.4-11 © Canadian Standards Association Annex L (informative) Classification of biohazardous agents by risk group Note: This Annex is not a mandatory part of this Standard. L.1 Additional references The following references are provided to assist a qualified person in selecting an appropriate risk group classification for bioaerosols. Centers for Disease Control and Prevention. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf Health Canada. “Infection Control Guidelines: Prevention and Control of Occupational Infections in Health Care.” Canada Communicable Disease Report. Volume 28S1, March 2002. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/ Health Canada. “Infection Control Guidelines: Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Health Care: Revision of Isolation and Precaution Techniques.” Canada Communicable Disease Report, Volume 25S4, July 1999. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/ Table 6, Transmission characteristics and empiric precautions by clinical presentation: Recommendations for acute care centres Table 7, Transmission characteristics and empiric precautions by specific etiology: Recommendations for acute care centres IRSST (Institut de recherche Robert-Sauvé en santé et en sécurité du travail) documents http://www.irsst.qc.ca/en/find-a-publication.html Pathogen Safety Data Sheets (PSDSs) (previously titled Material Safety Data Sheets for infectious substances) http://www.phac-aspc.gc.ca/msds-ftss/index-eng.php Provincial Infectious Diseases Advisory Committee (PIDAC). Routine Practices And Additional Precautions In All Health Care Settings, Appendix N: Clinical Syndromes and Conditions with Level of Precautions Required. Ministry of Health and Long-Term Care, Ontario. August 2009; revised May 2010. http://www.health.gov.on.ca/english/providers/program/infectious/diseases/best_prac/bp_routine.pdf Public Health Agency of Canada. Laboratory biosafety guidelines, 3rd edition, 2004. http://www.phac-aspc.gc.ca/publicat/lbg-ldmbl-04/index-eng.php Public Health Agency of Canada. 2010 Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Health Care (at press). Note: See also Annex N of this Standard for additional guidance on respirator selection in health care environments. 92 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators L.2 Risk group classification For the purpose of classifying bioaerosols into risk groups in Clause 7.3.2.3.5, this Standard has adapted the risk group classifications BI to BIV of the NIH Guidelines for Research Involving Recombinant DNA Molecules, Appendix B, “Classification of Human Etiological Agents on the Basis of Hazard”. An excerpt from this Appendix is reproduced below. Note: Appendix B of the NIH Guidelines clarifies and augments the current biosafety guidance for research with potentially pandemic influenza viruses and harmonizes with the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (5th edition) and other regulatory policies in the United States. Users of CSA Z94.4 can view the NIH Guidelines at http://oba.od.nih.gov/rdna/nih_guidelines_oba.html The list given in the Appendix is extensive and includes many pathogens that are not known to be transmitted by inhalation. The mode of transmission should always be determined by a qualified person. Excerpt from NIH Guidelines for Research Involving Recombinant DNA Molecules, Appendix B Risk Group 1 (RG1) Agents RG1 agents are not associated with disease in healthy adult humans. Examples of RG1 agents include asporogenic Bacillus subtilis or Bacillus licheniformis (see Bacillus subtilis or Bacillus licheniformis Host-Vector Systems, Exceptions); adeno- associated virus (AAV) types 1 through 4; and recombinant AAV constructs, in which the transgene does not encode either a potentially tumorigenic gene product or a toxin molecule and are produced in the absence of a helper virus. A strain of Escherichia coli (see Escherichia coli K-12 Host Vector Systems, Exceptions) is an RG1 agent if it (1) does not possess a complete lipopolysaccharide (i.e., lacks the O antigen); and (2) does not carry any active virulence factor (e.g., toxins) or colonization factors and does not carry any genes encoding these factors. Those agents not listed in Risk Groups (RGs) 2, 3 and 4 are not automatically or implicitly classified in RG1; a risk assessment must be conducted based on the known and potential properties of the agents and their relationship to agents that are listed. Risk Group 2 (RG2) Agents RG2 agents are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. Risk Group 2 (RG2) — Bacterial Agents Including Chlamydia Acinetobacter baumannii (formerly Acinetobacter calcoaceticus) Actinobacillus Actinomyces pyogenes (formerly Corynebacterium pyogenes) Aeromonas hydrophila Amycolata autotrophica Archanobacterium haemolyticum (formerly Corynebacterium haemolyticum) Arizona hinshawii — all serotypes Bacillus anthracis Bartonella henselae, B. quintana, B. vinsonii Bordetella including B. pertussis Borrelia recurrentis, B. burgdorferi Burkholderia (formerly Pseudomonas species) except those listed in Appendix B-III-A (RG3)) Campylobacter coli, C. fetus, C. jejuni Chlamydia psittaci, C. trachomatis, C. pneumoniae Clostridium botulinum, Cl. chauvoei, Cl. haemolyticum, Cl. histolyticum, Cl. novyi, Cl. septicum, Cl. tetani Corynebacterium diphtheriae, C. pseudotuberculosis, C. renale Dermatophilus congolensis Edwardsiella tarda Erysipelothrix rhusiopathiae August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 93 Z94.4-11 © Canadian Standards Association Escherichia coli — all enteropathogenic, enterotoxigenic, enteroinvasive and strains bearing K1 antigen, including E. coli O157:H7 Haemophilus ducreyi, H. influenzae Helicobacter pylori Klebsiella — all species except K. oxytoca (RG1) Legionella including L. pneumophila Leptospira interrogans — all serotypes Listeria Moraxella Mycobacterium (except those listed in RG3) including M. avium complex, M. asiaticum, M. bovis BCG vaccine strain, M. chelonei, M. fortuitum, M. kansasii, M. leprae, M. malmoense, M. marinum, M. paratuberculosis, M. scrofulaceum, M. simiae, M. szulgai, M. ulcerans, M. xenopi Mycoplasma, except M. mycoides and M. agalactiae which are restricted animal pathogens Neisseria gonorrhoeae, N. meningitidis Nocardia asteroides, N. brasiliensis, N. otitidiscaviarum, N. transvalensis Rhodococcus equi Salmonella including S. arizonae, S. cholerasuis, S. enteritidis, S. gallinarum-pullorum, S. meleagridis, S. paratyphi, A, B, C, S. typhi, S. typhimurium Shigella including S. boydii, S. dysenteriae, type 1, S. flexneri, S. sonnei Sphaerophorus necrophorus Staphylococcus aureus Streptobacillus moniliformis Streptococcus including S. pneumoniae, S. pyogenes Treponema pallidum, T. carateum Vibrio cholerae, V. parahemolyticus, V. vulnificus Yersinia enterocolitica Risk Group 2 (RG2) — Fungal Agents Blastomyces dermatitidis Cladosporium bantianum, C. (Xylohypha) trichoides Cryptococcus neoformans Dactylaria galopava (Ochroconis gallopavum) Epidermophyton Exophiala (Wangiella) dermatitidis Fonsecaea pedrosoi Microsporum Paracoccidioides braziliensis Penicillium marneffei Sporothrix schenckii Trichophyton Risk Group 2 (RG2) — Parasitic Agents Ancylostoma human hookworms including A. duodenale, A. ceylanicum Ascaris including Ascaris lumbricoides suum Babesia including B. divergens, B. microti Brugia filaria worms including B. malayi, B. timori Coccidia Cryptosporidium including C. parvum Cysticercus cellulosae (hydatid cyst, larva of T. solium) Echinococcus including E. granulosis, E. multilocularis, E. vogeli Entamoeba histolytica Enterobius Fasciola including F. gigantica, F. hepatica Giardia including G. lamblia 94 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Heterophyes Hymenolepis including H. diminuta, H. nana Isospora Leishmania including L. braziliensis, L. donovani, L. ethiopia, L. major, L. mexicana, L. peruvania, L. tropica Loa loa filaria worms Microsporidium Naegleria fowleri Necator human hookworms including N. americanus Onchocerca filaria worms including, O. volvulus Plasmodium including simian species, P. cynomologi, P. falciparum, P. malariae, P. ovale, P. vivax Sarcocystis including S. sui hominis Schistosoma including S. haematobium, S. intercalatum, S. japonicum, S. mansoni, S. mekongi Strongyloides including S. stercoralis Taenia solium Toxocara including T. canis Toxoplasma including T. gondii Trichinella spiralis Trypanosoma including T. brucei brucei, T. brucei gambiense, T. brucei rhodesiense, T. cruzi Wuchereria bancrofti filaria worms Risk Group 2 (RG2) — Viruses Adenoviruses, human — all types Alphaviruses (Togaviruses) — Group A Arboviruses Eastern equine encephalomyelitis virus Venezuelan equine encephalomyelitis vaccine strain TC-83 Western equine encephalomyelitis virus Arenaviruses Lymphocytic choriomeningitis virus (non-neurotropic strains) Tacaribe virus complex Other viruses as listed in the reference source (see Footnotes and References of Sections I through IV) Bunyaviruses Bunyamwera virus Rift Valley fever virus vaccine strain MP-12 Other viruses as listed in the reference source (see Footnotes and References of Sections I through IV) Caliciviruses Coronaviruses Flaviviruses (Togaviruses) — Group B Arboviruses Dengue virus serotypes 1, 2, 3, and 4 Yellow fever virus vaccine strain 17D Other viruses as listed in the reference source (see Footnotes and References of Sections I through IV) Hepatitis A, B, C, D, and E viruses Herpesviruses — except Herpesvirus simiae (Monkey B virus) (see Risk Group 4 (RG4) — Viral Agents) Cytomegalovirus Epstein Barr virus Herpes simplex types 1 and 2 Herpes zoster Human herpesvirus types 6 and 7 August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 95 Z94.4-11 © Canadian Standards Association Orthomyxoviruses Influenza viruses types A, B, and C (except those listed in Risk Group 3 (RG3) — Viruses and Prions) Tick-borne orthomyxoviruses Papovaviruses All human papilloma viruses Paramyxoviruses Newcastle disease virus Measles virus Mumps virus Parainfluenza viruses types 1, 2, 3, and 4 Respiratory syncytial virus Parvoviruses Human parvovirus (B19) Picornaviruses Coxsackie viruses types A and B Echoviruses — all types Polioviruses — all types, wild and attenuated Rhinoviruses — all types Poxviruses — all types except Monkeypox virus (see Risk Group 3 (RG3) — Viruses and Prions) and restricted poxviruses including Alastrim, Smallpox, and Whitepox (see Footnotes and References of Sections I through IV) Reoviruses — all types including Coltivirus, human Rotavirus, and Orbivirus (Colorado tick fever virus) Rhabdoviruses Rabies virus — all strains Vesicular stomatitis virus — laboratory adapted strains including VSV-Indiana, San Juan, and Glasgow Togaviruses (see Alphaviruses and Flaviviruses) Rubivirus (rubella) Risk Group 3 (RG3) Agents RG3 agents are associated with serious or lethal human disease for which preventive or therapeutic interventions may be available. Risk Group 3 (RG3) — Bacterial Agents Including Rickettsia Bartonella Brucella including B. abortus, B. canis, B. suis Burkholderia (Pseudomonas) mallei, B. pseudomallei Coxiella burnetii Francisella tularensis Mycobacterium bovis (except BCG strain, see Risk Group 2 (R2) — Bacterial Agents Including Chlamydia), M. tuberculosis Pasteurella multocida type B — “buffalo” and other virulent strains Rickettsia akari, R. australis, R. canada, R. conorii, R. prowazekii, R. rickettsii, R, siberica, R. tsutsugamushi, R. typhi (R. mooseri) Yersinia pestis Risk Group 3 (RG3) — Fungal Agents Coccidioides immitis (sporulating cultures; contaminated soil) Histoplasma capsulatum, H. capsulatum var.. duboisii Risk Group 3 (RG3) — Parasitic Agents None 96 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Risk Group 3 (RG3) — Viruses and Prions Alphaviruses (Togaviruses) — Group A Arboviruses Semliki Forest virus St. Louis encephalitis virus Venezuelan equine encephalomyelitis virus (except the vaccine strain TC-83, see RG2) Other viruses as listed in the reference source (see Footnotes and References of Sections I through IV) Arenaviruses Flexal Lymphocytic choriomeningitis virus (LCM) (neurotropic strains) Bunyaviruses Hantaviruses including Hantaan virus Rift Valley fever virus Flaviviruses (Togaviruses) -— Group B Arboviruses Japanese encephalitis virus Yellow fever virus Other viruses as listed in the reference source (see Footnotes and References of Sections I through IV) Orthomyxoviruses Influenza viruses 1918–1919 H1N1 (1918 H1N1), human H2N2 (1957–1968), and highly pathogenic avian influenza H5N1 strains within the Goose/Guangdong/96-like H5 lineage (HPAI H5N1). Poxviruses Monkeypox virus Prions Transmissible spongioform encephalopathies (TME) agents (Creutzfeldt-Jacob disease and kuru agents) (see Footnotes and References of Sections I through IV, for containment instruction) Retroviruses Human immunodeficiency virus (HIV) types 1 and 2 Human T cell lymphotropic virus (HTLV) types 1 and 2 Simian immunodeficiency virus (SIV) Rhabdoviruses Vesicular stomatitis virus Risk Group 4 (RG4) Agents RG4 agents are likely to cause serious or lethal human disease for which preventive or therapeutic interventions are not usually available. Risk Group 4 (RG4) — Bacterial Agents None Risk Group 4 (RG4) — Fungal Agents None Risk Group 4 (RG4) — Parasitic Agents None Risk Group 4 (RG4) — Viral Agents Arenaviruses Guanarito virus Lassa virus August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 97 Z94.4-11 © Canadian Standards Association Junin virus Machupo virus Sabia Bunyaviruses (Nairovirus) Crimean-Congo hemorrhagic fever virus Filoviruses Ebola virus Marburg virus Flaviruses (Togaviruses) — Group B Arboviruses Tick-borne encephalitis virus complex including Absetterov, Central European encephalitis, Hanzalova, Hypr, Kumlinge, Kyasanur Forest disease, Omsk hemorrhagic fever, and Russian spring-summer encephalitis viruses Herpesviruses (alpha) Herpesvirus simiae (Herpes B or Monkey B virus) Paramyxoviruses Equine morbillivirus Hemorrhagic fever agents and viruses as yet undefined 98 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Annex M (informative) Illustrations of acceptable and unacceptable facial hair for tight-fitting respirators Notes: (1) This Annex is not a mandatory part of this Standard. (2) This Annex is to be used in conjunction with Clause 9.2.2 and 10. (3) The examples provided in this Annex are illustrations of the application of the criteria specified in the Standard. These examples are limited, not comprehensive, and are provided only as guidance for program administrators, fit testers, supervisors, and users. Variations not illustrated in this Annex do not necessarily meet the criteria for acceptable facial hair. (4) Acceptable facial hair for respirator fit testing and use does not interfere with (a) the respirator sealing surface; or (b) valve or respirator function. Acceptable August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 99 Z94.4-11 © Canadian Standards Association Unacceptable Note: Adapted with permission from Brookhaven Lab. 100 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 © Canadian Standards Association Selection, use, and care of respirators Annex N (informative) Additional guidance for qualified persons on respirator selection in health care environments Notes: (1) This Annex is not a mandatory part of this Standard. (2) This Annex is adapted from the Public Health Agency of Canada’s draft 2010 Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Health Care. N.1 General This Annex provides additional guidance for qualified persons responsible for determining levels of risk associated with micro-organisms transmitted by the airborne route in health care environments. N.2 Probability of airborne exposure The probability of airborne exposure to a micro-organism contained in a bioaerosol is influenced by several factors: (a) proximity of the infected source (patient) to the host (respirator user); (b) particle sizes containing the infectious agent; (c) viability of the infectious agent; and (d) animate and inanimate environment of a room. N.3 Conditions for airborne transmission The following conditions must be present for airborne transmission of infection to occur: (a) Micro-organisms contained in the particles must be capable of remaining viable in the air for a prolonged period of time. (b) There must be a susceptible host. (c) The susceptible host must be exposed to a sufficient concentration (infectious dose) of the viable micro-organisms. (d) The appropriate cell-surface receptors for the micro-organisms are present at the site of exposure. N.4 Additional routes of transmission When micro-organisms have additional routes of transmission or a patient is infected with more than one type of micro-organism with multiple routes of transmission, the qualified person takes all routes of transmission into consideration during the risk assessment stage. If there is also a risk of acquiring the disease by the contact route, the qualified person considers the risk to the user of self-inoculation from contaminated personal protective equipment and to anyone else who might come into contact with that equipment. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. 101 Z94.4-11 © Canadian Standards Association N.5 Micro-organisms known to be transmitted from human to human by the airborne route Susceptible workers should use a respirator when caring for a patient, resident, or client with a suspected or confirmed infection caused by any of the following micro-organisms until the patient or environment is deemed no longer to be infectious: (a) rubeola (measles virus); (b) monkeypox; (c) respiratory (pulmonary, laryngeal, pleural) Mycobacterium tuberculosis (also M. africanum, M. bovis). A respirator is also recommended while performing aerosol-generating medical procedures on non-pulmonary lesions infected with Mycobacterium tuberculosis (also M. bovis, M. africanum); (d) variola virus (smallpox); (e) vaccinia; (f) varicella zoster virus (varicella/chickenpox); and (g) varicella zoster virus (disseminated herpes zoster/shingles). N.6 Aerosol-generating medical procedures with possible airborne transmission from human to human The following diseases can be transmitted from human to human by the airborne route during aerosol-generating medical procedures (e.g., intubation, bronchoscopy): (a) coronavirus in severe acute respiratory syndrome (SARS CoV); and (b) emerging respiratory infections. N.7 Aerosol-generating medical procedures where it is theoretically possible to have human-to-human airborne transmission Viral hemorrhagic fevers due to Lassa, Crimean-Congo, Ebola, and Marburg viruses could theoretically be transmitted from human to human by the airborne route during aerosol-generating medical procedures. 102 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. August 2011 Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited. R ISBN 978-1-55491-684-9 DA I MP IM E D I N CA DA PRI TE NA N The Canadian Standards Association (CSA) prints its publications on Rolland Enviro100, which contains 100% recycled post-consumer fibre, is EcoLogo and Processed Chlorine Free certified, and was manufactured using biogas energy. A AU CAN 100% Licensed for Alison Reineke, University of Manitoba, Sold by CSA on 6/08/2012. ~Single user license only. Storage, distribution or use on network prohibited.
© Copyright 2026 Paperzz